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Summary 
Age-related macular degeneration (AMD) is predicted to affect 196 million people by 
2020 (Wong et al. 2014). To date there is no clear pathogenesis for the condition 
however, hypoxia has been implicated (Stefánsson et al. 2011).  Currently, treatment 
is only available for neovascular AMD. To develop treatments targeted for early AMD 
a better understanding of the pathogenesis is required. There is also a need for 
sensitive functional biomarkers to improve diagnosis and monitoring and to expedite 
the evaluation of therauptics in clinical trials. 
The aim of this research was to investigate the hypothesis that hypoxia is involved in 
the pathogenesis of early AMD. Studies were carried out exploring the effect of 
transient systemic hypoxia (14% oxygen) and hyperoxia (60% oxygen) on scotopic 
thresholds and electroretinograms (ERGs) of participants with early AMD. It was 
hypothesised that the visual function of participants with AMD, but not age-matched 
controls, would improve during the hyperoxic episode and that hypoxia would have a 
greater detrimental effect on visual function in people with early AMD. 
There were no significant differences in scotopic thresholds within each group when 
breathing 60% or 14% oxygen compared to medical air (21% oxygen). There were also 
no significant differences in full-field ERG parameters between gas conditions or 
groups, apart from the amplitude of the b-wave which was significantly reduced under 
hypoxia in the control group. The amplitude of the focal flicker ERG was significantly 
higher in the control group than the AMD group when breathing both 14% and 21% 
 
ii 
oxygen. However, there were no significant differences in the parameters of the focal 
ERG within each group.  
These findings suggest that hypoxia is not responsible for the elevation of scotopic 
thresholds reported in AMD. There is also no evidence that ERG changes are 
attributable to hypoxia. This thesis provides no evidence to support the role of 
hypoxia in the pathogenesis of early AMD. 
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1 
1 Introduction 
1.1  General introduction 
Age-related macular degeneration (AMD) is a disease characterised by progressive central 
vision loss due to outer retinal degeneration in the macula. It is the leading cause of 
blindness among white populations in the USA in persons over the age of 40 (Congdon et 
al. 2004) and is predicted to affect 196 million people globally by 2020 (Wong et al. 2014). 
There are currently treatments available for one form of the late stage of AMD 
(neovascular AMD), but there are no treatments targeted at the early stage of the 
condition, or the other late stage (geographic atrophy). Treatments targeted at early age-
related macular degeneration (early AMD) are appealing due to the preservation of many 
aspects of visual function at this stage. However, for these to be developed, a greater 
understanding of the pathogenesis of early AMD is required and functional biomarkers 
for the condition are necessary for clinical trials and for diagnosing and monitoring the 
condition. 
Age-related macular degeneration is a multifactorial condition and hypoxia has been 
implicated in the early pathogenesis (Feigl 2009; Stefánsson et al. 2011). This thesis 
primarily aims to investigate the hypothesis that hypoxia is involved in the pathogenesis 
of early AMD and whether aspects of scotopic visual function can be used as functional 
biomarkers of hypoxia in early AMD. 
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Chapter one will provide an overview of the healthy retina, tissue oxygenation, hypoxia 
and AMD. Chapters two and three provide systematic reviews of literature exploring the 
effect of hypoxia on visual function and the role of hypoxia in the pathogenesis of AMD. 
Chapters four to seven are experimental chapters describing the effect of hyperoxia and 
hypoxia on scotopic visual function and Chapter 8 concludes the thesis by providing a 
general discussion and plans for future work. 
1.2 Morphology and function of the retina and blood supply 
This section will provide an overview of the healthy retina and a description of each 
retinal layer. The later sections will concentrate on the macula and the retinal blood 
supply. 
1.2.1 General retinal structure 
The retina is a highly specialised multifunctional tissue consisting of nine layers lying 
between the vitreous and the choroid of the posterior eye (Klob 2012). During 
phototransduction, the photoreceptors collect photons of light energy and transform 
them into electrical impulses to be interpreted by the visual cortex. Although each layer is 
specialised to perform a specific function, each is also intricately linked to and dependent 
on the others. Therefore successful retinal function is dependent on a normal physiology 
of all the layers. Figure 1-1 shows the retinal layers in more detail. 
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Figure 1-1 Diagram of the structure of the retina (Purves et al. 2001). 
 The following section will consider the retinal layers and associated structures in more 
detail, starting from Bruch’s membrane and progressing to the inner layers. 
1.2.2 Bruch’s membrane 
Situated between the choroid and the retinal pigment epithelium (RPE), Bruch’s 
membrane is a 2-4 μm thick (Bhutto and Lutty 2012), five-layer structure. Acellular, it is 
rich in collagen and elastin with each layer containing ligands with three primary 
functions: to regulate the diffusion of molecules including nutrients and waste products 
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between the choroid and RPE, to act as a barrier for cellular migration between the two 
layers and to provide physical support for RPE cell adhesion (Booij et al. 2010). Bruch’s 
membrane are known to be affected by many factors including age (Pauleikhoff et al. 
1990; Hogan et al. 1967) and genetics (Piguet et al. 1993).   
The structure of Bruch’s membrane undergoes the following changes with age: 
 A thickening of 135% in 10 decades (Bhutto et al. 2012).  
 A reduced capacity for macromolecular permeability (Moore and Clover 2001), 
altering the metabolic exchange between the RPE and the choroid.   
 An increase in collagen cross-linking which increases strength, but decreases 
elasticity and has a negative effect on permeability (Booij et al. 2010).  
 Calcification which results in brittleness and breaks, facilitating neovascularisation 
(Spraul et al. 1999).  
 The accumulation of advanced glycation end products (AGEs), which could lead to 
reduced lysosomal enzyme degradative capacity resulting in the accumulation of 
lipofuscin and RPE dysfunction (Glenn et al. 2009). 
 The accumulation of lipid which is associated with the destruction of Bruch’s 
membrane architecture and which may lead to photoreceptor dysfunction 
(Pauleikhoff et al. 1990). 
 A decreased RPE adhesion to Bruch’s membrane (Afshari and Fawcett 2009). 
 The development of drusen. These are extracellular deposits formed by Bruch’s 
membrane deposited between it and the RPE.  
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1.2.3 Retinal pigment epithelium. 
Lying adjacent to Bruch’s membrane on the basolateral side and extending apical villi to 
surround photoreceptor outer segments, the RPE is a pigmented, single layer of 
hexagonal cells. It forms a selectively permeable blood retinal barrier between the 
choroidal blood supply and the photoreceptors.  High resistance occluding junctions 
between cells control retinal homeostasis by regulating the transepithelial movement of 
nutrients and waste to and from the photoreceptors. It also supports the photoreceptors 
in their functions in the following ways (see Boulton and Dayhaw-Barker 2001 for review): 
 Phagocytosing the periodically shed discs of the receptors.  
 Aiding in the regeneration of visual pigments. 
 Absorbing scattered light in melanin granules.  
 Storing and transporting retinoids.  
 Synthesising some growth factors and enzymes.  
 Providing a retinal defence against reactive oxygen intermediates (ROIs) though 
the high density of melanin pigment contained within cells.  
 
Photoreceptor survival is intrinsically linked to the RPE functioning correctly. Poor disc 
phagocytosis, altered transepithial transport and changes in the secretion of growth 
factors can all lead to photoreceptor degeneration or proliferative disease (Marneros et 
al. 2005; Lutty et al. 1999; Jackson et al. 2002). The RPE and the photoreceptors can be 
considered together as a functional unit. Evidence to support this includes the synergistic 
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interaction of the tissues in the visual cycle, where the structure of the visual pigment 
retinal is altered by both the RPE and the photoreceptors. Also, the effect of genetic 
abnormalities, for example the photoreceptor gene ABCR leads to RPE degeneration, 
whilst abnormal RPE genes such as RPE65 affect the photoreceptors (Strauss 2005). 
1.2.4 Photoreceptor cells 
The retina contains over 92 million rod and 4.6 million cone photoreceptors (Curcio et al. 
1990) enabling vision across a wide range of wavelengths, light levels and temporal 
frequencies. Cone photoreceptors provide a higher level of spatial and temporal 
resolution and allow colour vision, but are insensitive to low levels of light. Rods on the 
other hand give better sensitivity in low light levels, but poor spatial and temporal 
resolution and provide only monochromatic vision. The information sent to the visual 
cortex from phototransduction depends on the amount of light falling on the 
photoreceptor receptive field, the type of photopigment stimulated and the influence of 
other photoreceptors and contributing interneurons such as amacrine and horizontal 
cells.  
Rods and cones are not present uniformly across the retina; cone density peaks at the 
fovea and decreases rapidly with eccentricity. In the peripheral retina the cone density is 
highest in the nasal region, being 40-45% higher than in the temporal retina (Curcio et al. 
1990). Rods are absent from the fovea and rod density is greatest in an elliptical ring 
around 3-5mm (around 10-15 degrees) from the foveola (Jonas et al. 1992).  
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As seen in Figure 1-2, structurally both rods and cones have outer segments (cone outer 
segments have a shorter, conical structure), cell bodies containing the cell nucleus, inner 
segments containing mitochondria (cone inner segments are around 4 microns larger 
than the rods) and axon terminal which extends into the outer plexiform layer.  
                               
Figure 1-2. Diagram of the rod (left) and cone (right) photoreceptors (Wright et al. 
2010). 
Both rod and cone outer segments contain stacks of double folded disc membranes 
containing the visual pigment. This pigment consists of a protein (opsin) and a 
chromophore (retinal). Rods contain a single visual pigment, rhodopsin, and each cone 
contains one of three different types of pigment, each excited by a specific wavelength of 
light. The spectral sensitivity of S-cones peaks at approximately 440 nm, M-cones at 545 
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nm and L-cones peak at 565 nm. The differential responses of the cone types with their 
overlapping spectral sensitivity curves allows colour discrimination to occur.  
In the dark, photoreceptors are depolarized and metabolically active, resulting in a 
continuous release of the neurotransmittor glutamate. This activity results in the energy 
demands of the rods being the greatest of any cell in the body (Arden et al. 2005). 
Phototransduction takes place in the outer segment of a photoreceptor. It is initiated by 
light, causing the photoisomerization of the chromophore 11-cis-retinal to all-trans-
retinal (Palczewski and Baehr 2005). This triggers hyperpolarisation of the cell, resulting in 
less glutamate being released at the synapse with the bipolar and horizontal cells in the 
outer plexiform layer. After phototransduction has taken place, the photoreceptor cannot 
react to further light until the visual pigment has been regenerated. This regeneration 
process is refered to as the retinoid cycle, which is the recovery of visual pigment to a 
regenerated state. Detailed reviews of these processes can be read in Lamb and Pugh 
(2004) and Lamb and Pugh (2006).  
1.2.5 Bipolar cells  
Bipolar cells transmit information from photoreceptors to the retinal ganglion cells 
(RGCs). Their cell bodies are in the inner nuclear layer, with processes extending into both 
the inner and outer plexiform layers. There have been 11 types of bipolar cell found in the 
human retina, differentiated by their connection to rods (one type) or cones (ten types) 
(Kolb et al. 1992). Cone bipolar cells connect to a single cone, or sum information from 
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only few cones, whereas rod bipolar cells sum information from as many as 40-45 rods in 
the peripheral retina (Kolb et al. 1992). 
Bipolar cells can also be characterised by their response to the signal received from the 
photoreceptors. ON bipolar cells are stimulated by the decrease in glutamate released by 
the photoreceptors at light onset and depolarise, sending a graded potential to nearby 
cells. Whereas OFF bipolar cells are inhibited (hyperpolarise) in response to reduced 
glutamate at light onset and no signal is sent.  
1.2.6 Horizontal cells  
Horizontal cells are involved in the lateral modification of the visual signal. Their cell 
bodies are present in the inner nuclear layer and their dendrites synapse with 
photoreceptors and bipolar cells. Three types of horizontal cell have been discovered 
(Kolb et al. 1992) and their main function is to create the centre surround organisation of 
the bipolar cell receptive field. 
1.2.7 Amacrine cells 
Amacrine cells are interneurons residing in the inner nuclear layer of the retina. They 
synapse with bipolar cells and retinal ganglion cells in the inner plexiform layer, serving to 
modify the retinal signal to the ganglion cells. To date, over 30 different types of amacrine 
cell have been discovered (Kunzevitzky et al. 2010). AII amacrine cells are the most 
common amacrine cell type (Demb and Singer 2012) and are unique as they are not 
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involved in lateral processing but in the vertical flow of information from rods to the inner 
retina. They integrate rod signals into the cone pathway, which is involved in the removal 
of noise and enhancing the rod signals under scotopic conditions.   
1.2.8 Ganglion cells 
Retinal ganglion cells have their cell bodies in the ganglion cell layer, with axons in the 
retinal nerve fibre layer that exit the eye via the optic nerve. In the primate retina 
classification is based on the area of terminal projection, giving three main catagories. 
Magnocellular ganglion cells have large cell bodies and dendritic axons that cover a large 
area up to 270ϻm2 (Kolb et al. 1992). This cellular pathway is stimulated by movement 
but saturates when viewing targets at high contrast, so can only resolve coarse data 
(Derrington and Lennie 1984). Parvocellular cells have smaller dendritic trees and are 
found mainly in the fovea, where they have a 1:1:1 relationship with cone and bipolar 
cells (Kolb and Marshak 2003), resulting in excellent resolution and colour discrimination. 
Around 10% of RGCs are konicellular cells which process information regarding 
blue/yellow colour vision (Yücel et al. 2003). Not all RGCs are concerned with the 
processing of visual information. A ganglion cell type containing melanopsin comprises of 
1-3% of the RGC population (Wässle 2004). These photosensitive ganglion cells have been 
shown to respond directly to light, sending information to the suprachisamic nucleus and 
the pretectum, influencing the circadian rhythm and the adaptation of pupil size to 
luminance (Wässle 2004; Berson 2003).  
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1.2.9 Specialisation of the macula  
 Grading scales consider the macular region to be 6mm in diameter, centred on the fovea 
and corresponding to 20⁰ visual angle (Davis et al. 2005; Bird et al. 1995). The area can be 
further divided into the foveola, fovela, parafoveal and perifovea. Figure 1-3 shows the 
densities of rods, cones and RGCs present in the macular region.  
                   
Figure 1-3. Panel A Regions of the macula; Panel B rod, cone and RGC densities across 
the macula (Provis et al. 2005). 
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 The foveola is located at the centre of the fovea, it is 350µm in diameter and contains 
only cone and Müller cells (Nag and Wadhwa 2012). All retinal cell layers are present in 
the remaining area of the fovea which totals 0.8mm in diameter (Curcio et al. 2000). The 
parafovea, a rod dominated area, is where the retina is at its thickest due to the 
displacement of the foveal RGCs (Provis et al. 2005). The perifovea is at the periphery of 
the parafovea and forms the edge of the macula. Figure 1-4 shows the retinal thickness of 
the macula at different locations and the layers present. 
                    
Figure 1-4. Photomicrographs showing the relative thickness of the adult human retina, 
and its constituent layers, at different locations (Provis et al. 2005). GCL- ganglion cell 
layer. INL- inner nuclear layer. ONL- outer nuclear layer. FH- fibres of Henle. 
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The macula contains the highest levels of macular pigment in the retina. Composed of 
lutein and zeaxanthin, macular pigment absorbs blue light (Pease et al. 1987). Beatty et 
al. (2000) discussed in their comprehensive review that macular pigment may limit 
oxidative damage by filtering blue light. 
1.2.10 The retinal blood supply 
Like all tissues, the retina requires a constant supply of oxygen (O2). In fact, the levels of 
O2 required by the retina have been reported to be higher than those required by the 
brain (Ames et al. 1992). This is due to the photoreceptors having the highest metabolic 
demand of any cell, in particular the rods, each of which requires 108 ATP s-1 in the dark 
(Okawa et al. 2008). With the stimulation of light, cones use more ATP than rods, 
however the retina has adapted to reduce this demand by having overall fewer cones in 
the retina and concentrating them where they are required. Another adaptation to 
facilitate the effective use of O2 by the retina is the depolarization of photoreceptors in 
the dark, this means that in the light, retinal O2 consumption rate actually decreases by 
around 36-68% (Wangsa-Wirawan and Linsenmeier 2003). This is mainly due to the drop 
in ATP required by the rods as the dark current is suppressed, meaning they require less 
than a quarter of the energy they require in the dark (Okawa et al. 2008).  
The retina has a dual blood supply. The inner retinal layers are supplied by the retinal 
blood supply, and the photoreceptor layer is supplied by the choroidal circulation, which 
supplies around 90% of the O2 to photoreceptors in the dark (Wangsa-Wirawan and 
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Linsenmier 2003). The retinal blood supply can be seen clinically as a sparse system that 
extends from the central retinal artery, entering the eye via the optic nerve. It then 
branches into four retinal arteries, which further branch into the superficial and deep 
vascular plexus. 
The choroid is supplied by the ophthalmic artery via the short posterior ciliary arteries 
that supply the posterior choroid, and the long posterior ciliary arteries that supply the 
anterior choroid, iris and ciliary body. They pierce the globe around the optic nerve head, 
branching out to form three layers of the choroidal circulation (Lange and Bainbridge 
2012a). The three vascular layers of the choroidal circulation include the outer Haller's 
layer composed of large blood vessels, the inner Sattler's layer of medium and small 
arteries and arterioles and the choriocapillaris (Nickla and Wallman 2010). The 
choriocapillaris is the capillary component of the choroidal vasculature which is a single, 
continuous layer lying adjacent to Bruch’s membrane (Bhutto et al. 2012). It is thickest at 
the fovea at 10μm, thinning to 7μm in the periphery (Nickla et al. 2010). Venous drainage 
is from the four vortex veins (Hayreh 1990). The location of retinal and choroidal 
circulation can be seen in Figure 1-5. 
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Figure 1-5. Histology and corresponding schematic diagram highlighting the vascular 
supply of the human retina (Lange et al. 2012a). 
The choroidal and retinal blood supplies differ in their blood flow and velocities. The 
retinal supply has a low blood flow but good autoregulation and a high oxygen extraction 
ratio (8ml O2 per 100ml) (Lange et al. 2012a). Its sparse vasculature is advantageous as it 
does not block light (Caprara and Grimm 2012), which would shadow the underlying 
photoreceptors. The choroid has poor autoregulation and a poor oxygen extraction ratio, 
however it is highly vascularised (Caprara et al. 2012) and the blood flow is 20 fold greater 
than the retinal supply (Lange et al. 2012a). 
Despite the fact that the retina seems to be a well vascularised tissue, the O2 supply has 
been found to be barely sufficient under dark-adapted conditions. The oxygen tension at 
the proximal side of the inner segments of the photoreceptors reaches 0mmHg in the 
dark (Wangsa-Wirawan and Linsenmeier 2003), meaning that the O2  supplied is only just 
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sufficient to meet the metabolic needs of the photoreceptors. This can be seen in Figure 
1-6. 
            
Figure 1-6. Schematic of oxygen distribution in the retina of the rat (Caprara et al. 
2012). 
Changes to the ocular blood flow, in particular, a reduction in blood flow which leads to 
hypoxia, has been implicated in a number of conditions including AMD (Ciulla et al. 2002; 
Friedman 1997), glaucoma (Harris et al. 1999; Zhang and Ma 2007) and diabetic 
retinopathy (Pemp and Schmetterer 2008). 
The choroidal blood supply is not uniform throughout the retina and locally there are 
watershed zones within the choriocapillaris. This is because each arteriole behaves as an 
end arteriole with no anastomoses (Hayreh 1990), leaving tissue in this area between 
supplies and susceptible to the effects of a reduced blood supply. There has been a link 
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between watershed zones and neovascular AMD (nAMD) (Feigl 2009; Giovannini et al. 
1994; Mendrinos et al. 2009), with Mendrinos and Pournaras (2009) finding choroidal 
neovascularisation occurring within the watershed zones of 88% of their subjects. There 
are a high number of watershed zones in the macula (Xu et al. 2010; Hayreh 1990) which 
has been found to be affected more by hypoxia then the peripheral retina (Feigl et al. 
2008).  Watershed zones also exist between the two blood supplies, with the inner 
nuclear layer lying between the choroidal and retinal supplies.  
There is a difference between the peripheral and central inner retinal oxygenation, with 
the oxygenation saturation of blood in peripheral arterioles (94.7%) found to be less than 
that of macular vessels (99.7%) (Heitmar and Safeen, 2012). Within the macula itself 
there is also a dissimilarity in blood supply, with the parafovea having a dense inner 
retinal capillary supply and the fovea being an avascular zone, with a choroidal supply 
only (Yu et al. 2010). 
Blood supply does not remain stable though out life, even in the absence of any disease 
there are changes with age. A review by Ehrlich et al. (2009) concluded that choroidal 
blood flow declines with age, possibly due to vascular constriction and vessel drop out. 
For example, Grunwald et al (1993) reported that there was a 20% decrease in velocity 
with age, whilst Grunwald et al (1998) found that foveolar blood flow decreases with age. 
This was linked to the decrease in diameter of the blood vessels and the decrease in 
density that occurs with ageing.  
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1.3 Tissue oxygenation and hypoxia  
This section of the introduction will discuss tissue oxygenation. The importance of 
oxygenation homeostasis and regulation is discussed, along with the consequences of a 
lack of oxygenation, with particular emphasis given to the effects at a retinal level. This is 
significant as this thesis is concerned with the potential role of reduced retinal 
oxygenation in the pathogenesis of AMD. 
To ensure that tissues have a constant supply of oxygen and a means of waste removal, 
aerobic organisms have developed a complex circulation system. This network is so 
extensive that nearly every cell in the body is within 100-200 μm of a capillary (Polverini 
2002). A decrease in blood supply to a tissue leads to ischaemia. Common causes of 
ischaemia include narrowing (stenosis) or blockage of the arteries. This, eventually, will 
lead to hypoxia; an insufficient supply in oxygen to the tissue, leading to cell death as 
adenosine triphosphate (ATP) production is reduced. Hypoxia can also be caused by a 
reduction in oxygen carried in the blood. Peripheral oxygen saturation (SpO2) describes 
the percentage of haemoglobin saturated with O2 at any one time and should be 97-99% 
in a healthy individual. A decrease in SpO2  can be the result of reduced pulmonary 
efficiency or when breathing air at high altitudes. At high altitudes the oxygen saturation 
of the air is reduced, for example, from 20.9% at sea level to 11.3% at 16000 ft (the height 
of Montblanc).  
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The development of the vascular network results from vasculogensis, with vessels 
forming from the aggregation and differentiation of endothelial precursor cells 
(angioblasts) (Zhang et al. 2007). This network is then expanded by angiogenesis; the 
growth of new blood vessels from existing ones. Both of these processes also occur 
postnatally via chemical regulation during reproduction and physiological wound healing, 
where the growth takes place over a short time span. However, new vessels can also 
grow pathologically, where the process can remain in place for months or years (Polverini 
2002). Angiogenesis has been implicated in many systemic conditions including 
inflammatory conditions such as Crohn’s disease, arthritis and psoriasis (Polverini 2002). 
New blood vessels formed during angiogenesis have an abnormal structure, lacking a 
basement membrane and pericytes (Zhang et al. 2007), therefore they are fragile and 
predisposed to leaking and haemorrhage.  
Chemical upregulation leading to angiogenesis has been found to be stimulated by 
hypoxia (Yue and Tomanek 1999), and inflammation (Wagner et al. 2008). Many 
chemicals have been found to be involved in angiogenesis, and in healthy tissue there is a 
balance between growth factors (e.g. vascular endothelial growth factor (VEGF), 
angiopoietins and basic fibroblast growth factor) and growth inhibitors (e.g. pigment 
epithelium-derived factor (PEDF) and thrombospondin-1 (TSP-1)). It is the imbalance of 
these factors that leads to the growth of new vessels. These vascular growth regulators 
will be discussed in more detail in section 1.3.1 .  
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The regulation of O2 is extremely important to the structural and functional integrity of 
healthy tissue. Both hypoxia and hyperoxia can lead to cell death, with hyperoxia leading 
to the creation of reactive oxygen intermediates (ROIs) and oxygen toxicity (Semenza 
1999). Systemically there are oxygen-sensing mechanisms that detect changes in supply 
and, in the case of reduced O2, start the process for metabolic adaptation or to restore 
the supply. This can be acheved by increasing the efficiency of energy producing 
pathways at a cellular level by switching to glycolysis (Michiels 2004) and promoting of 
the utilisation of glucose (Kaur et al. 2008; Michiels 2004) or by modifying the existing 
supply. For example vessel dilation (Lange et al. 2012a) and enabling the growth of new 
vessels from the surrounding vasculature (a form of angiogenesis referred to as 
neovascularisation).  
Oxygen sensing pathways are controlled by molecular regulators, such as hypoxia-
inducible-factor transcription factors (HIFs), and intracellular organelles, for example 
mitochondria (Giaccia et al. 2004). Hypoxia-inducible-factors consist of a hetero-dimer (a 
protein composed of two polypeptide chains differing in composition) with α and β 
subunits, and are a key transcriptional regulator involved in the process of restoring 
oxygen homeostasis. Although these pathways are crucial, they themselves can also have 
detrimental effects. The molecular regulators for example, play a role in the development 
of tumours by facilitating the adaptation of tumour cells to hypoxic conditions, enabling 
angiogenesis. Hypoxia-inducible-factor-1α has been found to be over expressed in the 
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majority of breast and colon cancer metastases (Semenza 1999). Hypoxia-inducible-
factors will be discussed in more detail in section 1.3.1 
Hypoxia also has effects at a retinal level. It can stimulate physiological processes such as 
retinal vessel growth in ocular development (Kim et al. 2012), but is also linked to the 
aetiology of retinal pathology including AMD (Feigl 2009) and diabetic retinopathy 
(Caprara et al. 2012). In these conditions a lack of oxygen due to changes in the existing 
vasculature leads to neovascularisation. These vessels are unstable and unregulated as 
demonstrated by the increased choroidal blood flow seen with changes in ocular 
perfusion pressure in eyes with nAMD, but not in healthy controls (Pournaras et al. 2006). 
This is thought to be due to the new vessels in the neovascular membrane being unable 
to increase their flow resistance.  
The following section provides a detailed description of the physiological molecular 
mechanisms that regulate tissue oxygenation. 
1.3.1 Molecular response to hypoxia 
Hypoxia-inducible-factors regulate the expression of hundreds of genes, either directly or 
indirectly concerned with biochemical events. This includes the instigation of 
angiogenesis by up regulating VEGF (Ratcliffe 2007), and stimulating the transcription of 
erythropoietin, which is a regulator of red blood cell production (Michiels 2004). It also 
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plays an important role in the developing retinal vasculature (Sheridan et al. 2009; 
Semenza 1999). 
There are 3 isoforms of HIF α subunits, with HIF-1α and HIF-2α being closely related, 
sharing 48% of amino acid sequencing (Ke and Costa 2006) and HIF-3α having a more 
distant relationship (Ratcliffe 2007). Little information is currently available on HIF-3α, but 
HIF-1α and HIF-2α have been researched extensively. Both HIF-1α and HIF-2α function to 
overcome the cellular effects of hypoxia, however whereas HIF-1α is expressed 
systemically, HIF-2α is mainly expressed in the lung (Ema et al. 1997). Although there is 
evidence to suggest that both HIF-1α and HIF-2α are involved in regulation of 
erythropoietin (Ratcliffe 2007) and VEGF (Lange et al. 2012b), HIF-1 α  is the primary 
factor mediating the hypoxia response. HIF-1α is constantly being produced and degraded 
during normoxia, having a short half-life of 5-8 mins (Berra et al. 2001). Although it is 
expressed in all cells, its activation results in different responses, due to the differing cell 
types, other cell signals taking place, or the duration of the hypoxia (Semenza 1999). 
Degradation occurs via the ubiquitin/proteasome pathway, due to interaction with the 
von Hippel-Lindau (VHL) protein, this process is shown in Figure 1-7. Under hypoxic 
conditions however, this degradation does not occur and the protein concentration of 
HIF-1α increases with lowering O2 concentrations (Yu et al. 1998; Semenza 2000). When 
this occurs HIF-1α relocates to the nucleus, where the α unit can dimerize with the β unit, 
activating HIF. There has also been some recent evidence to suggest that HIF -1α is 
continuously expressed and active in the retina, and not degraded, suggesting an ocular 
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neuroprotective role, which is independent of a hypoxic environment (Hughes et al. 
2010).  
 
Figure 1-7. HIF activity under hypoxic and normoxic conditions (Ratcliffe 2007). 
Ferrara and Henzel (1989) reported the discovery of a potent growth factor which was 
selective for vascular endothelial cells, which they named VEGF. This growth factor we 
now know as one of the key angiogenic growth factors with important physiological and 
pathological roles (Marneros et al. 2005; Alon et al. 1995; Nishijima et al. 2007). These 
include roles in cell migration, cell proliferation, vascular permeability and cell apoptosis 
(Penn et al. 2008). The VEGF family includes five isoforms of VEGF, (due to alternative 
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exon splicing and differing heparin and heparan-sulfate binding ability), placenta growth 
factor and snake venom VEGF. Although all VEGF isoforms are involved in tissue growth it 
is VEGF-A, of which there are nine subtypes, which has the greatest influence during 
neovascularisation. Of these subtypes VEGF 121 and VEGF 165 are the predominate 
forms (Neufeld et al. 1999). The regulation of VEGF gene expression is mediated by HIF 
and stimulated by hypoxia, UV and H2O2 (Grisanti and Tatar 2008). There are also other 
pathways of expression, with inflammatory cytokines, other growth factors and 
hormones all able to upregulate VEGF (Ferrara 2004). 
These other pathways indicate that there is localised control over growth factor 
regulation, and suggest a role for inflammation in neovascularisation. This link to 
inflammation is an important one as inflammation has been associated with the 
development of choroidal neovascular membranes (CNV) in AMD (Campa et al. 2010). 
The complement cascade (part of the innate immune system) and its final membrane 
attack complex (MAC) have been associated with an increase in growth factors including 
VEGF and neovascularisation (Bora et al. 2005). Also the depletion of complement 
component 3 and MAC have been found to lead to a reduction in VEGF and the inhibition 
of CNV (Bora et al. 2006; Bora et al. 2005). Several inflammatory markers such as 
metalloproteinases and macrophages have also been associated with neovascularisation 
(Buschini et al. 2011; Bressler 2009). Metalloproteinases are secreted by the RPE and can 
increase the bioavailability of VEGF (Tatar et al. 2007).  
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Vascular endothelial growth factor has also been found to be a direct neuroprotectant 
against ischaemic damage, independent of an increased blood supply, both in the brain 
after ischaemic injury (Sun et al. 2003) and in the retina (Nishijima et al. 2007). Vascular 
Endothelial Growth Factor-A promoted the survival of neurones in the absence of an 
increase in blood flow in rats where transient ischaemic episodes had been created in the 
eye (Nishijima et al. 2007). The authors concluded that RGC viability was directly linked to 
VEGF, when it was depleted in the retina they found a dose dependant decrease in RGC 
numbers. This evidence of an important physiological role for VEGF in the healthy eye has 
obvious implications for the current treatment for nAMD that inhibits VEGF expression.  
1.3.2 The intraretinal effect of hypoxia 
With the blood supply, metabolic demand and structure of each retinal layer differing, 
the susceptibility to and effect of hypoxia is different throughout the retina.  
The photoreceptor layer is highly susceptible to hypoxia due to its reliance on the 
choroid, which has poor autoregulation. Under normal conditions, an adequate supply of 
O2 can be maintained. However, there are factors which can either increase the 
metabolic demand of the photoreceptors or decrease either the choroidal blood supply 
or oxygen saturation of the blood, leading to hypoxia. Some of these can be encountered 
on a regular basis such as changes in altitude (Arjamaa et al. 2009), with altitudes above 
3000m causing chronic hypoxia (Feigl 2009), whilst flying in an aircraft can result in a 
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hypoxic environment due to reduced cabin pressures (Connolly and Hosking 2006; Feigl et 
al. 2008). 
The inner retinal supply is able to increase blood flow to meet extra demand, with 
Brinchmann-Hansen et al. (1989) finding that human retinal arteries dilated by 9.4% in 
response to acute hypoxia. However, the choroidal response to changes in O2 is poor 
(Wangsa-Wirawan and Linsenmeier, 2003; Lange et al. 2012a), although there is some 
capability to autoregulate (Polska et al. 2007; Luksch 2003). Polska et al (2007) found that 
a change in perfusion pressure led to changes in choroidal blood flow, which Luksch 
(2003) concluded was regulated by nitric oxide.  
The bipolar cells and the inner nuclear layer may also be affected by hypoxia. These cells 
are metabolically active, containing large numbers of mitochondria, and therefore have a 
high oxygen demand (Caprara et al. 2012). The post receptoral hypothesis for AMD onset 
suggests that the cells located in the inner nuclear layer are affected by hypoxia due to 
this area being located in the watershed zone between the retinal and choroidal blood 
supplies. It has been suggested that this area is affected first by early AMD (Feigl 2007; 
Feigl 2009). Inner retinal cells, including RGCs can also be affected by a reduction in the 
inner retinal blood supply. For example, a reduced inner retinal circulation, and disruption 
to the auto regulation of the retinal supply have been implicated in glaucoma (He et al. 
2011; Flammer et al. 2002).  
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1.4  Age-related macular degeneration  
Age related macular degeneration is a progressive, degenerative disorder of the macula 
causing an exaggeration of the normal ageing process. Early AMD leads to two different 
advanced subtypes, nAMD and geographic atrophy (GA). Loss of vision tends to be more 
rapid in nAMD, but both subtypes eventually cause a loss of central vision.  This chapter 
aims to provide the reader with a overview of the current understanding of AMD, 
including its grading, pathogenesis, effect on visual function, investigation techniques, 
and current treatments.  
1.4.1 Prevalence  
Age-related macular degeneration is the most common cause of legal blindness in 
developed countries (Roth et al. 2004; Seddon and Chen 2004), with 25-30 million people 
being affected worldwide (Schmiert al. 2006). This prevalence is set to increase along with 
the ageing population, to around 679,000 to 755,867 cases of late stage AMD by 2020 in 
the UK alone (Owen et al. 2012; Minassian et al. 2011). Age-related macular degeneration 
has personal consequences for individuals, being linked to falls (Cruess et al. 2008) and to 
an increased risk of depression (Casten et al. 2004; Berman and Brodaty 2006; 
Siaudvytyte et al. 2012). Brody et al. (2001) found that 32.5% of 151 people with AMD 
had a depressive disorder, a proportion comparable with life threatening conditions 
including cancer and cerebrovascular disease.  People with AMD, even with mild vision 
loss (VA <6/12), have also been found to struggle with daily activities, including reading 
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and recognising faces (Hassell et al. 2006). There is also a wider socioeconomic effect, 
with the average annual societal cost (including direct vision related medical costs, direct 
non- vision- related costs and non-medical- related costs) per patient treated for bilateral 
nAMD estimated at €5300 in the United Kingdom (Cruess et al. 2008).   
1.4.2 Clinical features 
1.4.2.1 Early age-related macular degeneration 
Under the International Classification and Grading System early AMD (also known as Age-
Related Maculopathy or ARM) is commonly seen in patients over the age of 50 years (Bird 
et al. 1995). It is defined by the Beckman Initiative for Macular Research Classification 
Committee as the presence of medium drusen (>63 µm but ≤125 µm) without AMD 
pigmentary abnormalities (focal hyper or hypopigmentation) (Ferris et al. 2013). 
Drusen are the most common manifestation of early AMD. They are deposits between 
the RPE and the inner collagenous zone of Bruch’s membrane and are classified by their 
location, size and appearance (Booij et al. 2010). Hard drusen are small [less than 63ϻm 
(Ferris et al. 2013)],  well defined, discrete yellow deposits and in themselves are not a 
risk factor for AMD (Bird et al. 1995). However they are associated, along with soft 
drusen, with local photoreceptor changes, as even small drusen can cause structural 
disruption. Also a large number of hard drusen are a risk factor the development of soft 
drusen and pigmentary abnormalities (Klein et al. 2002).  As the drusen size increases, 
changes, such as photoreceptor displacement and an altered RPE eventually lead to 
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photoreceptor abnormalities (Johnson 2003). Clinically, soft drusen are paler than hard 
drusen, larger in size and have a sloping border with indistinct edges (see Figure 1-8). 
They constitute a risk factor for advanced AMD (Klein et al. 1997; Feigl 2007), with the 
risk of advanced AMD increasing with the size and confluence of soft drusen (Bird et al. 
1995; Ferris et al. 2005).   
                                                      
Figure 1-8 Retinal photograph of soft drusen. Black arrow shows drusen >63µm, green 
arrow shows drusen >125µm and white arrow shows drusen >250µm. (Miller 2013). 
The theory of drusen formation, despite many studies, is still inconclusive, but the 
contents of drusen point towards inflammatory processes and oxidative stress (Booij et 
al. 2010). Although still unproven, the link to inflammatory and immune mediated 
responses comes from the presence of cells in drusen linked to immune processes. These 
include macrophages and fibroblasts (Booij et al. 2010) and cells linked to the acute phase 
of inflammation including amyloid P components and complement proteins (c5a) 
(Hageman et al. 2001; Rodrigues 2007). It is thought that the accumulation of these 
chemokines and cytokines initiates an inflammatory response which leads to a 
degenerative effect on RPE cells and adjacent photoreceptors, stimulating AMD 
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progression (Rodrigues 2007). This theory is reinforced by a genetic link between AMD 
and genes from the complement system such as complement factor H (Hageman et al. 
2005). Many molecular components of drusen such as lipids and carbohydrates are 
thought to be phagocytosed waste material from shed photoreceptor outer segment 
discs (Grisanti et al. 2008). Booij (2010) found that drusen also contain proteins from the 
choroidal cells. 
First described by Mimoun at al. (1990), reticular pseudodrusen (RPD) are  collections of 
granular material situated in subretinal space between the RPE and the boundary of the 
inner and outer segments of the photoreceptors (Zweifel et al. 2010b) which can be 
classified as dot, ribbon or peripheral (Suzuki et al. 2014).  
Reticular pseudodrusen can be viewed using fundus photography, blue channel fundus 
photography, OCT imaging, infra-red reflectance and FAF. It has been proposed that at 
least two different imaging techniques are used to confirm the presence of RPD 
(Sivaprasad et al. 2016; Ueda-Arakawa et al. 2013b), of which one should be OCT (Zweifel 
et al. 2010a), as each class has a different optimum detection method (Suzuki et al. 2014). 
Although similarities exist in the composition of drusen and RPD, with both containing 
complement factor H, vitronectin and Apolipoprotein E (Rudolf et al. 2008; Hageman et 
al. 2001), they do not contain material derived from photoreceptors (Rudolf et al. 2008) 
suggesting that they differ in origin from soft drusen. Genetically, the incidence of RPD 
has been linked to both the CFH and the ARMS2 genes, which are also linked to AMD 
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(Joachim et al. 2014; Ueda-Arakawa et al. 2013a; Yoneyama et al. 2014). The link with 
inflammatory genes and the presence of inflammation mediators in RPD suggests a role 
of inflammation in their pathogenesis and it has been proposed by Sivaprasad et al. 
(2016) that there may be a  link with parainflammation. There are also links with the 
development of RPD and hypoxia, with a reduced macular choroidal thickness found in 
eyes with RPD and an association of RPD with choroidal watershed zones (Alten et al. 
2013). 
Reticular pseudodrusen are thought to be a risk factor for early AMD, with Huisingh et al. 
(2016) finding that eyes that are classified by the AREDS scale as normal, but with the 
presence of RPD were 2.24 times more likely to develop early AMD than eyes without. 
There are also links with the progression to late stage AMD (Hogg et al. 2014; Joachim et 
al. 2014), and in particular GA (Finger et al. 2016; Finger et al. 2014). 
1.4.2.2 Intermediate AMD 
Intermediate AMD  indicates a progression of the condition. Clinical signs include drusen 
larger than 125 microns and/ or changes the the RPE which result in hyper and 
hypopigmentation (Ferris et al. 2005). 
1.4.2.3 Geographic atrophy 
Geographic atrophy (GA) comprises 85-90% of advanced AMD cases (Bhutto et al. 2012). 
Usually bilateral, it may develop at different rates in each eye, causing a gradual 
deterioration of vision over months or even years, eventually leading to central scotomas 
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(Ambati et al. 2003). There is currently no treatment for GA (Ambati and Fowler 2012), 
and it is responsible for 20% of registrations of legal blindness due to AMD (Buschini et al. 
2011).  
Geographic atrophy is characterised by sharply delineated roughly round areas over 
175μm in diameter of hypopigmentation or depigmentation (Bird et al. 1995), which can 
be associated with drusen. This represents an area of RPE atrophy, which is often 
associated with the atrophy of the underlying choriocapillaris. Ultimately, GA leads to 
photoreceptor death. Atrophy onset is associated with an increased visibility of 
underlying large choroidal vessels, and is often preceeded by regression of previously 
visible drusen (Ambati et al. 2003). Often developing in the parafoveal region, GA spares 
the fovea until the later stages of the disease (Ambati et al. 2003). Progression is slow 
compared to the neovascular form of the disease but GA can co-exist in eyes with nAMD 
(Bhutto et al. 2012). 
1.4.2.4 Neovascular Age related macular degeneration.  
Neovascular AMD results from the growth of new blood vessels from the choroid. Clinical 
features may include a green-grey lesion, haemorrhages and hard exudates from vessel 
leakage (Bird et al. 1995), leading to RPE detachments and scarring. Visual symptoms 
tend to be acute in onset with early manifestations of metamophopsia ultimately leading 
to a central scotoma (Blasiak et al. 2013). Choroidal neovascularisation has been sub 
classified into two groups, based on the presence of a sub-retinal (classic) or sub-RPE 
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(occult) neovascular membrane (Ambati et al. 2003). Classification is based on the 
presentation on fluorescein angiography. Classic CNV is described by a well-demarcated 
area of intense early hyperfluorescence (Bhutto et al. 2012) which progressively leaks in 
the late phases of the angiogram. Occult CNV is characterised by a poorly demarcated 
lesion appearing later in the fluorescein angiogram and leaking intensely.  
A pigment epithelial detachment (PED) is the separation of the RPE from the inner 
collagenous layer of Bruch’s membrane and is a clinical feature in in many chorio-retinal 
diseases including AMD.  Symptoms may include metamophopsia and a reduction in 
central vision or it may be asymptomatic (Zayit-Soudry et al. 2007). Clinically, hyperopia 
may be present due to the raised retina, seen as a single, or multiple elevations 
accompanied by pigmentary changes.    
Pigment epithelial detachment can have a direct link with hypoxia, with the RPE elevation 
increasing the distance oxygen travels from the choroid to the photoreceptors, thus 
decreasing the oxygen flux according to Fick’s law of diffusion (Wangsa-Wirawan and 
Linsenmeier 2003; Stefánsson et al. 2011). 
The progression and outcome of all types of PED are similar (Pauleikhoff et al. 2002). 
Treatment, where appropriate, involves photodynamic therapy (Zayit-Soudry et al. 2007) 
or anti VEGF injections (Lommatzsch 2010). 
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1.4.3 Grading and Classification Systems for AMD  
There have been numerous different classifications and severity scales based on 
photographic images of the retina (Bird et al. 1995; The age-related eye disease study 
research group 2001; Sparrow et al. 1997; Davis et al. 2005; Ferris et al. 2013). In 1995 a 
collaboration of several groups formed the international ARM epidemiological study 
group. They published The International Classification and Grading System for Age-
Related Macular Degeneration (Bird et al. 1995), a detection and grading scale designed 
to standardise the assessment of AMD for use in research.  The Age-Related Eye Disease 
Study (AREDS) group also developed a grading scale for use in its studies and trials (The 
Age-related Eye Disease Study Research Group 2001), both of these scales were 
developed from the  Wisconsin Age-Related Maculopathy Grading System. More recently, 
the Beckman Initiative for Macular Research AMD Classification Committee outlined a 5–
step grading scale for AMD which ranged from ‘no ageing changes’, through ‘normal 
ageing changes’, ‘early AMD’, and ‘intermediate AMD’, to ‘late AMD’ (Ferris et al. 2013).  
Classification of AMD status in this thesis is based on the simplified AREDS 5 point scale 
that has been widely used to grade AMD severity (Ferris et al. 2005).  This grading scale 
takes into account the disease status for both eyes and is shown in Table 1-1. It is derived 
from longitudinal data obtained from the AREDS trial (Ferris et al. 2005), and an increased 
grade is strongly related to an increased 5 year risk of developing advanced AMD.  
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Table 1-1. Simplified AREDS scale (Ferris et al. 2005). 
The aim of this PhD was to compare the effect of the different gas conditions on people 
with early AMD and healthy controls i.e. only a binary grading of normal or early AMD 
was required. A detailed grading of the severity of AMD related changes was not 
instrumental to the data analysis. It was therefore considered unnecessary to use a scale 
providing greater resolution such as the AREDS 9 point scale. The simplified scale also had 
the advantage of allowing a risk grade for a fellow eye, when the eye studied shows 
no/very early signs of AMD. Studies have shown that, in these cases, participants may 
have changes to choroidal perfusion and visual function in the better eye, which indicate 
that a subclinical stage of AMD is present although the fundus displays minimal features 
of AMD (Remulla et al. 1995; Chen et al. 1992).  As the principal objective of the research 
in this thesis was to determine the role of retinal hypoxia in visual function in early AMD, 
it was essential to be able to grade these very early stages of the disease. 
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1.4.4 Pathogenesis of age-related macular degeneration  
The pathogenesis of AMD is a widely researched topic and current conclusions and 
reviews concentrate on three main theories:  
 The oxidative theory 
 The inflammation theory 
 The hypoxia theory 
This next section will discuss the evidence for each theory and the links between them. 
1.4.4.1 The oxidative theory  
Oxidation is a process referring to the removal of electrons from a chemical; it is an 
essential metabolic process to allow energy to be gained from carbohydrates, proteins 
and lipids. Reactive oxygen intermediates (ROI) are produced by enzymes involved in the 
oxidative process or as a result of photochemical reactions (Boulton et al. 2001b; Beatty 
et al. 2000). Reactive oxygen intermediates include free radicals, hydrogen peroxide and 
singlet oxygen; these molecules are unstable and claim electrons from surrounding stable 
molecules with the intention of achieving a stable state for themselves. This leaves the 
donor molecule unstable and accumulation of these molecules causes oxidative stress.   
Reactive oxygen intermediates have the ability to damage many cell materials including 
carbohydrates, proteins, nucleic acids (Beatty et al. 2000) and mitochondria (Blasiak et al. 
2013) leading to cellular degeneration. Oxidative stress has been linked to the ageing 
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process and is the suspected cause of many degenerative diseases including Parkinson’s 
disease (Yildirim et al. 2011), Alzheimer’s disease (Kaarniranta et al. 2011; Blasiak et al. 
2013) and AMD (Beatty et al. 2000; Blasiak et al. 2013). 
The retina is prone to oxidative stress with the daily exposure of 1012  to 1015 photons of 
light (Hunter et al. 2012) causing photochemical damage. Visible wavelengths cause 
tissue damage when absorbed by one of the several retinal chromophores including 
melanin, retinal and lipofuscin (Boulton et al. 1990; Chalam et al. 2011). Photochemical 
damage varies with wavelength; as the energy of a photon is inversely proportional to its 
wavelength, UV and blue light causes the most damage (Chalam et al. 2011). Although 
blue light damage has been proposed to be a risk factor for AMD, further research 
including a large scale clinical trial on blue light filters is required (Margrain et al. 2004). 
The retina is prone to the creation of ROIs owing to its high oxygen tension due to the 
high blood flow in the underlying choiocapillaris, providing the oxygen necessary for ROI 
reactions to take place. Also photoreceptor outer segments contain large amounts of 
readily oxidised polyunsaturated fatty acids; around 50% of rod outer segments (Stone, 
Farnsworth and Dratz 1979). This is the highest concentration of any human tissue and 
can result in a chain reaction with the ability to produce large amounts of ROIs. Age also 
influences retinal oxidative stress, although protection from shorter wavelength light 
occurs with the ageing of the crystalline lens, there is an age related reduction in 
antioxidant protection and an accumulation of lipofuscin (Hunter et al. 2012; Wing et al. 
1978). 
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Lipofuscin is a recognised hallmark of ageing, increasing with longevity. It is an aggregate 
of un-degradable polymers located in the lysosome of metabolically active cells 
throughout the body. Usually formed from the autophagic breakdown of cellular 
products, retinal lipofuscin differs in its composition with its major component being un-
degradable end products from the phagocytosis of photoreceptor outer segments 
(Sparrow and Boulton 2005). 
Although the exact components are still elusive, lipofuscin is known to be a chromophore, 
containing N-retinylidene-N-retinylethanolamine (A2E). Lipofuscin not only has the ability 
to compromise the host cell, but is also a ROI generator, particularly sensitive to short 
wavelength light (Różanowska et al. 1998).  
Evidence of a link between oxidative stress and AMD comes from several different 
sources. A major association is between the reduction of retinal antioxidants with age and 
AMD. Melanin, a free radical scavenger, reduces with age, with the volume present in RPE 
cells reducing from 8% in the first two decades of life to 3.5% in the fourth to ninth 
decade (Feeney-Burns et al. 1990). This, along with the increase in the  photoreactivity of 
melanosomes (Rózanowska et al. 2002) is thought to contribute to AMD development 
(Chalam et al. 2011). Smoking, the principal modifiable risk factor for AMD, is linked both 
to an increase in oxidative stress and a decrease in macular pigment (Alves-Rodrigues and 
Shao 2004; Fletcher and Chong 2008). Lipofuscin has also been linked to AMD, with a 
correlation between RPE lipofuscin content and photoreceptor death reported in early 
studies (Dorey et al. 1989). However, recent evidence suggests that the relationship 
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between lipofuscin accumulation and AMD may not be as strong as previously suggested 
(Rudolf et al. 2013; Hwang et al. 2006). Rudolf et al. (2013) found that although areas 
with advanced RPE abnormalities corresponded with the presence of lipofuscin, this may 
be due to vertically superimposed cells influencing autoflorecence rather than actual 
increases in lipofuscin. Furthermore, Hwang et al. (2006) found that lipofuscin 
accumulation was not a strong risk factor for the development of GA. There is also a 
possible link between UV radiation and inflammation in drusen formation (Chalam et al. 
2011), which unites the oxidative and immunological theories. 
1.4.4.2 The inflammation theory  
Inflammation, the immune system’s defensive response to harmful stimuli or injury, is an 
essential healing process to maintain homeostasis. However, inflammation is also linked 
to many disease processes including Alzheimers disease (Kaarniranta et al. 2011), 
Parkinson’s disease, Huntington’s disease (Buschini et al. 2011) and AMD (Penfold et al. 
2001; Buschini et al. 2011), with the common response to various stimuli in all of these 
conditions being chronic uncontrolled inflammation. It is the autoimmune (Patel et al. 
2005; Luthert 2011) and in particular the complement system (Bhutto et al. 2012), rather 
than acute inflammatory responses which are implicated in AMD (Buschini et al. 2011).  
Chronic inflammation is a prolonged response to a stimulus, resulting in tissue damage.  
The complement system is an innate biochemical cascade that promotes inflammation 
triggering an amplification cascade which results in the activation of the cell-killing 
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membrane attack complex (MAC) (Bhutto et al. 2012). Macrophages are also involved in 
chronic inflammation, in both vasculogenesis and angiogenesis. 
Along with other neurological tissues, the eye has long been thought of as immune 
privileged (Penfold et al. 2001), with anti-inflammatory and immunosuppressive 
molecules being expressed within the eye (Niederkorn 2003). The RPE is important in 
forming the blood retinal barrier and maintaining the immune privileged status. It has 
been postulated that changes in the RPE cells may disrupt this and lead to AMD 
development (Buschini et al. 2011). Evidence suggests though that central nervous 
system tissue is not completely isolated from the peripheral immune system (Carson et 
al. 2006). 
In AMD the immune process has been implicated in drusen formation, with several 
immune molecules present in drusen including C3, C5 and C5b9 complement proteins 
vitronectin, amyloid P and apolipoprotein E (Kaarniranta et al. 2011; Buschini et al. 2011; 
Bhutto et al. 2012; Rodrigues 2007). Many constituents of drusen are also found in other 
immune related disease deposits, such as those found in Alzheimer’s disease (Kaarniranta 
et al. 2011) and atherosclerosis (Rodrigues 2007). Geographic atrophy and nAMD are also 
thought to have an immunological component (Rodrigues 2007). Macrophages can 
secrete MMPs (Grisanti et al. 2008) and proteolytic enzymes which thin Bruch’s 
membrane (Ambati et al. 2003), facilitating the migration of vascular endothelial cells and 
increasing the bioavailability of VEGF. Monocytes, from which macrophages originate 
have been found to be associated with nAMD (Chen et al. 2016). The complement 
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cascade has also been implicated in the formation of CNV (Rohrer et al. 2011; Rohrer et 
al. 2009) with MAC formation central in CNV development (Bora et al. 2007; Bora et al. 
2005). The stimulus for the immune response has been postulated to be oxidative 
(Luthert 2011), possibly related to lipofuscin formation, as A2E is known to activate the 
complement system (Luthert 2011). 
Genetic evidence strengthens the role of the immune system in AMD, with mutations in 
several genes regulating the immune response being linked to an increased risk of AMD. 
The single nucleotide polymorphic change at Y402H, in the complement factor H gene 
which regulates the complement immune system, has strong links with AMD (Edwards et 
al. 2005). Also, the deletion of complement factor H related genes CFHR1 and CFHR3 and 
variations in the complement genes C2, C3 and factor B  have also been linked to AMD 
(Hughes et al. 2006; Seddon et al. 2013; Gold et al. 2006). Parainflammation has also 
been linked with sustained oxidative stress in ageing and AMD, linking the theories of the 
oxidative stress theory and inflammation (Chen and Xu 2015). 
1.4.4.3 The hypoxia theory  
Histologically, hypoxia has a strong link with AMD. Structural changes in early AMD such 
as an impairment in choroidal perfusion (Ciulla et al. 2002; Ciulla et al. 1999b; Grunwald 
et al. 2005), increased scleral rigidity (Friedman 2008) and a thickening of Bruch’s 
membrane (Stefánsson et al. 2011; Pauleikhoff et al. 1992) could all result in retinal 
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hypoxia. The role of hypoxia in the pathogenesis of AMD is discussed in the systematic 
literature review in  chapter 3. 
1.4.5 Treatment 
As understanding of the disease aetiology of AMD has improved, treatments have rapidly 
evolved. However they are still currently only available for the nAMD. Current 
treatments, for example anti VEGF therapies, are expensive and intensive with patients 
requiring retreatment monthly for the greatest improvement in VA (Rosenfeld et al. 
2006).   
1.4.5.1 Geographic atrophy and early age-related macular degeneration. 
There are no current treatments for GA or early AMD, with the emphasis for these 
patients being the prevention of the development to nAMD by reducing oxidative stress 
(not smoking, wearing sunglasses) and taking antioxidant supplements (Age Related Eye 
Disease Study Research Group. 2001).  However there are treatment strategies currently 
under investigation for GA including complement inhibition, for example POT-4 (Velez-
Montoya et al. 2012), neuroprotection (Yehoshua et al. 2011) and increasing choroidal 
perfusion (Velez-Montoya et al. 2012). A phase III trial is currently underway investigating 
the role of the complement inhibitor Lampalizumab to reduce the progression of GA (Jack 
et al. 2016). In the phase II MAHALO trial Lampalizumab reduced disease progression by 
20%, and in a subset of patients with the compliment factor I biomarker the disease 
progression was reduced by 44% (Gemenetzi and Lotery 2016). 
 
43 
1.4.5.2 Neovascular Age-related macular degeneration 
There are currently several treatments with NICE approval for the treatment of nAMD 
including photodynamic therapy and anti-VEGF treatment. By neutralising VEGF-A, anti-
VEGF treatment can control and cause regression of neovascularisation in AMD. There 
are four key pharmacological agents which have been used to treat nAMD; Ranibizumab 
(Lucentis), Bevacizumab (Avastin), Pegaptanib (Macugen), Aflibercept (Eylea). 
Ranibizumab and Afibercept are both licenced for use in nAMD by NICE (NICE 2008; NICE 
2013). Their administration results in reduced new blood vessel formation by reducing 
cell proliferation, and it minimises vessel leakage. Ranibizumab treatment of neovascular 
AMD improves VA (Boyer et al. 2007; Kourlas and Abrams 2007) with a gain of 7.2 letters 
shown when injected with 0.5-mg Ranibizumab, compared with a decrease of 10.4 letters 
in a sham-injection group (Rosenfeld et al. 2006). Aflibercept (VEGF Trap-Eye) is a new 
VEGF inhibitor which has a 200 times greater affinity for binding VEGF than Ranibizumab 
(Chakravarthy et al. 2010a) and is comparable in terms of VA outcomes (Stewart 2012). It 
has a similar costing per injection compared to Ranibizumab, however as it remains in the 
vitreous for longer (Chakravarthy et al. 2010a), the overall cost of treatment may be less 
as Aflibercept is approved for use every 8 weeks (Stewart 2012). 
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1.5 Assessment of retinal structure and function in age-related 
macular degeneration. 
This section of the thesis will give an overview of the assessment of AMD including a 
summary of clinical assessments used in practice. It will then concentrate on methods 
used in a research setting. Emphasis will be given to the psychophysical testing of 
scotopic thresholds and electrophysiology, which are the assessment methods used in 
this thesis. Finally, the chapter will discuss imaging techniques that may be used in the 
assessment of AMD.   
1.5.1 Clinical tests of visual function in AMD 
1.5.1.1 Visual acuity 
Visual acuity (VA) remains the principal functional measure used to monitor AMD disease 
progression in clinical practice and it requires detection, resolution and recognition of a 
target. As detection and resolution are measurements of macular function, VA is often 
affected in late AMD, however, other aspects of retinal function are compromised before 
this change is seen (Lovie-Kitchin and Feigl 2005). The same size AMD lesions can result in 
varying losses of VA, (Neelam et al. 2009) making it an unreliable diagnostic tool, or 
indicator of disease progression. Depending on the size and position of the resulting 
scotoma, VA can still be good even when a subject is struggling, for example, with reading 
(Sarks et al. 1988). In 173 eyes diagnosed with late AMD it was found that 71.7% had a 
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reasonable recorded VA of 6/9-6/12 (Vinding 1990), and although Klein et al. (1995) 
found that late AMD did cause a reduction in VA of 7 lines, they also agreed that other 
measures of visual function may be more sensitive in detecting AMD.  
1.5.1.2 Amsler chart 
Self-monitoring is important for the timely detection of progression and successful 
treatment of nAMD (Trevino 2008). The Amsler grid (Amsler 1953) is given to patients at 
risk of developing nAMD for this purpose, and is designed to detect scotomas and 
metamorphopisa. Subtending 20⁰ at 30 cm, the chart uses a grid pattern composed of 1⁰ 
squares, with the patient asked to report any metamorphopsia (perceived distortions) or 
scotomas (gaps in the chart) whilst looking at a central fixation dot. However studies have 
suggested that patients are failing to notice these changes, with 77% of scotomas of 6⁰ 
diameter or less not being detected by Amsler testing (Schuchard 1993). These failings 
may be due to poor patient understanding of the test (Trevino 2008), poor or eccentric 
fixation (Loewenstein 2007) or due to a filling in effect (Crossland and Rubin 2007). Other 
self-monitoring methods, including Preferential Hyperacuity Perimetry (Crossland et al. 
2007; Trevino 2008) and Macular Mapping (Trevino 2008) are currently under 
investigation. 
1.5.1.3 Perimetry 
Perimetry is a subjective technique that assesses the topographical sensitivity of the 
visual field. Accurate visual field assessment relies on central fixation, which is difficult for 
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patients with advanced AMD, however, certain perimetric techniques have been shown 
to be sensitive to AMD (Acton et al. 2012a).  
Flicker perimetry measures the contrast threshold for a stimulus presented at a fixed 
temporal frequency. Flickering targets have been shown to be sensitive to GA progression 
and to monitoring AMD (Mayer et al. 1994; Phipps et al. 2004), being more sensitive than 
static perimetric targets (Phipps et al. 2004). They can also be used to predict progression 
from early to late AMD (Luu et al. 2012). Frequency doubling perimetry (FDT) measures 
the contrast sensitivity for a grating of fixed temporal frequency to assess the visual field. 
The short testing time and independence of results from pupil size makes this test 
attractive in AMD assessment. However, it has limited use in the functional evaluation of 
AMD due to its insensitivity in the detection of small AMD lesions (Sheu et al. 2002). It 
can, though, provide information about the size and depth of an area of sensitivity loss 
that correlates with reading speed in AMD (Anderson et al. 2011). 
Short wavelength automated perimetry (SWAP) preferentially measures s-cone mediated 
thresholds. In the detection of AMD, VA has been found to better differentiate between 
people with AMD and those without than SWAP. Age-related macular degeneration 
lesions found with SWAP perimetry have been found to be greater in area and depth 
when compared to standard automated perimetry (Acton et al. 2012a). A correlation 
between lower SWAP sensitivity and soft drusen (Remky et al. 2001) has also been 
reported.  
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Microperimetry assesses the visual function of a specific area of the retina and correlates 
it with a fundus image, giving a comparison of structure and function. It can rapidly assess 
early vision loss in AMD (Dinc et al. 2008) and may be a useful tool in the detection and 
monitoring of AMD (Querques et al. 2008; Midena et al. 2007). A significant correlation 
has been found between reduced retinal sensitivity and drusen volume (Hartmann et al. 
2011) and between field defects and a significant thinning of the outer segment 
associated with photoreceptor loss (Acton et al. 2012b). 
1.5.1.4 Contrast sensitivity 
Visual acuity measures the highest spatial frequency at which a high contrast target can 
be seen. An image, however, is made up of many different contrasts and spatial 
frequencies, so a contrast sensitivity assessment provides a comprehensive overview of 
an individual’s spatial visual function. Contrast sensitivity is affected by many factors 
including light levels, eccentricity, hypoxia and age, reducing with normal ageing (Owsley 
2011). Contrast sensitivity losses have been found to precede changes in VA in patients 
with early AMD (Stangos et al. 1995; Midena et al. 1997) GA, (Sunness et al. 1997) and 
with the increased sub retinal tissue volume seen in nAMD (Keane et al. 2010).  It has 
been suggested that contrast sensitivity should be included as an outcome measure in the 
assessment of treatments for nAMD as it may show an improvement in visual function 
after treatment when VA does not (Monés and Rubin 2005; Rubin and Bressler 2002). 
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1.5.1.5 Colour vision 
Tritan (blue-yellow) colour vision defects have been found in people with early and 
advanced AMD (Feigl et al. 2005b; Cheng and Vingrys 1993; Holz et al. 1995; Arden and 
Wolf, 2004; Dimitrov et al. 2011), which is possibly due to a reduction in S-cone sensitivity 
(Eisner et al. 1992). However this is not a universal finding in early AMD, possibly due to 
the changes being too subtle to respond to testing (Midena et al. 1997).  A study by 
O’Neill-Biba et al. (2010) found that both tritan and red-green defects could be used as a 
sensitive measure of functional change in AMD. 
1.5.2 Psychophysical Assessment of Visual Function in AMD 
1.5.2.1 Introduction to psychophysics 
Psychophysics is the study of the relationship between a stimulus and the sensation it 
evokes (Gescheider 1997). Based around threshold testing, it assumes that a sensation 
must exceed a critical threshold level to be perceived. The studies described in Chapters 
4, 5 and 6 used a psychophysical assesement of scotopic visual function, therefore this 
section will give an overview of psychophysics. 
The difference threshold is the difference that is required between two stimuli for them 
to be noticed as being different. Weber’s law states that the difference threshold is 
linearly related to stimulus intensity (a higher stimulus intensity results in an increased 
difference threshold) (Gescheider 1997). The absolute threshold is the smallest amount of 
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stimulus energy required to produce a sensation, therefore at this point the stimulus is 
just detectable.  
1.5.2.2 The psychometric function 
A signal is not pure, but a mixture of signal and random noise. Therefore, when presented 
with a stimulus a participant must make the a decision if it is is just noise or if the stimulus 
is actually present. When the stimulus is weak, this is difficult and there are many errors 
that decrease as the stimulus signal increases. For this reason, thresholds are often 
defined in probabilistic terms (Neelam et al. 2009) and  a psychometric function is used to 
determine the threshold (see Figure 1-9). 
             
Figure 1-9.  A typical psychometric function (Gescheider, 1997). Threshold is the 
stimulus intensity that would be detected 50% of the time. 
The psychometric function plots the probability of detection at different stimulus 
intensities, indicating that when the same stimulus is presented repeatedly to an 
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observer at a particular intensity the response is variable, resulting in an ogive curve, 
rather than the consistent seen or not seen response that would be expected by a perfect 
observer. For example, in Figure 1-9 it can be seen that when a stimulus intensity of 12 is 
presented it will be seen 50% of the time by the observer. A stimulus towards the upper 
end of the y-axis is almost always detected, and the lower end represents a stimulus 
intensity that is almost never detected (Gescheider 1997). 
There are two main techniques of gathering response data from a participant to plot a 
psychometric function, a yes/no or forced choice procedure. In the yes/no procedure for 
absolute thresholds the participant must judge in each trial if a stimulus is present or 
absent. A response is required on each trial and a cue is given to alert the participant to 
the trial. A proportion of these trials will be catch trials that contain no signal; if the 
participant responds positively to these trials they are recorded as false positives. A high 
percentage of false positives may indicate that the participant’s confidence is high, or that 
there is a response bias. 
The forced choice procedure is a sensitive method for assessing threshold which is 
uncontaminated by fluctuations in criterion (Gescheider 1997). In a two alternative forced 
choice procedure two intervals are presented, one of these intervals contains the 
stimulus and the other does not, the participant should then choose the interval when 
the stimulus was present. Even if the participant is unsure, they must give a response. 
This procedure eliminates response bias (Li et al. 2010), however it may still be affected 
by attention and memory. There may be any number of intervals presented, and with 
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increased intervals there is less likelihood that the participant guesses correctly by chance 
alone. 
1.5.2.3 Classical psychophysical methods 
The classical psychophysical methods were developed by Gustav Fechner in 1860 and 
consist of the method of constant stimuli, the method of limits and the method of 
adjustment. These techniques are limited by factors influencing participant responses, 
including the learning effect, response bias, participant confidence and fatigue. Therefore 
the assumption that the thresholds measured with these methods is a direct neural 
response is incorrect. There are also shortfalls of the testing procedure, including large 
amounts of wasted data if the stimuli presented are far from threshold and a lack of 
theoretical justification for aspects of the trials (Treutwein 1995). Adaptive procedures 
were developed to overcome some of these critiisms and will be discussed in the next 
section, with an empasis on the quick estimate by sequential testing (QUEST) procedure 
which was used to collect data for Chapters 4-6. 
1.5.2.4 Adaptive psychophysical procedures 
Unlike in classic psychophysical testing, when the stimuli chosen to present are known 
before testing, the stimuli used in adaptive procedures can be chosen dependent on the 
responses given on a previous trial/ trials, driven by an adaptive algorithm towards 
threshold (Leek 2001). This allows for the stimuli presented to be nearer the presumed 
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threshold.  Adaptive procedures should take into account the following questions 
(Treutwein 1995): 
1) When to change the testing level and where to place the trials on the physical stimulus 
scale? 
2) When to finish the session? 
(3) What is the final estimate of the threshold? 
1.1.1.1.1 Theory of signal detection method 
This method, proposed by Tanner & Swets (1954), is a forced choice method developed 
to remove the lack of control over the participant’s decision criteria and to remove bias 
(Treutwein 1995) by conceptualizing what participants do when they are making a 
decision after being presented with a stimulus. 
1.1.1.1.2 Maximum likelihood procedures 
Maximum likelihood procedures calculate a new psychometric function after each trial 
based on information about the set of stimulus levels presented so far and the proportion 
of correct responses at each intensity level (Leek 2001). This means a statistical 
estimation of the participant’s threshold can be calculated after each trial and used to 
decide on the next stimulus intensity to be presented. Prior knowledge is also used in 
these methods, with the method taking into account information about the expected 
shape of the psychometric function and an estimation of the participant’s threshold 
(Watson and Pelli 1983). This information could be the result of preliminary trials before 
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testing, or by using a uniform prior probability density function (Treutwein 1995). The 
calculation of the final threshold estimate in maximum likelihood procedures differs with 
each procedure, but is commonly reached after a set number of trials has been 
completed, a step size interval has been attained or by using a dynamic stopping criterion 
(Treutwein 1995). In a study comparing the use of a set number of trials and a dynamic 
stopping criterion, it was found that there was little advantage in using a dynamic 
criterion (Anderson 2003)  
There are several different maximum likelihood procedures including PEST (Parameter 
Estimation by Sequential Testing), ZEST (Zippy Estimate of Sequential Testing), SITA 
(Swedish Interactive Threshold Algorithm – which is a modified ZEST), YAAP and QUEST.  
QUEST, which is the method which was used to collect scotopic threshold data in 
Chapters 4-6, will be discussed in more detail in the next section. 
1.1.1.1.3 QUEST 
Published as a Bayesian adaptive psychometric method by Watson & Pelli (1983) based 
on the staircase method, the QUEST method assumes the participant’s psychometric 
function follows a Weibull distribution and requires the input of prior knowledge 
regarding the expected threshold and variance  (Watson et al. 1983). This means that the 
level of each presented stimulus is chosen based on the maximum likelihood of it being 
the threshold based on the prior knowledge and the responses from previous 
presentations. After a set number of trials has been completed, threshold (which is the 
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mode of the psychometric function) and the slope of the psychometric function are 
produced. The slope provides information on the variability of the participant’s 
judgements, with high variability data resulting in a shallow slope (Neelam et al. 2009). 
The final threshold does not make use of the prior information, therefore is unbiased. 
QUEST is based on the following assumptions (King-Smith et al. 1994): 
 That the psychometric function has the same shape under all conditions, when 
expressed as a function of log intensity. 
 That the participant’s threshold does not vary from trial to trial. 
 That individual trials are statistically independent. 
Modified versions of QUEST (minimum variance and ZEST) were proposed by King-Smith 
et al. (1994), which use the mean of each psychometric function to calculate stimulus 
intensity and final threshold instead of the mode. 
1.5.2.5 Limitations of adaptive psychophysical methods. 
Overall adaptive psychophysical methods are seen as efficient and accurate (Treutwein 
1995; King-Smith et al. 1994), however, there are limitations. Prior knowledge is required 
for most of the techniques, which require assumptions about the underlying slope of the 
psychometric function (Leek 2001). Although all techniques have been designed to be 
robust, there is still an element of participant variability. QUEST has taken this into 
account by including variability in the Weibull function, however this assumes a degree of 
intra-participant stability. Measurement bias, which is the result of repeated testing of a 
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threshold (the mean between these measurements and the actual threshold), is also 
present in adaptive methods (King-Smith et al. 1994). Finally, these techniques are also 
often computationally intensive (Leek 2001). 
1.5.3 Dark adaptation and AMD 
1.5.3.1 Introduction to dark adaptation and scotopic vision 
The human visual system has the ability to operate over a 10 log unit range of luminance 
(Stockman et al. 2010; Lamb et al. 2004). The term ‘dark adaptation’ usually refers to the 
time taken for visual thresholds to reach a minimum (‘absolute threshold’) in the dark, 
after exposure to a light source that bleaches a substantial proportion of visual pigment. 
The time taken to reach absolute threshold in total darkness after a previous exposure to 
bright light is typically around 50 minutes, a similar duration to the time taken for the sun 
to set (Reuter 2011). However, in the era of electric lighting, we move between different 
lighting conditions quickly and so the long time taken for dark adaptation to occur can be 
problematic. 
1.5.3.2 Factors affecting dark adaptation 
There are several factors that influence the shape of the dark adaptation function and the 
final scotopic threshold. These include external factors, for example the brightness of the 
initial bleaching light, the size and position of the area of retina being tested and the 
wavelength of the stimulus (Fasih et al. 2010). Internal factors include pupil size, 
photochemical processes and neural adaption. Testing in the peripheral field results in a 
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dominant rod section, due to the increasing density of rods (Curcio et al. 1990). Testing 
with stimuli at shorter wavelengths, to which the rods are maximally sensitive (507nm), 
will also result in a more prominent rod portion (Fasih et al. 2010). 
1.5.3.3  Ageing and dark adaptation 
A common complaint of the elderly, even in the absence of ocular abnormalities, is 
difficulty seeing at lower luminances (Robertson and Yudkin 1944; Owsley, 2011; Jackson 
et al. 1999). Older adults typically have a loss of a log unit of scotopic sensitivity 
compared to younger adults (Jackson and Owsley 2000) which can result in an increase in 
falls (McMurdo and Gaskell 1991) or the avoidance of night driving (Ball et al. 1998). 
There is also a slowing of the rate of dark adaptation with increasing age, with it taking 
over 10 minutes longer for 70-year-olds to reach pre-bleach light sensitivity compared to 
those in their 20s (Jackson et al. 1999). Owsley (2011) and  Jackson et al. (1999) suggest 
that it may be due to a slowing of the visual cycle with age, possibly due to a reduction in 
11-cis-retinal at the photoreceptors.  Figure 1-10 shows the increase in duration of dark 
adaptation and raised scotopic thresholds with ageing. 
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Figure 1-10. Dark adaptation as a function of decade of age (Jackson et al. 1999). 
There are several possible contributors to the age-related loss of scotopic sensitivity, with 
senile miosis and the increased optical density of the ageing eye elevating scotopic 
threshold by about a 0.10–0.15 log units (Owsley 2011). But even taking these factors into 
account, there is still a reduction of between 0.39 to 0.50 log units sensitivity (Sturr et al. 
1997). There must, therefore, be retinal factors contributing, which could include the age-
related loss of photoreceptors (Curcio et al. 1993) and RGCs (Harman et al. 2000). 
Although the number of cones remains stable with ageing, the density of rods declines by 
30% from 27 to 90 years old with the greatest loss in the parafoveal region (Curcio et al. 
1993). The morphology of the remaining rods alters, with larger inner segments filling the 
spaces left behind (Curcio et al. 1993). Although this loss of rods would seem to be a good 
explanation for the loss in scotopic sensitivity, Jackson et al. (1998) found that the loss of 
scotopic sensitivity was not accentuated in the parafoveal region where rod loss is 
greatest. In addition, although the density of rods reduces with age, the quantity of 
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rhodopsin does not (van Kuijk et al. 1991). This suggests that the reduction in scotopic 
sensitivity with age may be due to other factors.  
1.5.3.4 Dark adaptation and AMD 
Patients with AMD often describe difficulties with vision under low luminance before 
changes under normal lighting conditions (Steinmetz et al. 1993; Owsley et al. 2006) and 
they may also complain of prolonged time to recover when exposed to bright light 
(Steinmetz et al. 1993). This is also seen clinically with a decrease in scotopic visual 
function seen when photopic function (Sunness et al. 1997; Neelam et al. 2009) and 
clinical status (Owsley et al. 2007) are normal. Therefore it is not surprising that dark 
adaptation has been found to be affected by AMD (Dimitrov et al. 2012; Dimitrov et al. 
2011; Dimitrov et al. 2008; Owsley et al. 2001; Owsley et al. 2007; Steinmetz et al. 1993; 
Jackson et al. 2002; Sunness et al. 1997; Haimovici et al. 2002; Eisner et al. 1992; Eisner et 
al. 1991; Jackson et al. 2014b; Jackson et al. 2014a). Rod mediated parameters of dark 
adaptation have been suggested to be more susceptible to AMD than cone mediated 
functions (Owsley et al. 2007; Owsley et al. 2000; Owsley et al. 2001), corresponding to 
the histopathologic changes in AMD. Rod loss precedes cone loss in 75% of early and late 
AMD retinas (Jackson et al. 2002). Studies report changes in the dynamics of rod-
mediated DA, including a prolonged time course of DA (Owsley et al. 2001; Steinmetz et 
al. 1993; Haimovici et al. 2002; Dimitrov et al. 2008; Eisner et al. 1991; Eisner et al. 1992; 
Dimitrov et al. 2011) and a delay in the rod-cone break (Owsley et al. 2001; Dimitrov et al. 
2008). There is also an increase in the final scotopic threshold (Owsley et al. 2000; 
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Sunness et al. 1997; Steinmetz et al. 1993; Scholl et al. 2004). These changes are shown in 
the dark adaptation curves from a participant with no AMD, early AMD and intermediate 
AMD in Figure 1-11. The rate of rod recovery in DA was found by Dimitrov (2011) to be an 
indicator of functional loss in AMD that could be used for monitoring individuals at a high 
risk of developing advanced AMD. More recently, delayed rod- mediated dark adaptation 
has been found to be a functional biomarker for AMD (Owsley et al. 2016). 
                     
Figure 1-11. A Representative dark adaptation curves of a normal adult (closed circles), 
early AMD patient (open triangles), and intermediate AMD patient (open circles) 
(Jackson and Edwards. 2008). 
The time course of cone parameters of DA have also been found to be affected by AMD 
(Gaffney et al. 2011; Phipps, 2003; Dimitrov et al. 2011; Dimitrov et al. 2008). Gaffney et 
al (2011) found that the time to rod cone break and time to cone recovery were highly 
diagnostic for early AMD at 12 degrees eccentricity, but final cone thresholds were 
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unaffected. This diagnostic potential is important clinically as cone recovery can be 
quantified in as little as 10 minutes (Gaffney et al. 2011), which is attractive to clinicians. 
This suggests that the kinetics of cone function are affected prior to steady state 
measures. If underlying changes to Bruch’s membrane and the RPE are responsible for 
adaptation deficits, then cone adaptation may be expected to be affected regardless of 
the preferential loss of rods in AMD.  
In addition to the assessment of scotopic thresholds, electrophysiology will also be used 
to assess visual function in this thesis and is discussed in detail in the next section. This 
section provides background information and  an overview of the elements of the 
waveform which are to be analysed in chapter 7. 
1.5.4 Electroretinography 
Ocular electrophysiology provides an objective assessment of the integrity of the visual 
pathway from the eye to the brain. By recording the electrical signals produced by visual 
stimulation via the electroretinogram, electro-oculogram or visual evoked potential, the 
location and extent of the disruption in the visual pathway can be determined. These 
assessments measure evoked potentials that are transient electrical responses produced 
by neurones in response to a stimulus. 
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1.5.4.1  Electroretinogram  
The electroretinogram (ERG) is the objective recording of the summed electrical activity 
produced by the retina in response to a visual stimulus. This can be measured under 
photopic or scotopic conditions and with a flash or pattern stimulus. Although the ERG is 
a summed response, different groups of cells become active at different times after the 
onset of a stimulus. Hence, each part of the waveform produced gives information about 
different cells within the retina. Recording the ERG requires three electrodes, an active on 
the cornea, reference on the skin at the outer canthus, or in the contralateral eye and 
earth on the forehead.  
Since 1989 The International Society for Clinical Electrophysiology of Vision (ISCEV) has 
provided regularly reviewed standards for the recording parameters of full field clinical 
ERG techniques (McCulloch et al. 2014). The actual form of the wave produced depends 
on: 
 state of adaptation  
 stimulus wavelength 
 stimulus intensity 
 stimulus temporal frequency  
Low temporal frequencies, shorter wavelengths, lower luminance stimuli and dark 
adaptation all help to isolate the rod response (Perlman 2001). The stimulus can also be 
patterned, global or focal to isolate different retinal locations.  
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1.5.4.2 Flash electroretinogram 
Figure 1-12 shows the waveform produced in response to a single flash full field stimulus 
that records summed potentials from all the retinal cells. The resultant ERG has a 
repeatable waveform.   
                                                     
 
 
Figure 1-12. Flash electroretinogram waveform from a normal subject showing the 
amplitude of the a wave (a) and b-wave (b), and the implicit time of the a wave (t) 
(McCulloch et al. 2014). 
In 1933, Granit determined that the scotopic transient ERG of the cat was attributable to 
the summation of 3 physiological processes, PI, PII and PIII (Granit 1933). These three 
processes were numbered depending on the order of disappearance under progressive 
anaesthesia. PI is a positive wave of long latency, PII is a reasonably fast positive wave 
and PIII, which develops faster than PI or PII, is a negative wave. PIII has been further 
divided into the ‘fast’ and ‘slow’ components that have also been attributed to different 
layers of the retina. However, these processes cannot be isolated in the standard ERG. 
Figure 1-13 shows that the three processes sum together to form the overall ERG 
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waveform that is shown in black. The clinically recordable peaks and troughs of the ERG 
are referred to as the sub-components. The following section will discuss certain sub-
components of the ERG (those most relevant to this thesis), the recording parameters 
required to elicit them, and their proposed retinal origins.  
                       
Figure 1-13. Granit’s three processes of the ERG. 
1.5.4.3 The a-wave  
Appearing first in the waveform, the a-wave is a negative potential, and has been 
attributed to the leading edge of Granit’s PIII component seen in Figure 1-13. The origin 
of this wave has been has been determined by intra-retinal electrode studies which found 
signals from the photoreceptors contributed to PIII (Brown et al. 1957). Current source 
density analysis suggests that the rod outer segments are the main source of the scotopic 
ERG a-wave, as the photocurrent they produce is of a similar sign and waveform to the 
currents that underlie the a-wave (Penn and Hagins 1969). Studies using the glutamate 
agonist sodium aspartate, which prevents the transmission of glutamate from the 
photoreceptors to bipolar cells, have found that the a-wave is not extinguished by its 
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administration which is also suggestive of a photreceptor source (Wakabayashi et al. 
1988). In photopic conditions, the origins of the a-wave are more complicated and may 
involve postreceptoral activity from hyperpolarising bipolar cells or horizontal cells (Bush 
and Sieving 1994).  
1.5.4.4 The b-wave  
Evidence for b-wave origins come from single cell intracellular recordings from the inner 
nuclear layer.  It is this layer and the bipolar cells within it which contribute to the positive 
b-wave (Brown et al. 1957; Brown and Wiesel 1961), which is attributed to Granit’s 
process PII (Granit 1933). In particular, it is thought to be the ON bipolar cells that 
contribute to the b-wave. 2-amino-4-phosphonobutyrate, which abolishes the response 
of ON- bipolar cells to light has been found to diminish the b-wave (Tian and Slaughter 
1995; Stockton and Slaughter 1989). Studies of the mud puppy retina have also suggested 
that there may be an involvement of the Müller cells (Miller and Dowling 1970), although 
studies have found that blocking the Müller cell activity using Barium ions does not 
reduce the b-wave amplitude (Lei and Perlman 1999). 
1.5.4.5 The focal ERG 
The focal ERG allows the identification of localised defects by using a uniform flickering or 
flashing stimulus with a desensitising surround to record responses from the central 
retina. When centred on the macula, the combination of a small stimulus and the 
suppression of signals from the peripheral retina by the surround allow a focal cone 
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driven response to be recorded. The flicker stimulus results in a sinusoidal waveform, and 
a flicker of greater than 30Hz will result in a cone driven response (McCulloch et al. 2014). 
A postreptoral contribution to the flicker ERG has also been proposed due to the effect of 
glutamate on the waveform (Kondo and Sieving 2001). 
This recording is useful in conditions where localised functional changes occur such as in 
AMD and cone dystrophies, where small changes to the waveform may be swamped by 
the summed signals of the peripheral, healthy retina. However there are no international 
standards set for the recordings and good fixation is required (Berrow et al. 2010) which 
may make recording from individuals with nAMD and GA difficult.   
1.5.4.6 The ERG in AMD 
Different types of ERG recording have been used to investigate retinal function in AMD. 
Using the full field ERG to study peripheral visual function Sunness et al. (1985) concluded 
that peripheral visual function was not affected by AMD severity. Jackson et al. (2004) 
later agreed, finding no difference in the response onset or amplitude of the a-wave of 
the full field scotopic ERG, between participants with early and late AMD and age 
matched and younger controls. This is probably due to the full field ERG summing the 
overall retinal response, which would include peripheral rods not affected by macular 
degeneration and may mask macular abnormalities.  In contrast, significant reductions in 
the a and b-wave amplitudes of the full field rod ERG and prolonged b-wave implicit times 
have been found in another study, suggesting that there is a global impairment in AMD, 
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possibly due to vascular changes (Walter et al. 1999). The differences between these 
studies can be explained in part by the small sample (n=7) of late stage AMD participants 
used in the Jackson et al. (2004) study, whereas there was no breakdown of disease 
classification of the 66 participants studied by Walter et al. (1999), which included both 
participants with nAMD and GA, which may have skewed results.  
Using new multifocal ERG (mfERG) techniques which target the rod pathway, rod function 
has been found to be preferentially affected by AMD (Chen et al. 2004; Feigl et al. 2006). 
When assessing both cone and rod mfERGs, the rod mfERG response was found to be 
delayed in participants with early AMD, but there were no significant changes in the cone 
response (Feigl et al. 2005a). However, Li et al. (2001) did find changes in the foveal 
amplitude and latency of the cone dominated mfERG in participants with AMD and in 
asymptomatic eyes of participants with early AMD or AMD in the other eye, suggesting 
that the mfERG may be useful in diagnosing and monitoring at risk groups. Differences in 
the recordings have also been found between participants with nAMD and GA, with the 
response densities of N1 and P1 decreasing dramatically for the nAMD group compared 
to the participants with GA, suggesting that the mfERG may be used for AMD disease 
quantification (Huang et al. 2000). The mfERG may also be used for monitoring the 
effectiveness of treatments (Berrow et al. 2010). 
The focal cone ERG has been found to have delayed implicit times in eyes with early AMD 
(Binns and Margrain 2007) and in the fellow eyes of participants with unilateral nAMD 
(Sandberg et al. 1998; Sandberg et al. 1993) suggesting that changes in the focal ERG are 
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present before changes in VA. A reduction in mean amplitude has been found in patients 
with GA, which was correlated with GA severity (Falsini et al. 1999). There is also evidence 
that focal ERG abnormalities could precede the morphological changes typical of more 
advanced disease (Falsini et al. 1999). Implicit time delays of 1ms have been found in eyes 
with a choroidal perfusion defect (Remulla et al. 1995), which may underlie hypoxia 
driven progression of AMD as discussed in section 2.2.5.  
1.5.5 Imaging techniques  
Age-related macular degeneration has been evaluated using a number of imaging 
techniques including stereo and digital fundus photographs, fluorescein angiography, 
optical coherence tomography and fundus autofluorescence. The following section will 
describe in more detail the imaging methods that will be used in this PhD.  
1.5.5.1 Fundus photography 
Fundus photography provides images for the assessment of the retina. Providing an 
objective record of the retina, they can be used for monitoring and diagnosis. Fundus 
photography can be used to document all clinical stages of AMD. Figure 1-14 is a retinal 
photograph showing nAMD and Figure 1-15 shows GA.  
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Figure 1-14. Retinal photograph showing nAMD (Miller 2013). 
                                   
Figure 1-15. Retinal photo showing geographic atrophy (Miller 2013). 
1.5.5.2 Optical coherence tomography 
Optical coherence tomography (OCT) is a non-invasive in vivo imaging technology that 
uses low-coherence interferometry to produce cross-sectional images of the retina. 
Optical coherence tomography images showing a normal retina (Figure 1-16) and a retina 
with nAMD (Figure 1-17) are shown below. The image is based on optical scattering from 
internal tissue microstructures (Huang et al. 1991).  In AMD the technique is used for 
diagnosis, monitoring and management (Regatieri et al. 2011).  
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Figure 1-16. Optical coherence tomography of a normal retina 
Http://www.illinoisretinainstitute.com/index.php?p=1_6_Normal-Retina (2012). 
 
Figure 1-17. OCT image showing nAMD (Hageman 2016) avaliable at 
http://webvision.med.utah.edu/imageswv/Hagerman.Fig36.jpg. 
1.6 Rationale and Objectives of the PhD 
The financial burden of AMD depends on the stage of AMD present, with considerable 
costs associated with the late stages of the disease (Schmier and Levine 2013). In 2010, 
hospital spending on Lucentis was the third highest of all drugs costing the NHS £129 
million. When considering early AMD there are no direct non medical costs or indirect 
costs and changes to visual function have not yet taken place. Treating at the earlier stage 
of the disease is therefore appealing, but faces a number of challenges. These include the 
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requirement for clinical measurements for trial outcomes, a greater understanding of the 
earlier stages of the condition to develop treatments, methods of diagnosing the 
condition before clinical signs and symptoms are present. 
The principal objective of the research presented in this thesis was to determine the role 
of retinal hypoxia in visual dysfunction in early AMD. This will help to clarify the role of 
hypoxia in AMD onset and will determine whether aspects of visual function may be 
assessed in early AMD as biomarkers for hypoxia in the disease process. This could 
ultimately lead to the development of clinical tests which are sensitive to desease 
progression and would hasten the development of new treatments targeted at the early 
stages of the disease. The specific aims were: 
1) To investigate if the dark adapted healthy retina is hypoxic by comparing scotopic 
thresholds under hyperoxic and normoxic gas conditions. 
Hypothesis: the dark adapted retina is on a hypoxic knife edge, however it is 
hypothesised that in the normal population the oxygen supply meets its needs 
and therefore there will be no decrease in scotopic thresholds when breathing 
60% oxygen, but that there will be an increase in scotopic thresholds when 
breathing 14% oxygen.  
2) To investigate if there is a topographical retinal effect of hyperoxia or hypoxia on 
scotopic thresholds. 
Hypothesis: The maximum density of rods is at 12-18 degrees from the fovea 
(Curcio et al. 1990), and studies have found that hypoxia effects visual function 
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between 9-15 degrees (Feigl et al. 2011; Connolly and Hosking 2008b). Therefore 
it is hypothesised that hypoxia will affect the retina preferentially at 12 degrees.   
3) To investigate the effect of hyperoxia on scotopic threshold of participants with 
early AMD. 
Hypothesis: As hypoxia has the ability to raise scotopic thresholds in healthy 
young participants, it could be that hypoxia also causes the rise in scotopic 
thresholds seen in patients with early AMD. If this is the case then temporarily 
reducing hypoxia in participants with early AMD, by the inhalation of 60% oxygen, 
should result in a decrease in scotopic thresholds. 
4) To investigate the effect of hypoxia on the scotopic thresholds of participants with 
early AMD 
Hypothesis: A hypoxic episode will cause an increase in scotopic thresholds in both 
participants with early AMD and age-matched controls, but the effect will be 
greater in participants with early AMD. 
5) To investigate the effect of hypoxia on the amplitude and implicit time of the 
scotopic full field ERG a-wave and b-wave, and the amplitude and implicit time of 
the first harmonic of the flicker ERG.   
Hypothesis: A hypoxic episode will result in a reduction in amplitude of the 
scotopic full field ERG a-wave and a reduction in amplitude and increase in implicit 
time of the b-wave in participants with early AMD and in the control group. These 
changes are expected to be greater in the group with early AMD. It is also 
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hypothesised that there will be a delay in the onset and a reduction in the 
amplitude of the first harmonic of the flicker ERG. 
In order to develop a detailed understanding of the effect of hypoxia and visual function, 
and its potential influence on the pathogenesis of AMD, two systematic literature reviews 
were conducted: 
1) A  systematic literaure review into the effect of hypoxia on visual function. 
2) A systematic literature review into the role of hypoxia in early age-related macular 
degeneration. 
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2 A review of literature regarding the 
effect of hypoxia on visual function and 
the role of hypoxia in the pathogenesis 
of Age-related macular degeneration. 
This chapter summarises the findings from two literature reviews which were conducted 
on the effect of hypoxia on visual function and the role of hypoxia in the pathogenesis of 
AMD. 
The first section of this chapter will present the findings of a literature review 
investigating the effect of hypoxia on visual function. This question has been of 
longstanding interest since the advent of aviation due to the reduction in atmospheric 
pressure with increases in altitude, resulting in a decrease in the oxygen concentration of 
inspired air. As early as 1939, hypoxia was shown to have an effect on many aspects of 
visual function (McFarland and Evans 1939). As this PhD aims to investigate the effect of 
hypoxia and hyperoxia on visual function in AMD, it is valuable to review current 
understanding of the impact of blood oxygenation in people without the condition.  
The second section of this chapter will present the findings of a review conducted to 
investigate the relationship between hypoxia and AMD. The hypothesis that hypoxia has a 
role in the pathogenesis of AMD is based on the knowledge that the normal retina is on a 
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hypoxic knife-edge in the dark (Wangsa-Wirawan et al. 2003; Feigl et al. 2008). The theory 
suggests that, in early AMD, extra strain is placed upon an already critically limited outer 
retinal blood supply due to histological changes in the retina and associated structures, 
including the choriocapillaris and Bruch’s membrane. The resultant hypoxia then causes 
changes at a cellular level, can upregulate growth factors and also cause apoptosis 
leading to the signs seen in nAMD and GA respectively (Ambati et al. 2003; Gerona et al. 
2010; Guma et al. 2009). Current evidence suggests that there are three potential 
aetiologies for AMD (i.e. hypoxia, inflammation and oxidation; see section 1.4.4). 
However, there are possible overlaps between these putative mechanisms. For example, 
it has been proposed that inflammation may lead to hypoxia by increasing the metabolic 
demand of the retina, or that there may be changes in blood vessels secondary to 
inflammation (Arjamaa et al. 2009). There are also associations between hypoxia and 
genetics (Feigl 2009), and between the oxidative stress and hypoxia theories, with ROIs 
being created in hypoxic conditions (Kaur et al. 2008; Arjamaa et al. 2009).  
The findings of both studies will be summarised at the end of the Chapter. 
2.1 Search methods 
A search of the Web of Science database was conducted using the search terms in Table 
2-1. Hand searching of lists of references from included studies and literature reviews was 
also conducted.  
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Hypoxia 
 
AND 
Visual fields OR 
Colour vision OR 
Contrast sensitivity OR 
Dark adaptation OR 
Visual acuity OR 
Electroretinogram (search #1)  
 
Age-related macular 
degeneration OR  
AMD OR 
 ARMD (search #2) 
 
Table 2-1.Literature review search terms. 
 
Studies published from January 1900- October 2015 were included. With respect to the 
first review, studies were excluded if they did not investigate an aspect of visual function 
under conditions of hypoxia. With respect to the second review, studies were excluded if 
they did not investigate a stage of AMD, or they did not relate hypoxia to the 
pathogenesis of AMD. Studies were also excluded from either review if they were not 
written in the English language or if they were a conference abstract only. 
The abstracts of all potentially relevant studies were reviewed against the eligibility 
criteria, and full manuscripts were obtained for those which appeared to be eligible. Final 
eligibility was determined on assessment of the full manuscripts. In this review, when 
altitude/ simulated altitude conditions were given, equivalent oxygen concentration 
values were calculated using a hypoxia/altitude calculator, which can be accessed at 
http://www.altitude.org/air_pressure.php 
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2.1.1 Search results 
For the first search into the effect of hypoxia on visual function a total of 42 articles were 
identified as meeting the eligibility criteria for inclusion (see Figure 2-1). Summary data of 
all included studies are presented in Appendix I. Studies were grouped into six catagories; 
visual acuity, visual fields, contrast sensitivity, colour vision, ERGs and dark adaptation. Of 
the included studies, 55% (23 studies) simulated different air conditions using a breathing 
mask, 20% (8 studies) used a hypobaric chamber and 26% (11 studies) ascended to 
altitude. 
 
Figure 2-1. Flow chart showing results of the effect of hypoxia on visual function 
literature search. 
For the second search into the role of hypoxia in the pathogenesis of AMD a total of 49 
articles were identified as meeting the eligibility criteria for inclusion in the study (see 
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Figure 2-2). Summary data of all included studies are presented in appendix II. The studies 
were grouped into main sections relating to changes in specific morphological and 
functional features associated with hypoxia in AMD i.e. ocular vasculature, Bruch’s 
membrane, growth factors and inhibitors and visual function. Of these studies 80% (39 
studies) were on human eyes, 10% (5 studies) were on in vitro cells and 10% (5 studies) 
were on animal tissue. 
 
Figure 2-2. Flow chart showing results of the role of hypoxia in the pathogenesis of 
AMD literature search. 
2.2 The effect of hypoxia on visual function. 
2.2.1 The effect of hypoxia on visual acuity 
Three studies have assessed the effect of hypoxia on VA. Willmann et al. (2010) found no 
change in VA when 14 healthy subjects ascended to 4559m, this was despite SpO2 
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dropping to 69.35 +/4.36%. They discussed that this could be due to a range of 
autoregulatory mechanisms within the macular region to meet oxygen needs under 
exposure to hypoxia. A reduction in VA with both normobaric hypoxia (McFarland & 
Halperin 1940) and hypobaric hypoxia (Vecchi et al. 2014) has been observed. However, 
McFarland found that this was only significant under scotopic conditions whereas Vecchi 
et al. (2014) reported a reduction in VA under both photopic and scotopic conditions 
when participants were exposed to 13.44% O2. It is interesting to note that this only 
became statistically significant after 45 minutes of breathing the reduced oxygen levels. 
In conclusion, VA is relatively resistant to changes in hypoxia, but may be affected by 
increased durations of hypoxia  or at lower light levels. 
2.2.2 The effect of hypoxia on visual fields 
Studies of the effects of hypoxia on visual field thresholds have produced variable results. 
Of the nine studies included in this review three studies have found no evidence that 
hypoxia affects visual fields (Feigl et al. 2011; Falk et al. 1991; Yap et al. 1995). Feigl et al. 
(2011) studied the sensitivity to static and flickering stimuli in seven locations (1°, 3°, 6°, 
10°, 15°, 22° and 30° eccentricitiy) under photopic illumination in 14 normal subjects. 
Flickering stimuli are known to increase the metabolic demand of the retina and 
although, as expected, sensitivities were lower for flickering stimuli, the detection 
threshold of neither stimulus type was affected by breathing 12% oxygen. The effect of 
hypoxia on visual field sensitivity in subjects with glaucoma, in age matched normals and 
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in a group of younger subjects has also been investigated by measuring the central 
Humphrey 24-2 fields at ground level and at simulated 3000m altitude (15% oxygen) 
using a hypobaric chamber. Whilst older subjects had a lower sensitivity than younger 
subjects, altitude had no effect on these sensitivities in any participant group (Falk et al. 
1991).  
However, other studies have found hypoxia to have an effect on visual fields in photopic 
(Horng et al. 2008; Connolly et al. 2008b) and mesopic conditions (Feigl et al. 2011; 
Connolly and Hosking 2009b; Connolly 2011). A pilot study by Feigl et al. (2011) studying 
the effect of 12% O2 on static perimetric thresholds in mesopic conditions, found that 
sensitivity was reduced at eccentricities of up to 15°. Connolly and Hosking (2008) 
concluded from their study that hypoxia affected photopic visual fields up to 9 degrees 
from fixation when breathing 14.1% O2, with the effect reducing with further increases in 
eccentricity (out to 20 degrees). In comparison, some studies have found that the effect 
of hypoxia on photopic visual fields is greatest in the periphery, out to 30° (Horng et al. 
2008). The conflicting results of these studies could be due to the differing background 
luminances. The relative influence of rod photoreceptors would have been lower in the 
study by Connolly and Hosking (2008), which employed a photopic luminance of 100 
cd.m2, compared to the 10 cd.m-2 background luminance that was used in the study by 
Horng et al (2008). The effect of hypoxia in the peripheral retina could be due to the 
demands of the rods in the peripheral retina, as these contribute to vision up to 
200cd.m2, and are likely to be competing with cones for the limited oxygen supply 
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available (Horng et al. 2008). There is no evidence of a differential effect of hypoxia on 
photopic thresholds in the four field quadrants (Connolly and Hoskin 2008).  Hypoxia has 
been found to reduce sensitivity to flickering visual field targets to a greater extent in 
mesopic than in photopic conditions (Connolly et al. 2009b; Connolly 2011; Feigl et al. 
2011). This indicates that the outer retina may be operating under a state approaching 
hypoxia in mesopic conditions (Connolly et al. 2009b), possibly attributable to an 
increased rod and cone oxygen consumption under reduced light levels (Connolly 2011).  
A study looking at gender effects of oxygenation levels on frequency doubling perimetry 
recorded photopic thresholds across the central 40 degrees of visual field (Connolly and 
Hoskin 2008). Thresholds were measured when participants were breathing 14.1%, 21%, 
and 100% O2. Whilst participants showed a reduced performance under hypoxic 
conditions, in females alone, sensitivity was found to be enhanced in all retinal locations 
by the hyperoxic condition compared to normoxia (Connolly et al. 2008b). This study also 
observed an important effect of gas order, with prior hypoxia diminishing the benefit of 
subsequent oxygen, whilst if oxygen was presented first, then the impairment under 
hypoxia was not as great. However, the wash-out period between gas presentations in 
this study to prevent cross-contamination was only 2-3 minutes, which may have 
influenced these findings. 
Demir et al. (2012) tested central 30 standard automatic perimetry (SAP) and short 
wavelength automated perimetry (SWAP) in people with chronic obstructive pulmonary 
disease (COPD) that were on long term oxygen therapy. Mean deviation, pattern standard 
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deviation and corrected pattern standard deviation were all statistically different 
between participants with COPD and healthy controls. However no detail was given 
regarding the extent and distribution of the visual field defects, or the arterial blood gas 
results. Therefore, although the study concluded that hypoxia in COPD seems to affect 
the retina and optic nerve, the level and range of participant hypoxia is unknown. It is 
also unknown what oxygen therapy the patients were receiving at the time.   
In conclusion, the literature is somewhat inconclusive, but suggests that visual fields are 
affected by hypoxia under certain recording conditions. Under mesopic conditions there 
is some evidence to suggest that peripheral fields are relatively more affected, whilst 
under photopic conditions the central retina appears to be targeted by hypoxic effects. 
The impact of hypoxia on scotopic thresholds will be discussed in section 2.7, which 
discusses dark adaptation.  
2.2.3 The effect of hypoxia on contrast sensitivity 
Early animal studies recording single action potential activity from cat ganglion cells found 
that contrast sensitivity was preserved with hypoxemia (Enroth-Cugell et al. 1980). 
However, despite this evidence from animal studies, some human evidence suggests that 
hypoxia does reduce CS (Bridges and Kolder 1964; Nordmann and Roncin 1991; Connolly 
et al. 2009a; Connolly and Serle 2014). Bridges and Kolder (1964) found that breathing 
10% oxygen was associated with a reduced sensitivity that continued post hypoxia for 
over 10 minutes. However three subjects were tested twice and the repeat data may 
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have influenced the results. At high altitudes (5400m), equating to 11% oxygen tension, a 
decrease in contrast sensitivity in the low and medium spatial frequencies was recorded 
in 12 healthy mountain climbers who ascended by foot (Nordmann et al. 1991). Although 
this will give a more realistic view of the effects of altitude, it does introduce other, 
external factors such as subject fatigue and changes in background lighting. More 
recently, CS has been reported to be affected by hypoxia in the mesopic range (Connolly 
et al. 2009a; Connolly 2010). Connolly and Barbur (2009) found that when measuring low 
contrast acuities, hypoxia (breathing 14.1% oxygen) necessitated 50% more contrast to 
maintain the acuity achievable when the subjects were breathing 100% oxygen. This was 
at both the fovea and at various eccentricities out to 5⁰ when testing in the mid-mesopic 
range. 
In contrast, other studies have suggested that CS is resistant to hypoxia, with insignificant 
changes to visual capability down to an oxygen tension of 8% (Rossi et al. 1985; Kobrick et 
al. 1988; Yap et al. 1995; Connolly 2010). However Kobrick et al. (1988) only used 8 
subjects who, over a 40 day period, had a reduction in oxygen tension to 8% in a 
decompression chamber. A high stimulus luminance was used, which is less likely to be 
affected by hypoxia and two of the participants did not complete the experiment due to 
altitude sickness. There are no participant details in the Rossi et al. (1985) study. Studying 
contrast sensitivity at both 18,000ft and 25,000ft (10.92% and 8.19% oxygen respectively) 
Pescosolido et. al. (2015) found that the reduction in CS was only significant at 25,000ft. 
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Connolly (2010) reported that foveal contrast sensitivity was resistant to changes in 
oxygenation when lighting conditions favoured cone function (photopic conditions). 
Interestingly, Benedek et al. (2002) showed that short term hypoxia increased contrast 
sensitivity after measuring contrast sensitivity in the range of 0.5-4.8 cycles/degree in a 
hypobaric chamber at 5500m, equivalent to breathing 11% oxygen. He postulated that 
short hypoxic challenges (15 minutes) might enhance early visual processes, evidenced by 
a significant negative relationship between arterial oxygen saturation and contrast 
sensitivity values at low and medium spatial frequencies (0.5-4.8 c/deg). However there 
was no control of hypercapnia (high levels of CO2 in the blood), which could have 
distorted the results. It was still concluded that chronic hypoxia would result in a visual 
loss.  
Hypoxia has been postulated to be involved in the pathogenesis of diseases with vascular 
changes. The effect of breathing additional oxygen on the CS of patients with type 1 
diabetes suggested that hypoxic tissue might result in the decline in contrast sensitivity 
seen in diabetes (Harris et al. 1996). When breathing 100% oxygen, the defects that had 
been seen at 12 and 18 cpd when breathing room air were improved, and at 12 cpd 
actually reached normal values.   
In conclusion, contrast sensitivity, especially at low spatial frequencies, can be affected by 
hypoxia but is preserved at higher levels of illumination.  
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2.2.4 The effect of hypoxia on colour vision 
From the 13 studies reviewed looking at the effect of hypoxia on colour vision, 11 
concluded that colour vision was affected by hypoxia. Two studies found that hypoxia 
resulted in a protan type defect (Kobrick 1970; Bouquet et al. 2000) and two found a 
deutan type defect (Richalet et al. 1989; Richalet et al. 1998), although neither of these 
studies tested for a tritan defect. Seven studies reported a resultant tritan defect 
(Bouquet et al. 2000; Connolly et al. 2008; Karakucuk et al. 2004; Smith et al. 1976; 
Tekavcic-Pompe & Tekavcic, 2008; Willmann et al. 2010).  A generalised loss of colour 
vision for both red-green and blue-yellow perception was found by two studies (Vingrys 
and Garner 1987; Connolly et al. 2014) and a small red-green defect was reported by 
Connolly et al. (2008).  
Looking at the effect of oxygenation state and light levels on colour vision, both Connolly 
et al. (2008) and Connolly and Serle (2014) found that under mild hypoxia chromatic 
sensitivity decreased progressively with reducing luminance. This supports other results 
that the effect of hypoxia on colour vision is more pronounced under lower lighting levels 
(Kobrick 1970; Smith et al. 1976; Hovis 2012). Hovis  (2012) studied the effects of hypoxia 
on colour vision in normals and those with red-green defects at ground level and 3780m 
(13.5% O2) using three colour vision tests. The results suggested that mild hypoxia is 
equivalent to a slight reduction in luminance with respect to its effect on colour vision. 
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Smith et al. (1976) concluded that their tritan defect could be interpreted as evidence of 
the effect of hypoxia on the inner retina. Vingrys et al. (1987) also suggested an inner 
retinal effect of hypoxia. Discussing their colour vision results and the lack of an effect of 
hypoxia on a photostress test included in the same study they concluded that their 
generalised colour vision loss was similar to that found in optic neuritis- a condition 
affecting retinal ganglion cells. However Willman et al. (2010) and Connolly et al. (2008) 
proposed that the effects on photoreceptors are the cause of colour vision defects seen 
in hypoxic conditions. A tritan defect in hypoxic conditions was suggested by Willman et 
al. (2010) to be due the lower numbers of S cones in the retina. With only 5-10% of cones 
being S cones, if the maximum responses of all cone pathways were equal, the effect on 
the S cones would become detectable earlier than for the L and M cone pathways. 
Photoreceptor vulnerability was also suggested by Connolly et al. (2008), proposing that 
the S cones may have a higher metabolic demand than the other cone types.  
However, not all studies have found hypoxia and altitude to have a significant effect on 
colour vision. Schmeisser et al. (1997) found no change in colour vision up to 4,200m 
(12% O2) and Leid and Campagne (2001) studying up to 7,000m (9% O2) agreed. Using the 
desaturated D15 test, Leid and Campagne (2001) demonstrated that in trained subjects, 
severe hypoxia due to altitude (on foot) does not lead to changes in colour perception. 
However in a group of nine of subjects, one already had a tritan defect and several 
suffered from severe altitude sickness that may have affected results and led to only two 
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subjects making it to an altitude of 7,000m. It should also be noted that the desaturated 
D15 has a weak sensitivity to red-green defects. 
In conclusion, colour vision seems to be affected by hypoxia and studies have found this 
in the protan, deutan and tritan axes, particularly at lower light levels. Conclusions by two 
studies after analysis of ERG and the psychophysical findings were that the inner retina, in 
particular the RGCs, were sensitive to hypoxia and were responsible for this defect 
(Vingrys et al. 1987; Smith et al. 1976). The results of more recent studies (Connolly et al. 
2008a; Willmann et al. 2010), suggest the outer retina is affected and that these changes 
could be influenced by the different proportions of photoreceptor types (Willmann et al. 
2010) with the possibility that S cones have a greater metabolic demand (Connolly et al. 
2008a), making them more susceptible to dysfunction in hypoxic conditions. 
2.2.5 The effect of hypoxia on electrophysiology 
Animal studies have shown that the b-wave of the ERG is affected by ischaemia (Block 
and Schwarz 1998; Kang Derwent and Linsenmeier 2000). More recently, studies on 
human subjects have used mfERG and flash ERG recordings to assess retinal function 
under hypoxic conditions and most have found changes to the waveform (Tinjust et al. 
2002; Janáky et al. 2007; Klemp et al. 2007; Kofoed et al. 2009; Pavlidis et al. 2005; Feigl 
et al. 2007; Feigl et al. 2008; Schatz et al. 2014; Schatz et al. 2013). 
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Looking at the human photopic ERG, Tinjust et al. (2002), Janaky et al. (2007) and Brown, 
Hill, & Burke (1957) found that the a-wave amplitude and latency were not affected by 
hypoxia, suggesting that the PRs are spared from this effect. However, when recording 
scotopic ERGs, a significant decrease in the amplitude of the a-wave, but a preserved 
latency was found by two studies (Schatz et al. 2014; Schatz et al. 2013), suggesting a 
decrease in the quantity of cells that are responding, as opposed to a change in the 
functionality of the cells. A decrease in the photopic b-wave amplitude has also been 
reported in hypoxic conditions (Schmeisser et al. 1997; Tinjust et al. 2002; Schatz et al. 
2014; Schatz et al. 2013). It is of interest that Schatz et al (2013 & 2014) reported that 
changes to the amplitude of the b-wave were only found with stimuli that affected both 
PR types; when rod only stimuli were used (0.01 cd.s/m2), no significant changes were 
observed.  
Decreases in the amplitudes of the oscillatory potentials (OPs) OP1, OP2 and OP3 with 
hypoxia have also been recorded (Janáky et al. 2007; Tinjust et al. 2002). Changes to the 
OPs indicate that the inner retina is affected by oxygenation changes as their origins are 
thought to represent activity from the amacrine and ganglion cells (Wachtmeister 1998). 
However, Schatz (2013 & 2014) found no changes in OPs. Further evidence that the inner 
retina is affected by hypoxia comes from the pattern ERG. A delayed N95 implicit time 
and depressed N95 amplitude in pattern ERG recordings has been seen in the case of 
mild, transient hypoxia (Kergoat et al. 2006). The origins of the N95 component of the 
PERG have been ascribed to the retinal ganglion cells (Heckenlively and Arden 2006).  
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There are differences between the findings of these studies. For example, Janaky (2007) 
did not report reduced b-wave amplitudes and found greater reductions in the OP 
amplitudes when compared to Tinjust et al. (2002). This may be explained by difference in 
recording protocols. Whereas Tinjust et al. (2002) averaged only photopic ERGs which did 
not involve dark adaptation, ERGs recorded by Janaky (2007) were involved recording 
ERGs after 20 mins dark adaptation allowing the assesment of rod, cone and OP functions 
separately. 
Changes in the mfERG have been recorded, with the fovea being most sensitive to 
oxygenation changes (Klemp et al. 2007; Pavlidis et al. 2005; Feigl et al. 2007; Feigl et al. 
2008). Klemp (2007) found that the P1 and N2 amplitudes were reduced by up to 38.5% 
and 33.0% respectively by hypoxia in photopic conditions, however the implicit times of 
the waveform components were unchanged. The oscillatory potentials were reduced, but 
this effect was not regional. The fast flicker and slow flash mfERG have both been found 
to be affected by hypoxia with a decreased N1 P1 amplitude indicating that ON and OFF 
bipolar cells were most affected (Feigl et al. 2007; Feigl et al. 2008). Figure 2-3 shows data 
collected by Feigl et al. (2007), showing reduced amplitude waveforms and reduced 3D 
scalar product response densities when the participant is hypoxic.  
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Figure 2-3. 3D plots of the scalar product response density (top) and trace arrays 
(below) for the fast flicker (a) and slow flash (b) paradigm before (left) and during 
hypoxia (right) for two representative participants (Feigl et al. 2007). 
Kofoed et al. (2009) took a different approach to examining the effect of altitude, by 
taking residents living at 3600m and examining their mfERGs over 72 days after moving 
them to sea level, compared to eight healthy lowlanders. On day two, the highlanders 
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summed mfERG amplitude was 43.1% larger than the lowlanders’ reference, 47.1% larger 
for P1 and 59.9% for P2. These differences increased over time, so that on day 72 they 
were 73.2%, 76.0% and 87.01% for the summed, P1 and P2 amplitudes respectively, 
showing a supernormal level with the relative hyperoxia. Implicit times were not 
significantly different between the two groups. These findings were despite a decrease in 
haemoglobin of 10.6% over the experiment in the highlander group, possibly due to 
adaptation of the retina to a different metabolic environment, and suggesting that these 
participants had a different type of retinal neuronal fitness. 
The standing potential and the light rise in the electro-oculogram have also been shown 
to be affected when breathing 10% oxygen (Linsenmeier et al 1987). In this study, a 
subnormal light rise and an increase in the standing potential were found, suggesting 
either RPE or PR sensitivity to hypoxia. Linsenmeier (1990) later suggested that it was the 
PRs that were affected by hypoxia, based on a further study on cat retinas and a 
comparison with other electrophysiological papers at the time. 
In conclusion, the ERG responses are sensitive to changes in oxygenation, with several 
components including the a-wave, b-wave and OPs affected by hypoxia. A preserved a-
wave under photopic conditions suggests a resistance to hypoxia in cone PRs (Janáky et 
al. 2007), although there is evidence of a reduced a-wave amplitude in hypoxia under 
scotopic conditions (Schatz et al. 2014; Schatz et al. 2013), which may be due to the 
increased retinal metabolic demand in scotopic conditions. The mfERG shows changes 
with hypoxia, with a marked decrease in response density at the fovea.  Several studies 
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have found reduced N1P1 amplitudes, suggesting that the bipolar cells are most affected 
by hypoxia although other sections of the waveform have also been affected. 
2.2.6  The effect of hypoxia on dark adaptation. 
The effect of hypoxia on dark adaptation has been recognised since the 1930s, with early 
studies finding that dark adapted thresholds were elevated in response to hypoxia, but 
that the time taken for DA to occur seemed not to be affected (McFarland et al. 1939; 
McDonald and Adler 1939; Wald and Harper 1942a). McFarland and Evans (1939) and 
McDonald and Adler (1939) both found an elevation of 0.40 log units in absolute 
threshold with hypoxia in both the rod and cone systems, whilst the rate of dark 
adaptation appeared unchanged. Data collected from 20 subjects in the McFarland and 
Evans (1939) study, showed that rod photoreceptors were more sensitive to the 
reduction in oxygen tension.  
Figure 2-4 shows the mean adaptation curves of six subjects under reduced oxygen 
concentrations, ranging from 21% to 10.1% (McFarland & Forbes, 1940), and 
demonstrates raised dark adapted thresholds under hypoxic conditions. The data show 
that the thresholds for rod and cones were elevated, with the scotopic threshold ranging 
from 2.85 to 3.05 log microlamberts in the control series, to 3.50 to 3.85 log 
microlamberts when breathing 10.1% oxygen. It can also be seen that the curves are 
parallel with the control curves, showing the time course remained unaffected. Both 
McFarland and Evans (1939) and Mcfarland and Forbes (1940) found that, at the end of 
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the experiment when 100% oxygen was supplied to the subjects, the sensitivity increased 
rapidly. This led to the conclusion that the effect of hypoxia upon the dark adaptation 
function was not related to regeneration of visual pigment, as the recovery was too rapid, 
but instead to the neural retina and the central nervous system. This theory was also 
supported by the finding that reduced oxygen had a greater effect at lower light 
intensities (Hecht and Hendley 1946).  
      
Figure 2-4. Mean dark adaptation curves for 6 subjects under various oxygen tensions. 
(McFarland and Forbes. 1940). 
One recent study has found the time course of dark adaptation to be affected by hypoxia 
(Connolly et al. 2006). By studying dark adaptation using fixed stimulus intensities and 
measuring time as the dependent variable, recovery post bleach of both the cone and rod 
thresholds was recorded.  As can be seen in Figure 2-5 the rod cone break was delayed 
and the rod section of the dark adaptation curve was shifted to the right when 
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participants were at simulated 4572m (12% oxygen) when compared to the dark 
adaptation curves obtained at ground level. However this study did not evaluate 
quantitative measures of adaptation, such as the time constants of rod and cone 
recovery. 
 
Figure 2-5. Effect of hypoxia when breathing air at 4572m on the rate of dark 
adaptation in 5 subjects showing detection time displacement relative to a control dark 
adaptation breathing air at ground level Connolly and Hosking (2006). 
When comparing their results with the earlier findings of no change in the time course of 
the rod, cone or rod cone break portions of the curve, it seemed possible that the rod 
cone break in the earlier studies may have been missed by infrequent measurements of 
threshold.  Connolly and Hosking (2006) discussed that if the rod cone break was inferred 
in the absence of data points, it could mean that the rod section of the curve may have 
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actually included data from the cone portion of the curve, masking the delay in the rod 
cone break and shifting the rod section to the right. 
The effects of high altitude/ reducing oxygen concentration on thresholds have been 
found to be rapid and transient (Kobrick et al 1984; Wald & Harper, 1942). Wald and 
Harper (1942) found that the threshold adjusts rapidly (within 1-10 minutes) to hypoxia 
(8-11% oxygen), with exposures lasting five to six hours not translating to greater or more 
persistent changes. The results from Ernst and Krill (1971) indicated that the first four 
minutes of rod and cone adaptation were not affected by hypoxia, and concluded that 
this was due to this section relating to neural rather than photochemical processes. This 
hypothesis is in contrast to McFarland and Evans (1939), McFarland and Forbes (1940), 
McDonald and Adler (1939) and Hecht and Hendley (1946) who all concluded that the 
effect of hypoxia on dark adaptation was not related to photochemical processes but 
rather to neural processes. Kobrick et al. (1984), found that the major effect of hypoxia 
was in the first 10 minutes and suggested that the differences found could be due to the 
longer duration of hypoxia in their study. 
Several studies have used hypoxia induced by disease to study the dark adaptation 
process. Thylefors et al. (2009) assessed dark adaptation in patients with respiratory 
insufficiency, all of which were on long-term oxygen therapy (for at least 4 months) when 
breathing their normal oxygen dose, and when they had been without it for at a mean of 
4 hrs. They found no change in the dark adaptation function without oxygen, despite a 
reduced arterial blood oxygen saturation of 5.8%. They hypothesised that this could be 
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due to the lack of hypocapnia that would, at high altitudes in a normal population, cause 
vasoconstriction and reduce not only the concentration of oxygen but also its delivery. 
The subjects in their study were hypercapnic or normocapnic so may have larger blood 
vessel lumens, which would be further dilated during hypoxia, therefore preserving dark 
adaptation. 
In conclusion, dark adaptation has been shown to be affected by hypoxia, with current 
evidence suggesting that it affects both final threshold and the rate of dark adaptation. 
2.3 The role of hypoxia in the pathogenesis of AMD. 
2.3.1 The relationship between changes to the ocular vasculature and 
AMD 
The hypothesis that the aetiology of AMD is linked to changes in the ocular vasculature 
was first proposed when changes to the choroidal vasculature, including narrowed 
capillary lumens and a diminution or loss of cellularity of the capillaries were found in 
eyes with AMD (Kornzweig 1977). Later, a reduction in the perfusion of the choroid was 
found in participants with AMD (Prünte and Niesel 1988) and an increased scleral rigidity 
was found in eyes with AMD (Friedman et al. 1989).  
The increase in scleral rigidity and vascular resistance has been further supported by 
other studies (Friedman et al. 1989; Pallikaris et al. 2006; Friedman et al. 1995). 
Increasing age is associated with an increase in ocular rigidity as well as the onset of 
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atherosclerosis and vascular lipid deposition and, therefore, a decrease in the compliance 
of the sclera and Bruch’s membrane (Friedman 2008). This decrease in compliance 
reduces venous choroidal blood flow due to the vortex veins passing through the 
hardened sclera. This has been hypothesised to affect the transportation of metabolites 
and waste products from the RPE, leading to drusen formation and GA (Friedman 2008).  
According to this theory the resultant increase in choriocapillary perfusion pressure 
culminates in nAMD (Friedman 2004). This pathway of progression can be seen in Figure 
2-6. 
 
Figure 2-6. Schematic representation of the vascular model of the pathogenesis of age- 
related macular degeneration. (Friedman 2004). 
However, not all studies have found ocular changes consistent with Friedman’s vascular 
model. Pallikaris (2006) measured the ocular rigidity of three groups of participants; age 
matched controls, participants with GA and participants with nAMD. The findings 
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supported the vascular theory in nAMD, showing that average ocular rigidity 
measurements were significantly higher in participants with nAMD compared to controls 
and to participants with GA. However, there was no statistically significant difference 
between controls and participants with AMD when the two AMD groups were reviewed 
as one. It is important to note that Pallikaris (2006) did not take into account age and axial 
length, which have been linked to a reduction in choroidal perfusion, increasing the risk of 
nAMD (Böker et al. 1993). This could potentially confound the link between an increased 
ocular rigidity and nAMD. Also the nAMD group had been treated with PDT, which may 
have influenced the results. There were also differences in the study designs with 
Friedman (1989) using a direct manometric measurement and Pallikaris using an indirect 
technique. Friedman (1989) also did not distinguish between AMD types in his study; an 
over-representation of participants with nAMD could have influenced the results.  
The vascular model is supported by studies finding a change in retrobulbar circulation. 
This is hypothesised to lead to a vascular impairment within the eye, altering the 
metabolic transport in AMD (Pallikaris et al. 2006; Friedman et al. 1995; Ciulla et al. 
1999a; Hosal et al. 1998; Dimitrova et al. 2002). Friedman et al (1995), Hosal et al. (1998) 
and Dimitrova et al. (2002) all found that there were abnormalities in the retrobulbar 
circulation, particularly in the supply from the posterior ciliary artery when comparing 
participants with AMD to controls, but they did not investigate AMD subtypes. Ciulla et al 
(1999) studied age matched controls and participants with GA.  It was concluded that 
participants with GA had a 26% decrease in mean end diastolic velocity in the nasal 
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posterior ciliary artery which was statistically significant. There was also a trend towards a 
lower peak systolic velocity in the nasal posterior ciliary artery and a lower end diastolic 
velocity in the temporal posterior ciliary artery. These findings are suggestive of a 
reduced flow and therefore perfusion in these vessels and the choroid in GA. Evidence 
has since suggested that the increasing blood pulsatility correlated with the severity seen 
in the retinal vessels of participants with AMD was due to a loss of compliance in the 
arterial vasculature (Sato et al. 2006).  
With the advent of new imaging techniques, imaging of the choroidal circulation in vivo 
has improved. Laser Doppler flowimetry is based on the assessment of the Doppler shift 
of low-power laser light, which is scattered by moving red blood cells to provide a non-
invasive, continuous measure of tissue blood velocity. It can therefore be used to assess 
the choroidal blood flow and volume and choroidal velocity can be calculated from these 
measurements. Indocyanine green angiography can also be used in the investigation of 
choroidal circulation. Changes in the choroidal circulation, which could lead to hypoxia, 
have been associated with AMD. Decreasing choroidal blood flow has been associated 
with ageing in normal participants (Grunwald et al.1998b), in participants with nAMD 
(Goldberg et al. 1998) and in participants with GA (Xu et al. 2010; Grunwaldet al. 1998a), 
which is possibly caused by a decrease in choroidal blood volume (Grunwald et al. 1998a). 
This suggests that an increasing risk of retinal ischaemia with age could be involved in the 
pathogenesis of AMD (Xu et al. 2010). Although no change in choroidal volume, flow or 
velocity was found in early AMD by Remsch (2000), choroidal filling defects were 
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associated with drusen in other studies (Staurenghi et al. 1992; Zhao et al. 1995). This is 
possibly due to an accumulation of hydrophobic material in Bruch’s membrane with age. 
As Bruch’s membrane should stretch to accommodate changes in blood volume (Curcio 
and Johnson 2013), this accumulation of material may alter its elasticity, resulting in 
localised obstruction. More recently a significant inverse relationship has been found 
between the total drusen area and choroidal blood volume and flow (Berenberg et al. 
2012). As total drusen area has been associated with an increased risk of progression to 
advanced AMD (Solomon et al. 2009) these studies linking changes in blood flow with 
total drusen area suggest that ischaemia may be the reason for progression from early to 
late AMD (Berenberg et al. 2012). However, in the pathogenesis of drusen it is still 
unknown if ischaemia precedes drusen development (Bhutto et al. 2012) or if it is a 
consequence of drusen formation.  
Choroidal changes such as a reduction in choroidal blood flow, volume and perfusion 
have been found to precede the development of nAMD (Metelitsina et al. 2008; Boltz et 
al. 2010; Grunwald et al. 2005; Üretmen et al. 2003; Mori et al. 2001). Pulsatile ocular 
blood flow and pulse amplitude were found to be lower in participants with nAMD 
compared to normal participants (Mori et al. 2001). However Chen (2001) and Remsch et 
al. (2000), comparing eyes with unilateral nAMD found that blood flow was higher in eyes 
with nAMD, possibly due to an autoregulative vascular response to a compromised 
metabolism. It was also found that pulsatile ocular blood flow (Chen et al. 2001) and 
perfusion (Remsch et al. 2000) were lower in eyes with disciform scarring. It could be that 
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these haemodynamic changes are the cause of nAMD and scarring or that haemodynamic 
changes could result from an increase in choroidal blood flow due to neovascularisation 
and a decrease in the requirement of circulation when there is disciform scaring. 
Therefore it is unknown if changes in circulation precede neovascularisation or GA or are 
a consequence of them. The differences between the findings of the Mori et al (2001) and 
Chen et al (2001) studies could be explained by differences in the stage of CNV being 
assessed; Mori et al (2001) did not classify the type of nAMD. It could be that the 
neovascular group had participants in that were not in the active stages of 
neovascularisation. There is also a possible effect of inter-individual variation such as age 
and blood pressure in the Mori et al (2001) study, which was controlled for by Chen et al 
(2001). Slow choroidal filling has also been found in early AMD (Pauleikhoff 1999), GA 
(Ciulla 2002; Prünte et al. 1988), nAMD (Chen et al. 1992; Giovannini et al. 1994; Zhao et 
al. 1995; Böker et al. 1993) and in the fellow eyes of participants with unilateral nAMD 
(Remulla et al. 1995).  
Histological changes to the ocular vasculature have also been associated with AMD, 
including a loss of choroidal blood vessels with overlying RPE atrophy, with remaining 
vessels having a statistically significant restriction in lumen diameter (McLeod et al. 2002; 
Kornzweig 1977). A decrease in choriocapillary density and diameter with late AMD and 
basal laminar deposits was also found by Ramrattan et al. (1994).  In contrast to the 
findings of Ramratten et al (1994), Spraul et al (1999) reported a loss of large choroidal 
vessels and an increase in the density of the choriocapillaris in the submacular area in 
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eyes with AMD compared to eyes without AMD. In the peripheral choroid an increase in 
the diameter of the large choroidal vessels has also been observed (Spraul et al. 1996). 
The differences between these studies could be explained by Ramrattan et al (1994) 
assessing eyes with GA and scarring, which are stages of AMD characterised by a loss of 
RPE, whilst Spraul et al. (1996) studied 21 eyes with nAMD and 19 with non-nAMD, few of 
which had GA.  
Other abnormalities in blood vessels have been observed linking hypoxia and AMD. These 
include deep retinal vascular anomalous complexes, a form of neovascularisation which 
grows into the sub-retinal space which is associated with AMD and thought to be a 
response to hypoxia (Hartnett et al. 1996). Watershed zones, which are areas already 
associated with ischaemia have also been associated with nAMD (Mendrinos et al. 2009; 
Giovannini et al. 1994; Chen et al. 2001; Ross et al. 1998).  
2.3.2 The relationship between changes to Bruch’s Membrane and 
AMD 
Bruch’s membrane is known to thicken with ageing (Booij et al. 2010; Ramrattan et al. 
1994), which could result in hypoxia at the photoreceptor level due to the increase in 
distance O2 has to diffuse (Stefánsson et al. 2011). Links have been made between these 
ageing changes in Bruch’s membrane and hypoxia in AMD. For example, a prolonged 
choroidal filling may be causally related to a diffuse thickening in Bruch’s membrane 
(Pauleikhoff et al. 1990; Staurenghi et al. 1992; Piguet et al. 1992). Thickened Bruch’s 
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membrane could also modulate the secretion of growth factors by RPE cells (Mousa et al. 
1999) and may also prevent the VEGF secreted by the RPE from reaching the 
choriocapillaris, resulting in choroidal atrophy. The resulting accumulation of VEGF on the 
basal side of the RPE may also induce neovascularisation (Blaauwgeers et al. 1999).  An 
increase in extracellular matrix components in cultured RPE cells which have undergone 
both hypoxia and reoxygenation has been found. Hypoxia and reoxygenation injuries are 
known to cause oxidative stress. An increase in the synthesis of extracellular matrix cells 
may contribute to their accumulation in Bruch’s membrane as basal laminar deposits 
(Fuchshofer et al. 2009). 
2.3.3 The relationship between hypoxia-led upregulation of growth 
factors and growth inhibitors, and AMD 
The role of vascular changes leading to ischaemia in retinal neovascularisation was 
reported in 1948 by Michelson who described oxygen regulated angiogenesis in the 
retina, mediated by factor x; which was later identified as VEGF (Michelson 1948). The 
process of retinal neovascularisation is now well understood but the pathogenesis of 
choroidal neovascularisation is less clear (Campochiaro 2000; Das and McGuire 2003). 
The influence of pro-angiogenic cytokines, including VEGF, which are up-regulated by the 
production of HIFs in response to hypoxia, have been proposed to be central to the 
development of nAMD (Sheridan et al. 2009). 
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Hypoxia increases the levels of VEGF in the RPE (Young et al. 2005; Wu et al. 2007; Mousa 
et al. 1999; Aiello et al. 1995; Shima et al. 1995; Coassin et al. 2010; Blaauwgeers et al. 
1999) and  HIF-1a mRNA in the retina (Fuchshofer et al. 2009; Zhang et al. 2011; Inoue et 
al. 2007). The expression of VEGF by the RPE in normoxic conditions has been reported to 
be higher on the basal side, facing the choroid, which is suggestive of a role in 
choriocapillaris maintenance (Blaauwgeers et al. 1999). HIF -1 and HIF -2 have been found 
in choroidal neovascular membranes, mainly expressed in RPE cells, suggesting that RPE 
cells are hypoxic in AMD and that they are initiating a wound healing response (Sheridan 
et al. 2009).  
Hypoxia-inducible factors not only upregulate VEGF, but also connective tissue growth 
factor which has been found to be expressed in RPE cells with hypoxia (Fuchshofer et al. 
2009). This increases extracellular matrix components including fibronectin and collagen 
type IV in the RPE which may result in Bruch’s membrane thickening in AMD (Fuchshofer 
et al. 2009).  
The maintenance of the choroidal circulation is dependent on the balance of pro-
angiogenic growth factors, such as VEGF, and anti-angiogenic factors, such as PEDF, which 
decreases in expression with age (Ogata et al. 2004).  PEDF concentrations have been 
found to be significantly lower in RPE cells, RPE basal lamina, Bruch's membrane, and the 
choroidal stroma of eyes with nAMD when levels of VEGF were not different between 
aged controls and tissues with nAMD (Bhutto et al. 2006). These findings suggest that a 
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decrease in PEDF may disrupt the balance and be permissive for the formation of 
choroidal neovascularisation. 
2.3.4 Hypoxia led cellular changes and AMD 
Hypoxia not only causes changes in the expression of growth factors and inhibitors, but 
also affects the concentrations of other proteins and cell regulators involved in 
neovascularisation. Jun kinases (JNK) regulate cellular processes including cell 
proliferation and migration. They have also been found to be a critical factor in hypoxia-
induced retinal VEGF production and in promoting hypoxia induced pathological 
angiogenesis, as seen in AMD (Guma et al. 2009). Protein 53 (P53), a tumour suppressor 
protein which regulates cell cycles and can cause RPE cell apoptosis and an increased 
expression of P53 via HIF-1, has been found as a response to hypoxia in RPE cells and in 
the retina (Gerona et al. 2010; Rosenbaum et al. 1998). Stromal cell derived factor 1 (SDF-
1) recruits bone marrow derived cells to choroidal neovascular membranes, which can 
then differentiate into endothelial cells to participate in the neovascularisation process. 
Hypoxia induces SDF-1 expression in the retina (Lima e Silva et al. 2007), particularly in 
the RPE (Zhang et al. 2011). Vascular cell adhesion protein 1 (VCAM-1) mediates the 
adhesion of lymphocytes, monocytes and other cells to the vascular endothelium. It 
increases susceptibility to neovascularisation and its expression has been found to be 
high in the ischaemic retina, increasing further when both ischaemia and oxidative stress 
are present (Dong et al. 2011).  Heat shock protein 90 (HSP90) is also thought to be a 
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regulator of VEGF expression as pre-treatment with Geldamycin, a HSP90 inhibitor, 
reduces VEGF165 expression in RPE cells under hypoxia (Wu et al. 2007). 
It has been shown that the RPE has the ability to synthesise haemoglobin, this may have 
consequences for hypoxia, as quantitative and qualitative defects in this synthesised 
haemoglobin may underlie the hypoxia that leads to AMD (Tezel et al. 2009). 
2.3.5 The effect of hypoxia on visual function in AMD 
There is functional evidence that hypoxia is part of the aetiology of AMD.  Some visual 
functions such as dark adaptation (Owsley et al. 2000; Owsley et al. 2001), contrast 
sensitivity (Midena et al. 1997; Sunness et al. 1997),  colour vision (Eisner et al. 1991) and 
flicker sensitivity are reduced in AMD. These same functions are also reduced in a 
comparable way in normal subjects under a hypoxic episode  (Connolly 2010; McFarland 
and Forbes 1940; see chapter 2.2), suggesting that hypoxia could be the cause of the 
functional deficits seen in participants with AMD.  
Areas in the retina with altered choroidal circulation have been associated with localised 
changes in visual function in participants with AMD. Areas of choroidal perfusion 
abnormality have been co-localised with discrete areas of raised scotopic threshold in 
participants with drusen (Chen et al. 1992). An association has also been found between a 
prolonged focal ERG implicit time and areas of delayed choroidal perfusion in the fellow 
eyes of participants with unilateral nAMD (Remulla et al. 1995).  
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2.4 Conclusions 
In conclusion, the literature review into the effect of hypoxia on visual function found 
that all aspects of visual function are affected by hypoxia. Some functions, including visual 
fields and contrast sensitivity are preserved until lower oxygen concentrations/ higher 
altitudes are reached, whereas dark adaptation, colour vision and electrophysiological 
responses appear to be more sensitive indicators of hypoxia. 
There is yet to be a consensus on which layer or cell type of the retina is most susceptible 
to hypoxia. Some studies conclude that the photoreceptors may be vulnerable due to the 
changes in visual function relating to the metabolic demand of the rods in mesopic 
studies (Connolly et al. 2009b; Connolly et al. 2008b; Connolly et al. 2008a), others that 
there is a preferential postreceptoral susceptibility (Feigl et al. 2007; Kang Derwent and 
Linsenmier 2000; Smith et al. 1976; Vingrys et al. 1987; Tinjust et al. 2002; Kergoat et al. 
2006), and some that both are affected (Pavlidis et al. 2005). Kang Derwent and 
Linsenmeier (2000) suggested that the function of the photoreceptors may be preserved 
under hypoxemia as when oxidative metabolism is affected; they switch to glycolysis for 
energy production. 
Considering the central and peripheral retina, there is some dispute as to the area most 
affected by hypoxia, dependant on the visual function being tested. Some studies 
conclude that the peripheral retina, out to 40-45° is more sensitive to changes in 
oxygenation (Ernest and Krill 1971; Horng et al. 2008; Connolly et al. 2008b), but Pavlidis 
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et al. (2005) and  Klemp et al. (2007) suggested that it is the macula. This may depend on 
the function being assessed and the state of retinal adaptation. 
All of the visual functions were affected by hypoxia more in scotopic and mesopic than 
photopic conditions. This can be explained by the increased metabolic activity of the 
retina in the dark.  
There are a few points to note in the comparison of the data.  Ernest and Krill (1971) and 
Vingrys and Garner (1987) cautioned against comparing studies conducted by the dilution 
of oxygen with those which altered the atmosphere, such as using a decompression 
chamber, due to the possible independent effect of barometric pressure. A review 
comparing hypobaric hypoxia (a low barometric pressure and low oxygen level) to 
normobaric hypoxia (normal barometric pressure and low oxygen levels) found that SpO2 
was lower in hypobaric hypoxia for the same partial pressure of oxygen for short term 
exposure (Coppel et al. 2015). The control of the test environment could also have 
influenced results in some experiments (Bouquet et al. 2000; Schmeisser et al. 1997), 
which may make it difficult to compare climbing studies on foot with those conducted in 
the laboratory.  
The possibility of carbon dioxide affecting results is something studies have aimed to 
control (Ernest et al. 1971; Vingrys et al. 1987). Hyperventilation has been found to raise 
visual thresholds short term by as much as 0.7- 1.0 log units (Wald et al. 1942a). This 
shows the potential impact of breathing patterns on results. More recent studies have 
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used subjects who are experienced in hypoxic environments, or provided training to 
minimise these effects (Leid et al. 2001; Pavlidis et al. 2005; Connolly 2011; Connolly et al. 
2006). 
The review into the role of hypoxia in the pathogenesis of AMD provided evidence that 
there is an altered blood supply to the outer retina in AMD. However, although the 
change in circulation has been shown in studies looking at the retrobulbar and the 
choroidal circulation, there is some question as to whether these changes lead to hypoxia 
(Campochiaro 2000). Thickening and deposition of Bruch’s membrane in early AMD is 
hypothesised to exacerbate any hypoxia by increasing the distance over which oxygen 
must travel to reach the retina (Wangsa-Wirawan et al. 2003). Further research is 
required to conclusively determine whether hypoxia results from the reduced blood 
supply and from sub-retinal deposits in AMD (Harris et al. 1999). 
Hypoxia is known to prevent the degradation of HIF, which leads to the up-regulation of 
growth factors including VEGF, stimulating neovascularisation in nAMD. A reduction in 
growth inhibitors, including PEDF, also influences the progression of neovascularisation 
(Bhutto et al. 2006). Hypoxia also influences the regulation of other proteins and cell 
regulators, which can also promote neovascularisation (Dong et al. 2011). There is new 
evidence that a reduction in the synthesis of haemoglobin by the RPE may also result in 
hypoxia in AMD (Tezel et al. 2009). 
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The visual deficits seen in AMD are also seen in normal participants during a hypoxic 
episode, suggesting that hypoxia could be the cause of these of deficits in AMD. This is 
evidenced by the co-localisation of changes in visual function with alterations in choroidal 
perfusion. 
The evidence in the literature to date suggests that hypoxia may be involved in the 
pathogenesis of AMD, both in the early stages and in nAMD and GA. However, there is 
currently only circumstantial evidence to link the changes in visual function associated 
with AMD to the onset of hypoxia. This thesis aims to probe this relationship by 
investigating the effect of transient systemic hyperoxia and hypoxia on visual function in 
AMD.  
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3 Effect of respired oxygen 
concentration on SpO2 and scotopic 
thresholds in healthy controls 
This chapter presents studies to investigate the effect of breathing 60% and 14% oxygen 
on scotopic thresholds in healthy controls, and the effect of the retinal location of the 
stimulus on the response to the hypoxia / hyperoxia. Studies also investigate the changes 
in SpO2 levels over time when breathing 10% and 14% oxygen. 
3.1 Effect of breathing 14% and 60% O2 on scotopic thresholds 
and SpO2 
3.1.1 Background and Aims 
Despite the presence of two vascular systems, the supply of O2 to the retina is barely 
sufficient when dark adapted (Wangsa-Wirawan et al. 2003). The first aim of this 
preliminary pilot study was to investigate whether the dark adapted healthy retina is 
hypoxic by comparing scotopic thresholds under hyperoxic and normoxic gas conditions. 
If scotopic thresholds were reduced (i.e. increased sensitivity) under the hyperoxic (60% 
O2) condition relative to normoxia (21% O2), this would indicate that insufficient oxygen is 
reaching the retina under dark adapted conditions.  It was hypothesised that the 
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inhalation of supplementary oxygen would have no effect on scotopic thresholds in dark 
adapted normals, as they are not expected to have hypoxic retinas.  
The literature review in chapter 3 concluded that many aspects of normal visual function, 
including colour vision (Connolly et al. 2008a), dark adaptation (McFarland et al. 1940) 
and electrophysiology (Janáky et al. 2007) are affected by hypoxia. Hence, the second aim 
of this study was to determine if an episode of retinal hypoxia (breathing 14% O2) would 
increase scotopic thresholds. It was hypothesised that scotopic thresholds would be 
elevated (i.e. reduced sensitivity) in this scenario. As the retina is on a hypoxic knife edge 
in the dark (Wangsa-Wirawan et al. 2003) a scotopic measure of visual function was 
selected on the hypothesis that it would be more affected than photopic visual function 
by outer retinal hypoxia . Dark adapted thresholds were therefore chosen as a measure of 
visual function in this study. They have also been found to be affected both by hypoxia in 
normals (as discussed in section 2.2.6) and by AMD (discussed in section 2.3.5) 
Concentrations of 14% and 60% oxygen were chosen as the hypoxic and hyperoxic gas 
mixtures in this study. 14% oxygen has been used for several studies preciously and has 
been shown to safely and  effectively reduce participants’ SpO2  (Connolly 2010; Connolly 
et al. 2009a). 60% oxygen has been used as a hyperoxic gas condition in a previous study 
of the effect of hyperoxia on visual function (e.g. Drasdo et al. 2002). In the studies 
reported in this thesis, participants were asked to breathe each gas condition for 5 
minutes. This duration was chosen on the basis of preliminary pilot data (collected before 
this project started), which suggested that a 5 minute duration of hyperoxia in people 
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with AMD would be sufficient to effect a change in threshold. This also exceeded the 2 
minutes allowed by Drasdo et al. (2002) before they commenced ERG data collection in 
the hyperoxic state in people with type II diabetes. 
The effect of hypoxia on visual function has been predominantly assessed at single 
locations (Connolly 2011; McFarland et al. 1939; Karakucuk et al. 2004; Feigl et al. 2007). 
Hence, the third aim of this study was to determine if there is a topographical variation in 
the effect of hypoxia on scotopic thresholds in healthy controls. Three retinal locations 2º, 
7º and 12º were chosen. This area contains the fovea, which may be predisposed to 
hypoxia as a result of the absence of the inner retinal circulation, and also the area 
between 10-15 degrees which may be preferentially affected by hypoxia as this is where 
retinal rod density and therefore oxygen demand is highest (Jonas et al. 1992). The retinal 
area within 12 degrees is also the region of the retina which shows the greatest 
dysfunction in AMD. In future studies investigating the role of hypoxia in visual 
dysfunction in AMD, we wish to select the area most predisposed to hypoxia for 
psychophysical testing. This pilot study aims to identify this location. 
3.1.2 Participants 
Eighteen participants were recruited from the School of Optometry and Vision Sciences in 
Cardiff University and provided informed written consent before taking part. All 
procedures adhered to the tenets of the Declaration of Helsinki and the study was 
approved by the School of Optometry and Vision Sciences ethical committee. 
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Participants were excluded on the basis of: pregnancy; a history of asthma; chest disease; 
respiratory failure; chronic bronchitis; emphysema; an inability to walk more than 500 
yards due to a shortness of breath; cardiac disease or previous chest surgery;  if they 
were current smokers; a history of previous or current eye conditions known to affect 
retinal function; a VA less than 6/7.5 (0.1 logMAR). 
3.1.3 Equipment 
Stimuli were presented on a calibrated, gamma corrected (Methra, Vingrys and Badcock 
1993) high-resolution computer monitor (Iiyama LS 902UT) driven by an 8-bit (nVIDIA 
Geforce 9) graphics board under software control (Matlab, Math-works, Cambridge, UK). 
A neutral density filter, with an optical density (OD) of 3.3 log units, was used to 
attenuate the luminance of the stimuli and allow the monitor to function within its linear 
luminance range. Scotopic thresholds were measured using a 3-down 1-up staircase 
procedure. Participants fixated on a cross in the centre of the screen, and indicated the 
perception of the stimulus using a keyboard. The stimulus was presented for 200msec, 
followed by a 600msec response window and then a randomly determined interstimulus 
delay of 0.9-2.4 secs, which generated, on average, a stimulus every 2.45 secs. Response 
to the stimulus within 600 msec reduced the luminance of the next presentation by 0.3 
log units. If the response was outside this timeframe, or if there was no response, then 
the intensity of the following presentation was increased by 0.1 log units. Three locations 
were tested over 2 visits using targets stimulating the same total retinal area; a 2⁰ radius 
spot, a 7⁰ radius annulus (width 0.30º) and a 12⁰ radius annulus (width 0.20º). If the 
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computer detected that the lower end of the linear luminance range was being reached 
then it emitted a sound to indicate that a second neutral density filter (OD 1.5 log units) 
was required.  
Normoxic, hyperoxic and hypoxic gas conditions were provided by having the participants 
wear a 60% ventimask (Intersurgical Ltd). The 60% ventimask mixes the contents of the 
gas cylinder in a 1:1 ratio with ambient air. Hence, a cylinder containing 100% oxygen 
delivered 60% oxygen, medical air provided 21% oxygen and a canister containing 8% 
oxygen provided 14% oxygen for inspiration. The participants continued to wear the same 
mask for all gas conditions, and were masked as to which cylinder was attached to the 
mask at any time. Throughout all experiments, SpO2 was measured using a finger pulse 
oximeter (CMS 50E, Crucial Medical Systems). The pulse oximeter works by analysing the 
absorption characteristics of haemoglobin (Hb) and oxyhaemoglobin (HbO2) in near-
infrared zones. The output of the device is SpO2, pulse rate and the pulse waveform. The 
device can be seen in Figure 3-1. 
 
Figure 3-1. Crucial Medical Systems CMS 50E Pulse oximeter showing the output of the 
device. 
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3.1.4  Method 
Preliminary assessment included history and symptoms, measurement of visual acuity, 
slit lamp biomicroscope assessment of the anterior chamber angle using Van Herick 
technique, dilated binocular indirect fundus examination, fundus photography and OCT 
(Topcon 3D OCT 1000). 
The untested eye was patched and the eye being tested was dilated with 1% tropicamide 
(the eye with the best visual acuity or the right eye if both were equal). Refractive 
correction was worn if required. After an initial 30 minutes of dark adaptation, thresholds 
were measured at one of the retinal locations with the participant breathing one of the 
three gases. Each gas was inhaled for 5 minutes, followed by a 5 min washout period 
before the next gas was presented. Thresholds were recorded throughout. The 
participants returned for a second visit within 2 weeks of the first and data were collected 
from the remaining 2 retinal locations. A timeline of the data collection process is shown 
in Figure 3-2. 
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Dark adapt 30 mins 
with last 5 mins as 
practice time 
G1 NG G2 NG G3 NG 
Dark adapt 30 mins 
with last 5 mins as 
practice time 
G1 NG G2 NG G3 NG G1 NG G2 NG G3 NG 
  
 
Figure 3-2. Timeline of experiments on visit 1 and 2. G1= gas 1, G2= gas 2, G3= gas 3. 
NG= no gas wash out period. 
Both gas and location orders were randomised to minimise any impact from the learning 
effect or from fatigue. Results were exported straight into Microsoft Excel for analysis. 
SpO2 readings were recorded every minute throughout. The experiment was stopped if 
the SpO2 levels dropped below 85%.  The participant set up can be seen in Figure 3-3. 
 
 
 
 
Location 1 
Location 2                                         Location 3 
 
117 
 
 
Figure 3-3. Participant set up. 
3.1.5 Data analysis 
SpO2 and scotopic threshold data were tested for normality with a Shapiro-Wilkes test. 
The relationship between scotopic thresholds and SpO2  was analysed with a repeated 
measures ANOVA test or with the non-parametric alternative Friedman test. 
 
8% O2 Medical air 100% O2 Monitor with ND filters 
Pulse oximeter 
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3.1.6 Results 
Eighteen healthy individuals were recruited, between the ages of 20-48 years with a 
mean age of 24.7yrs +/- 7.0 SD. There was a gender split of 67% females and 33% males. 
Full datasets were collected for all three gases at all three locations for all participants.  
Figure 3-4 Shows the SpO2 data for a typical particiapant (RM) at the fovea over a visit. 
The gas order for this participant was 14% (5-10 minutes), 21% (15- 20 minutes) and 60% 
25-30 minutes). It can be seen that for this individual there is a reduction in SpO2 to 96% 
in this individual when breathing the hypoxic gas, but SPO2 was constant at 99% for both 
normoxic and hyperoxic conditions.  
 
Figure 3-4. SpO2 data for participant RM during scotopic threshold foveal data 
collection. 
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Figure 3-5 shows the group averaged SpO2 per minute for each of the three gases. It can 
be seen that breathing 60% oxygen resulted in a slight increase in SpO2 that was greatest 
in the 4th minute with an increase of 0.46% compared to medical air. The graph also 
shows a reduction in SpO2 with hypoxia, the greatest drop is in the 5th minute with a drop 
of 2.98% compared to medical air. Beyond the first minute, 95% confidence intervals for 
the 3 gases are not overlapping, indicating a significant difference in SpO2 between gas 
conditions.  
 
Figure 3-5. Group averaged SpO2 for each minute after commencing inhalation, with 
95% confidence intervals.   
This significance was confimed with Friedmans analysis on the full 5 minute grouped data 
for all three gas conditions (p<0.001). Post hoc analysis using a Wilcoxon signed-rank tests 
with Bonferroni correction applied (p<0.017) was also run and confirmed that there was a 
statistical difference between SpO2 readings for 14% and 21% (p=0.001), 14% and 60% 
95
95.5
96
96.5
97
97.5
98
98.5
99
99.5
0 1 2 3 4 5 6
A
ve
ra
ge
 S
P
O
2
 R
ea
d
in
gs
Time in Minutes
Hypoxia SPO2
Medical Air SPO2
Hyperoxia SPO2
 
120 
(p= 0.001) and 21% and 60% (p=0.001).  The SpO2 readings for the 14% O2 show no 
plateau within the 5 minutes, whilst a ceiling effect for the hyperoxia gas is evident. This 
is due to the SpO2 already averaging at near saturation (98.5%) with medical air. 
Figure 3-6 to Figure 3-8 show the threshold data recording which took place over 30 
minutes for a typical participant (TC) at 2, 7 and 12 degrees. Each data point is shown 
(blue diamonds) along with the gas order.  It can be seen that there is no obvious change 
in threshold with either hyperoxic (60% O2 at 5-10 minutes) or hypoxic (14% O2 at 15-20 
minutes) gas conditions compared to medical air (21% O2 at 25-30 minutes) at any of the 
locations. There was no apparent trend in threshold vs. gas condition for any individual 
dataset.  
 
 
Figure 3-6. Plot of threshold as a function of time for a typical participant (TC) at 2 
degrees. 
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Figure 3-7. Plot of threshold as a function of time for a typical participant (TC) at 7 
degrees. 
 
Figure 3-8. Plot of threshold as a function of time for a typical participant (TC) at 12 
degrees. 
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Figure 3-9, Figure 3-10 and Figure 3-11 show the group averaged mean final minute 
threshold for all three gases at each location. The final minute thresholds (i.e the 
thresholds obtained in the 5th minute of inhalation of each gas) were chosen as this is the 
interval when SpO2 was most affected by the 14% oxygen concentration (see Figure 4-7). 
The figures show that, overall, thresholds were highest at the fovea (Figure 4-9). This 
difference was statistically significant for each of the three gas conditions when 
compared to the other two locations (ANOVA – 14% p= 0.001, 21% p= 0.001, 60% 
=0.001). At location 12 degrees (Figure 4-11) there was the least variability in threshold 
recordings with smaller confidence intervals with all three gases compared to the other 
two locations. There was a slight trend for hypoxia to raise thresholds at all three 
locations. However, there was no significant difference in scotopic threshold with oxygen 
concentration at any of the three locations (ANOVA – fovea p= 0.673, 7 degrees p= 0.606, 
12 degrees p= 0.135).  
 
Figure 3-9. Group averaged final minute threshold for all three gases at 2 degrees 
eccentricity for the fovea (error bars show 95% confidence intervals for the mean).  
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Figure 3-10. Group averaged final minute threshold averages for all the gases at 7 
degrees eccentricity (error bars show 95% confidence intervals for the mean).  
 
Figure 3-11. Group averaged final minute threshold averages for all three gases at 12 
degrees eccentricity (error bars show 95% confidence intervals for the mean).  
Whilst there was no significant difference in group averaged thresholds recorded under 
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there is a relationship between SpO2 and threshold. This analysis removes the potential 
confounding effect of inter individual variability in the physiological response to breathing 
the hypoxic/hyperoxic gas.  Figure 3-12, Figure 3-13 and Figure 3-14 show the mean 
threshold for each minute for each individual plotted against SpO2 at all three locations. 
The R2 values for all three graphs indicate that the spread in threshold data cannot be 
explained by the participants’ SpO2. A maximum of 3% of the variation in threshold is 
explained by SpO2 (at the 7 degrees location).   
 
Figure 3-12. Mean threshold for each minute plotted against SpO2 for all 18 participants  
at 2 degrees eccentricity. 
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Figure 3-13. Mean threshold for each minute plotted against SpO2 for all 18 participants 
at 7 degrees eccentricity. 
 
Figure 3-14. Mean threshold for each minute plotted against SpO2 for all 18 participants 
at 12 degrees eccentricity. 
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Figure 3-15 shows the relationship between the change in SpO2 between 21% and 14% 
oxygen inhalation for the final minute and the change in final minute mean threshold 
between the two gas conditions at the fovea. Data points above the x axis indicate 
participants whose SpO2 was reduced when 14% oxygen was inhaled,this encompassed all 
except two participants, one of whose SpO2 marginally increased when 14% oxygen was 
inhaled and one of whom showed no change. Of the 16 participants who showed a 
reduced SpO2 when 14% oxygen was inhaled, 8 fall to the left of the Y-axis, indicating that 
their thresholds increased as SpO2 decreased, whilst 8 fell to the right of the Y-axis, 
suggesting that their thresholds were reduced by a reduction in SpO2. In other words, the 
graph shows an even split of thresholds increasing and decreasing in the hypoxic 
condition, this trend was also seen at 7 degrees and at 12 degrees.  
 
Figure 3-15. Relationship between change in final minute threshold data 21%-14% and 
change in final minute SpO2 21%-14% at the fovea.    
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3.1.7 Conclusion 
This study showed that in this population there was no significant difference in thresholds 
when participants were inhaling 14%, 21% or 60% oxygen at 0 degrees, 7 degrees 
eccentricity or 12 degrees eccentricity. The SpO2 data displayed in Figure 4-5 show that 
breathing 60% oxygen raised peripheral oxygen saturation minimally. On average, over 
the 5 minutes, SpO2 readings were raised by 0.33% to around 99%. This could be 
explained by a ceiling effect, as participants’ SpO2 was on average 98.5% when breathing 
medical air, leaving little room for 60% oxygen to raise it further. These readings are 
consistent with the literature, with hyperoxia raising thresholds to 99.1% in 2 studies 
(Connolly et al. 2006; Connolly et al. 2008b) and to 100% in another (Klemp et al. 2007). It 
is not, therefore, surprising that the hyperoxic condition had no effect on thresholds. 
However, based on the evidence in the literature that visual function is affected by 
hypoxia (Connolly et al. 2006; Connolly 2011; Connolly et al. 2008b; Feigl et al. 2008; Feigl 
et al. 2007; Feigl et al. 2011; Connolly et al. 2008a), it was more surprising that thresholds 
were unaffected by breathing 14% O2.  An overall trend for thresholds to be raised by 
hypoxia was seen in all retinal locations, but this was not statistically significant, even at 
the 12 degrees location where confidence intervals were narrowest. 
Published literature has shown that visual function is affected by hypoxia (see Chapter 2 
for review). Colour vision (Connolly 2011; Hovis 2012), visual fields (Connolly 2011), dark 
adaptation (Ernest and Krill 1971; Connolly et al. 2006) and contrast sensitivity (Connolly 
2011) have all been reported to be altered by hypoxia. Scotopic thresholds have also 
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been reported to be raised under conditions of induced hypoxia (Ernest et al. 1971; 
McFarland et al. 1939; Wald et al. 1942a; McFarland et al. 1940) which is in contrast to 
the results found in this study. There are several differences between these study designs 
and the design used here. Firstly, 10% oxygen was used in these studies, which would be 
expected to reduce SpO2 to a greater extent than the 14% used in this experiment. These 
studies also used a longer duration hypoxic episode than that used here, with McFarland 
and Evans (1939) and Wald and Harper (1942) using a duration of 30 minutes or more. 
The 5 minute duration used in this study was less than any found in the literature, with 
most using a duration of a minimum of 15 minutes (Connolly et al. 2009b; Connolly et al. 
2009a) or until a steady state of hypoxia was reached (Feigl et al. 2008; Feigl et al. 2011) 
which, when breathing 12% oxygen was found to take 2-3 minutes (Feigl et al. 2011). 
Hypoxia induced by breathing 14% oxygen in this study decreased SpO2 by, on average, 
1.68% (to around 95.5% over the 5 minutes). However, SpO2 decreased progressively with 
time breathing 14% oxygen and the greatest effect on the participants’ oxygen saturation 
was in the fifth minute. It is unknown if, at this point, the participant had reached a 
hypoxic plateau or if the continued inhalation of 14% oxygen would have had further 
effect. Literature suggests that our participants had not reached a minimum SpO2 after 5 
minutes, with other studies reporting SpO2 dropping to between 85.7% to 90.6% when 
breathing 12-14.1% oxygen (Connolly et al. 2006; Connolly 2011; Connolly et al. 2008b; 
Feigl et al. 2008; Feigl et al. 2007; Feigl et al. 2011; Connolly et al. 2008a). Two studies 
suggested an SpO2 of 92% to indicate that significant hypoxia had been reached (Feigl et 
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al. 2011; Feigl et al. 2008), which was not achieved here. Even in a study where 15.2% 
oxygen was inhaled, an average SpO2 of 92.8% was obtained (Connolly 2011), which is less 
than the lowest mean SpO2  in this experiment of 95.6%.   
A change in threshold with 60% oxygen was not expected to be seen in this population of 
young, healthy adults. Although the retina is on a hypoxic knife-edge in scotopic 
conditions, it is expected that there is enough oxygen present to meet demands. 
However, there is evidence that certain aspects of visual function, including threshold 
sensitivity to frequency doubling stimuli, low contrast acuity in mid mesopic conditions 
and dark adaptation parameters, are enhanced when in hyperoxic conditions at sea level, 
suggesting that the increased metabolic demand at reduced light levels may lead to a 
local retinal hypoxia sufficient to affect the performance of particular tasks (Connolly et 
al. 2009a; Connolly et al. 2009b; Connolly et al. 2006). Connolly and Hosking (2006) found 
that hyperoxia did not affect final scotopic thresholds or cone adaptation but did hasten 
the timecourse of rod dark adaptation. These effects would not be seen in this study, as 
the dynamics of the dark adaptation function were not investigated.  
Few studies have looked at the topography of visual function under hypoxic conditions, of 
those that have, the data is conflicting. Feigl (2011) found all eccentricities between 1-15 
degrees to be affected by hypoxia under mesopic conditions. Ernst and Krill (1971) 
studying dark adaptation found that peripheral rods tested at 45 degrees were affected 
more than central rods at 5 degrees. In contrast, mfERGs collected by Klemp (2007) 
suggested that the central retina was more sensitive to hypoxia. Connolly (2008) also 
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found that, when tested with FDT, the central 5-10 degrees from fixation were affected 
by hypoxia - although the fovea was unaffected. This diversity of results may indicate that 
hypoxia affects different aspects of visual function in a different fashion, which may 
reflect the different pathways governing different visual function thresholds. This study 
found no significant difference between the retinal locations tested, although there was 
some suggestion from individual datasets that the 12 degree location was more sensitive 
to changes in oxygenation, with a trend towards raised thresholds with 14% oxygen. 
The main limitation of this study was the possible lack of steady state hypoxic conditions 
during the measurement of  scotopic thresholds, either caused by the short duration of 
the hypoxic episode or the relativley high oxygen concentration. Two further studies were 
undertaken to address the questions generated by these results. Specifically:  
 What duration of inhalation of 14% oxygen is required to reach equilibrium? 
 If SpO2 is reduced further, is there evidence of a significant elevation in scotopic 
thresholds and if so, which retinal location is affected most? 
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3.2 Investigation of the time course of changes to SpO2 during 
inhalation of 14% oxygen. 
3.2.1 Background and aims 
The results of the previous study showed that SpO2 declined with time over a five-minute 
period of inhaling 14% oxygen but did not plateau.  The aim of this experiment was to 
monitor the time course of changes to SpO2 when breathing 14% oxygen over 15 minutes 
in healthy control participants. It was hypothesised that SpO2 readings will continue to 
decline past the 5 minute period, but plateau within 15 minutes. Based on the literature, 
15 minutes was believed to be sufficent to produce steady state hypoxia (Connolly et al. 
2009b; Connolly et al. 2009a). 
A second aim was to compare the timecourse in older and younger individuals. As neither 
group had respiratory problems, such as asthma, it was hypothesised that there would be 
no difference between the SpO2 readings of the two groups when breathing 14% oxygen. 
The results of this study were required to determine the time required for a change in 
oxygenation level to have maximal effect on SpO2 . 
3.2.2 Participants  
Nine healthy control participants were recruited from the School of Optometry and Vision 
Sciences in Cardiff University, between the ages of 24-71. Inclusion and exclusion criteria 
were as described in section 3.1.2. Participants were divided into two groups; a younger 
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group age 24-36 years old and an older group age range 58-71yrs old. All procedures 
adhered to the tenets of the Declaration of Helsinki. The study was approved by the 
School of Optometry and Vision Sciences ethical committee. 
3.2.3 Method 
Participants were seated for the duration of the experiment and were advised to report 
any symptoms of hypoxia including dizziness.  A finger pulse oximeter was used to 
measure the peripheral oxygen saturation data (see section 3.1.3). Baseline SpO2 data 
were collected in  normoxic conditions for 5 minutes, with the participant breathing room 
air. Then, using 8% oxygen delivered though a 60% venti mask (see section 3.1.3), the 
participant breathed 14% oxygen for 15 minutes.  SpO2 data were collected at 1 minute 
intervals in the hypoxic condition for a minimum of 15 minutes. The experiment was 
stopped if the SpO2 levels dropped below 85%, or if symptoms such as dizziness or 
confusion were reported. After cessation of inhalation of 14% O2, SpO2 readings were 
taken until the participant’s SpO2 readings had returned to a normal level. 
3.2.4 Results 
The mean age for group 1 was 27.8 +/- 4.50 years and the mean age for group 2 was 66.5 
+/- 5 years. Full 15 minute datasets were collected for all participants. 
The group mean SpO2  levels with confidence intervals are shown in Figure 3-16. It shows 
that the mean SpO2 when no gas was inhaled for group 1 was 99.0% and for group 2 was 
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97.8%. This dropped to 97.0% for group 1 when breathing 14% oxygen and 93.6% for 
group 2. The graph shows that mean SpO2 reached a minimum at around 8 minutes after 
commencing breathing the hypoxic gas for group 1. For group 2 the mean SpO2 stabilised 
after 8 minutes and reached a minimum after 11 minutes of breathing 14% oxygen. For 
both groups the data plateaued after this point. The SpO2 readings returned to within a 
normal level within 1 minute for group 1 and 5 minutes for group 2. The confidence 
intervals show that the data were less variable for group 1. It also demonstrates that 
there was a significant difference between groups as the confidence intervals do not 
overlap. The SpO2  was significantly lower for group 2 at baseline, and was affected more 
by hypoxia than for group 1, as evidenced by the greater drop in SpO2 value when 
breathing 14% oxygen. 
Figure 3-16. Group average data from younger (group 1) and older (group 2) 
participants, showing confidence interval bars. 
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3.2.5 Conclusions 
The results from this study show that a period of longer than 5 minutes is required for the 
inhalation of 14% gas to result in the maximum effect on SpO2 readings. The younger 
group’s mean SpO2  fell at a faster rate, taking 8 minutes compared to 11 minutes for 
group 2 to reach a minimum.  
The results from this study appear to contradict earlier findings that suggested no 
difference in the SpO2 readings between older and younger populations. Feigl (2008) 
found that when breathing 12% oxygen the SaO2 levels decreased significantly for both 
groups, but that there was no difference between the two groups with the younger group 
dropping to 90% +/-2% and the older group dropping to 91% +/- 0.4%. However, the 
mean age of the older population used in their study was 55 years old, substantially 
younger than the older population used in this study (mean age 66.5 years old). It should 
also be noted that the sample size in our study was small and hence the comparisons 
between Feigl’s study and this one should be interpreted with caution.   
The reduction in SpO2 measured in this study is less than that observed by other 
investigators, where drops to between 85.7% to 90.6 were found when breathing 12-
14.1% oxygen for a 15 minute period (Connolly et al. 2006; Connolly 2011; Connolly et al. 
2008b; Feigl et al. 2008; Feigl et al. 2007; Feigl et al. 2011; Connolly et al. 2008a). 
Comparing the study designs, Connolly (2006) used a hypobaric chamber to simulate an 
altitude of 15,000 ft. This method of reducing oxygen may not be comparable with the 
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methods used in this study. Also, an altitude of 15,000 ft is equivalent to an oxygen 
concentration of less than 12%, therefore SpO2 would be expected to drop to a lower 
level than in this experiment. Feigl (2008) and Feigl (2007) also used oxygenation 
concentrations lower than 14%, using 12% oxygen. Furthermore, different mask types 
were used in previous studies. For example, Connolly et al (2008) used a Royal Air Force 
Aircrew Respirator MK5, consisting of an oxygen mask and headpiece that covered the 
head, neck and shoulders. Connolly and Hosking (2008) and Connolly (2011) both used 
masks that were suspended from a cloth helmet that ensured an adequate facial seal.  
Feigl (2008), Feigl (2011) used non-rebreathing masks and Feigl (2007) used a mouthpiece 
and nose clip. However, although the gas delivery system used in this study was different, 
participants were checked for the correct fitting of the mask in this study and fitting was 
adjusted if required, hence the gas delivered should have been broadly as expected.  
To summarise, the results of this study indicate that a period of 15 minutes adaption to a 
change in oxygen concentration is enough to allow SpO2 to reach a plateau and result in a 
steady respiratory state. However an inhaled oxygen level of <14% may be necessary to 
achieve the SpO2 levels reported in the literature.  
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3.3 The effect of breathing 10% oxygen on scotopic thresholds in 
a group of normal participants 
3.3.1  Background 
Our preliminary findings suggested that there was no significant change in the scotopic 
thresholds of healthy individuals when breathing 14% oxygen for 5 minutes, compared to 
medical air (see section 3.1). These findings are contrary to the literature, which suggests 
that scotopic thresholds are increased by acute hypoxia (McFarland et al. 1939; 
McDonald et al. 1939; Wald et al. 1942a; McFarland et al. 1940). A follow up experiment 
suggested that 14% oxygen needed to be breathed for 15 minutes for the reduction in 
oxygenation to reduce SpO2 levels to a stable minimum (see section 3.2). However, even 
when a stable SpO2 was achieved, it did not drop to the levels described in previous 
studies. On this basis, it was hypothesised that the lack of a significant effect of hypoxia 
on thresholds reported in Chapter 5 may be attributable to an insufficient intensity and 
duration of hypoxic episode.  
Therefore, the hypothesis of this follow-on study was that scotopic thresholds would be 
increased if the hypoxic episode was intensified by breathing 10% oxygen for 15 minutes. 
The aim of this study was to determine (i) whether an increased level of hypoxia would 
result in elevated scotopic thresholds, (ii) whether this effect is consistent across the 
three locations tested and (iii) to determine the gas flow rate required to achieve an 
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equilibrium SpO2 of between 85-90%. The findings of this study were intended to guide 
further investigations looking at dark-adapted visual function in people with AMD.  
3.3.2 Participants 
Six participants were recruited from staff at the School of Optometry and Vision Sciences 
at Cardiff University. Exclusion and inclusion critera were as detailed in section 3.1.2. The 
participants provided informed written consent before participation, and all procedures 
adhered to the tenets of the Declaration of Helsinki. The study was approved by the 
School of Optometry and Vision Sciences ethical committee. 
3.3.3 Method 
Initially all participants underwent a trial of 15 minutes breathing 10% oxygen [delivered 
from a cylinder of 8% oxygen, via a non-rebreathing mask (Intersurgical)]. Lights remained 
on at this stage, and the participant was encouraged to report any feelings of dizziness or 
discomfort. The participant was seated throughout in a chair with arm rests, and SpO2 
was recorded continuously. The aim of this preliminary experiment was to exclude 
potential participants who became faint when undergoing a hypoxic episode. Any 
participants who reported symptoms of dizziness, nausea, or breathlessness were 
excluded from further study.  
To dilate the pupils 1.0% tropicamide was then instilled into the eye being tested (the eye 
with the better VA or the right eye if both eyes were equal). At this point, lights were 
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extinguished and dark adaptation took place for 30 minutes. One of 3 targets (located at 
2 degrees, 7 degrees or 12 degrees eccentricity), was chosen at random for the first trial. 
The psychophysical procedure used to determine threshold was as described in section 
3.1.4. 
After 30 minutes of dark adaptation, a 5 minute training session took place where 
thresholds were recorded continuously at location 1, but no gas was delivered. Gas 1 was 
then turned on and the participant breathed the first of two randomly assigned gases; 
medical air or 10% oxygen. Medical air was delivered at a flow rate of 15 L/min, whilst the 
8% oxygen was delivered at the variable flow rate determined in the preliminary 
experiment. Participants were masked to which gas they are receiving at any time. 
For the next 15 minutes, the measurement of scotopic thresholds continued at the first 
retinal location.  After the 15 minutes, gas 1 was turned off and the participant continued 
to respond to the program during a 5 minute ‘washout’ period (pilot data suggested that 
5 minutes were sufficient to eliminate any residual effect of the previous gas on 
thresholds). Thereafter, gas 2 was turned on and scotopic thresholds were measured for 
the next 15 minutes. A timeline for the experiment is shown in Figure 3-17. 
dark adaptation 
30 mins 
Practice 
5 mins 
Testing gas 1 
15 min 
Wash out 
5 mins 
Testing gas 2 
15 mins 
Figure 3-17. Timeline of experiment. Gases 1 and 2 were medical air and 10% O2, with 
the gas order randomly selected.  
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Participants’ peripheral haemoglobin oxygen saturation (SpO2) was closely monitored 
throughout the experiment using a pulse oximeter with finger probe to ensure that the 
oxygen saturation did not fall below 85%. The experiment was to be terminated if SpO2 
fell below this level, or if symptoms such as dizziness or confusion were reported. The 
participant was monitored (and asked to remain seated) until SpO2 rose back to baseline 
at the end of the experiment.  At visit one the experiment was run once, testing one 
location. At the second visit, the remaining locations were tested, with the experiment 
running twice with a rest in of at least 10 minutes between. 
3.3.4 Results 
Five participants were recruited for this study. The mean age of the participants was 33 
years (range 25-48 years) and the group contained 60% females. The required flow rate 
to achieve an SpO2 of 85-90% was 13 l/min for the hypoxic gas for all apart from one 
participant; participant AB required the maximum flow rate of 15 l/min to show any 
reduction in SpO2.  One participant, AW, was excluded due to dizziness during the 
preliminary 10% oxygen trial.  Full sets of data were collected for all remaining 
participants for all locations, apart from participant TC at location 24 degrees, where 
there were no threshold data for the final 4 minutes as the SpO2 dropped to the cut-off 
point and the mask was removed. The participant felt well and their SpO2 continued to be 
monitored and returned to a value of 99%. 
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Figure 3-18 shows the group averaged SpO2 per minute for both gases. It can be seen 
that, when inhaling medical air, the SpO2 was stable, with the mean at 98.2%. The small 
error bars indicate that the inter-individual variability was low. When inhaling 10% oxygen 
it can be seen that the highest SpO2 reading was in the first minute (97%). Thereafter, 
SpO2 dropped steadily within the first 5 minutes, reaching a plateau before dropping 
again. The lowest SpO2 (88%) was seen in the 11th minute. The confidence intervals 
indicate that there was more variability between participants when compared to the 
medical air data. The difference in SpO2 was significant at all time points between the two 
gases after the first minute with the confidence intervals not overlapping at any time. 
 
Figure 3-18. Group averaged SpO2 for each minute of gas inhalation with 95% 
confidence intervals. 
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Figure 3-19, Figure 3-20 and Figure 3-21 show the thresholds recorded for each 
experiment for a typical participant at all three locations. It can be seen in Figure 3-20 
(relating to a retinal location at 7 degrees eccentricity) that, where the hypoxic gas was 
supplied between 5-20 minutes, the thresholds appear to be raised compared to when 
medical air was supplied between 25-40 minutes. No obvious change in threshold is 
apparent with the hypoxic gas for the other two retinal locations.  
Figure 3-19. Plot of threshold as a function of time for a typical participant (TM) at 2 
degrees. 
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Figure 3-20. Plot of threshold as a function of time for a typical participant (TM) at 7 
degrees. 
Figure 3-21. Plot of threshold as a function of time for a typical participant (TM) at 12 
degrees. 
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Table 3-1 shows the mean threshold obtained over the last 5 minutes for each gas for each 
participant. The final 5 minutes was chosen as this time was when SpO2 readings had 
stablised. For participant TC the mean threshold was calculated between minutes 30-35, 
due to the mask being removed during the final 5 minutes. Looking at this individual data 
it can be seen that inhaling 10% oxygen resulted in a significant rise in scotopic thresholds 
when compared to inhaling medical air in five instances. At 2 degrees it was significant for 
AN and MD, at 7 degrees it was significant for TM and 12 degrees it was significant for 
participants TC and TM. 
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 Location 2 degrees Location 7 degrees Location 12 degrees 
Participant 10% O2 Medical 
air 
10% O2 Medical 
air 
10% O2 Medical 
air 
AB -4.35 ± 
0.05 
-4.27± 
0.05 
-4.41± 
0.03 
-4.49± 
0.04 
-4.50± 
0.05 
-4.47± 
0.04 
AN -3.90± 
0.08 
-4.21± 
0.06 
-4.62±  
0.06 
-4.63 ± 
0.03 
-4.44 ± 
0.03 
-4.54 ± 
0.04 
TC -4.46 ± 
0.10 
-4.47± 
0.07 
-4.58± 
0.04 
-4.65± 
0.06 
-4.48± 
0.04 
-4.58± 
0.03 
TM -4.06± 
0.08 
-4.06± 
0.06 
-4.38± 
0.06 
-4.58± 
0.04 
-4.40± 
0.03 
-4.49± 
0.04 
MD -4.06 ± 
 0.06 
-4.21 ± 
0.07 
-4.51 ± 
0.06 
-4.56 ± 
0.05 
- 5.09± 
0.05 
-5.10 ± 
0.06 
Table 3-1. Mean threshold for the last 5 minutes of breathing each gas with 95% 
confidence intervals. Text in bold indicates no overlapping of the confidence intervals 
between the scotopic threshold between breathing 10% and 21% oxygen. 
The group averaged thresholds for the final 5 minutes of inhaling each of the gases at all 
three locations are shown in Figure 3-22. At all locations, mean threshold was highest for 
the hypoxic gas, however this failed to reach significance at 2 degrees or at 12 degrees, 
where the confidence intervals are overlapping (paired t-test p= 0.320 and Wilcoxon 
signed rank p= 0.136, for 2 and 12 degrees respectively). Threshold was elevated to a 
greater extent by the hypoxic episode at 7 degrees, with non-overlapping confidence 
intervals, but this also failed to reach statistical significance (paired t-test; p= 0.062). 
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(a) (b)  
(c)  
Figure 3-22. Group averaged thresholds for both gases (a) at 2 degrees, (b) 7 degrees 
and (c) 12 degrees (c). The error bars show 95% confidence intervals for the mean. 
Whilst SpO2 was reduced by breathing 10% oxygen in all individuals, there was variability 
in the magnitude of the effect. Therefore, further analysis was carried out to look at the 
relationship between SpO2 and threshold. Thresholds were plotted against SpO2 in a 
linear regression analysis. The individual threshold data plotted against SpO2 can be seen 
in for all three locations in Figure 3-23, Figure 3-24 and Figure 3-25. These graphs include 
the data from all 5 participants for every minute of gas inhalation. The low R2 value 
indicate that the variability in the threshold data were not well explained by SpO2 at any 
location.  
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Figure 3-23. Mean threshold for each minute plotted against SpO2 for all 5 participants 
at 2 degrees. 
 
Figure 3-24. Mean threshold for each minute plotted against SpO2 for all 5 participants 
at 7 degrees. 
 
Figure 3-25. Mean threshold for each minute plotted against SpO2 for all 5 participants 
at 12 degrees. 
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3.3.5 Conclusion 
Inhaling 10% oxygen for 15 minutes resulted in a decrease in SpO2 for all participants and 
an increase in mean thresholds at all locations, which approached statistical signficance at 
7 degrees. The effect of breathing 10% oxygen on SpO2 was more substantial in the first 5 
minutes then levelled out. The SpO2 dropped to its lowest reading in the 11th minute with 
a mean value of 88% recorded. The SpO2 was significantly different at all time points for 
10% oxygen, when compared to medical air. 
The literature has shown that scotopic thresholds are elevated by hypoxia (McFarland et 
al. 1939; McDonald et al. 1939; Wald et al. 1942a; McFarland et al. 1940). However, the 
mean change in threshold observed here was relatively small, just 0.078, 0.082 and 0.054 
log units for the 2, 7 and 12 degree locations respectively.  
A few studies have looked at the topography of visual function in hypoxic conditions 
(Feigl et al. 2011; Ernest et al. 1971; Klemp et al. 2007; Connolly et al. 2008b). However, 
this is the first study to compare the effect of hypoxia on scotopic thresholds at different 
locations across the macula.  The 7-degree location was found in this study to be most 
affected by hypoxia, which is consistent with the literature evaluating other types of 
visual function. Connolly (2008) studying frequency doubling contrast sensitivity, found 
that the retina was preferentially affected by hypoxia at 9 degrees and that the fovea was 
unaffected. Ernst and Krill (1971), studied the effect of hypoxia on dark adaptation at 
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locations up to 5 degrees and also 45 degrees. They found that rod dark adaptation was 
affected preferentially at 45 degrees compared to 5 degrees.  
The findings of slightly raised thresholds while breathing 10% O2 in this study suggest that 
our prevous negative findings were due to the very modest effect of 14% O2 on SpO2.  In 
this study, hypoxia seems to affect the retina most at 7 degrees, it suggests that the 
retina maybe more susceptible to the effects of hypoxia at this location when compared 
to the other locations. 
3.3.6 Summary 
The studies presented in this chapter indicate that: 
i) An acute episode of hyperoxia has little effect on SpO2 or scotopic thresholds in 
healthy controls (see section 4.1). This may be attributable in part to a ceiling effect, 
whereby SpO2 was approaching 100% in the normoxic condition. It also supports our 
hypothesis that the dark adapted retina is not hypoxic in healthy individuals. 
ii) Breathing 14% oxygen for 5 minutes was insufficient to induce a hypoxic level 
in controls of sufficient magnitude to affect scotopic thresholds (see section 
4.2). Observing the effect of breathing 14% oxygen on SpO2, it can be seen 
that more than 8 minutes were required for SpO2 to reach a steady state. An 8 
minute period was therefore selected as the minimum duration of breathing 
air types before data were collected in further studies in this thesis.  
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iii) Breathing 10% oxygen for 15 minutes induced a level of hypoxia in controls 
which was sufficient to cause an elevation in scotopic thresholds. The decrease 
in scotopic sensitivity approached statistical significance at an eccentricity of 7 
degrees, indicating that this region may be most sensitive to hypoxic insult. 
This location was therefore used for the remaining experimental work in this 
thesis. The 10% oxygen condition was not tolerated by all individuals, even in 
the healthy control group, and hence was not employed in the older cohort 
with AMD for ethical reasons. 
The next chapter of this thesis will study the effect of breathing 60% oxygen on the 
scotopic thresholds of participants with early AMD. It is hypothesised that breathing 60% 
oxygen will decrease scotopic thresholds in participants with early AMD due to the 
presence of a local retinal hypoxia. In the control group no difference in scotopic 
thresholds is expected when breathing 60% oxygen.  
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4 The effect of breathing 60% oxygen on 
scotopic thresholds in people with 
AMD  
4.1 Background and aims  
Delayed dark adaptation and raised scotopic thresholds are known to occur with ageing, 
with a 0.1 log unit of elevation of scotopic threshold occurring per decade (Jackson et al. 
2000; Owsley et al. 2001). Therefore, it is not surprising that difficulty seeing in the dark is 
a common complaint of the elderly, even when no pathology exists (Owsley 2011; 
Steinmetz et al. 1993). Elevated scotopic thresholds and delays in dark adaptation are 
observed to a greater extent in people with early AMD (Owsley et al. 2000; Steinmetz et 
al. 1993; Brown et al. 1986; Scholl et al. 2004; Dimitrov et al. 2008; Owsley et al. 2007). 
For example, Owsley et al. (2000) reported that the dark-adapted mean field sensitivity 
was significantly lower (by 6.7 dB) in people with AMD than a group of age-matched 
controls.  
A slowing of dark adaptation and raised scotopic thresholds have also been observed in 
young healthy participants, when transient hypoxia is induced (Connolly et al. 2006; 
McFarland et al. 1939), as discussed in chapter 2. Hence it is possible that hypoxia may 
contribute to raised thresholds in people with early AMD due to changes in the choroidal 
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circulation, a thickened Bruch’s membrane and changes at a cellular level, including 
altered expression of growth regulators (see chapter 2; Mousa et al. 1999; Schlingemann 
2004; Stefánsson et al. 2011; Giovannini et al. 1994; Pauleikhoff et al. 1990). If this is the 
case then temporarily reducing hypoxia in participants with early AMD, by the inhalation 
of 60% oxygen, should result in a decrease in scotopic thresholds i.e. a shift towards 
normal sensitivity.  
This study aimed to investigate this hypothesis by measuring scotopic thresholds in 
people with and without early AMD, whilst they breathe medical air (21% oxygen) and a 
hyperoxic gas mix (60% oxygen). It was expected that during the period of increased 
oxygen delivery, thresholds would decrease in people with AMD, whilst remaining stable 
in the control group. Such a finding would strengthen the case for a role of hypoxia in the 
pathogenesis of AMD.   
4.2 General Methods 
4.2.1 Participants 
Participants were recruited to the study from patients attending the University Hospital 
Wales Ophthalmology outpatients’ clinic and Cardiff University Eye Clinic, or directly from 
local optometrists in the Cardiff area between 01 April 2013 and 13 August 2015. For 
recruitment from the University Hospital Wales Ophthalmology outpatients’ clinic, TC 
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attended the nAMD treatment clinic and, along with the clinic consultant, reviewed the 
records of patients for eligibility.  
If a patient was thought to meet the inclusion and exclusion criteria, then they were 
approached in the clinic by TC and the project was discussed. If the patient was still 
considered as meeting the criteria and was agreeable to be contacted then contact 
details were gathered. Potential participants were then contacted by telephone at a later 
date to check that they were still interested in participating in the study and, if so, then 
the participant information sheet was sent out. Individuals were then contacted after 10 
days, and asked if they had read the information sheet. During all conversations the 
potential participant was encouraged to ask any questions. If they were still eligible and if 
they were happy to proceed then then an appointment was made for them to attend the 
School of Optometry and Vision Sciences where the PIS was reviewed once more before 
written, informed consent was obtained  to the study. The recruitment procedure from 
Cardiff University Eye Clinic involved identifying records of patients who appeared to 
meet the eligibility criteria as age matched controls or who had a record of early or nAMD 
and who had consented to being contacted for research purposes. These patients were 
then contacted and invited to take part using the same method as participants from the 
University Hospital Wales Ophthalmology outpatients’ clinic. Although information packs 
were sent to several local optometrists, no participants were recruited via this stream.   
Inclusion criteria for all participants were: age over 55 years, corrected visual acuity of 
6/12 or better, and a refractive error of < 6.00 DS in the most powerful meridian. 
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Exclusion criteria included: lung conditions (such as emphysema), systemic health 
conditions known to affect vision, taking medication known to affect visual function, 
significant cataract [above grade 2 on the LOCS III scale (Chylack et al. 1989)], ocular 
disease (other than AMD), repeatable visual field defect (a cluster of 3 or more points 
within the central 24 degrees of field), intraocular pressures above 21mmHg or narrow 
anterior chamber angles (Van Herick grades 0 and 1). Participants with a fundus 
appearance graded  by TC as having early AMD in one or both eyes i.e. 1-4 points on the 
simplified AREDS 5 point grading scale, (Ferris et al. 2005) which was discussed in section 
1.4.3 were assigned to the AMD group. This group also contained patients who were 
being treated for neovascular AMD in the non-test eye who had 0-2 risk points in the test 
eye (i.e. who had a total grade of 2-4 points on the simplified AREDS scale). The control 
group comprised participants with normal retinal ageing in both eyes and no sign of AMD 
(grade 0 of the AREDS 5 point scale). The study eye was the eye with the best visual acuity 
(control group), or the eye with early AMD (AMD group).  
In the case of bilateral early AMD, the eye with better visual acuity was chosen. In both 
groups, in the case of equal acuities, the right eye was used as the study eye. 
For grading purposes digital colour fundus photographs were displayed on a screen and 
the risk factors assigned according to the scale for each eye. If grading was ambiguous 
then a second grader, TM or AB was consulted for a second opinion. 
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All procedures adhered to the tenets of the declaration of Helsinki. The study was 
approved by South East Wales Research Ethics Committee. 
4.2.2 Sample size calculation 
The Bland and Altman nomogram was used to calculate the number of participants that 
should be recruited to each group. The nomogram is a graphical method of calculating 
sample sizes when the power, significance level and the standardised difference are set 
for a study. The power of a study is described as the probability that it will detect a real 
difference (of a set magnitude) as statistically significant, with a power of 80-90% 
commonly required (Bland and Altman 1999). The equation for calculating the 
standardised difference for continuous data is shown in equation 4-1. 
Standardised difference = δ/s 
Equation 4-1 Standardised difference equation (Bland and Altman. 1999), where δ = 
clinically relevant difference and s = standard deviation. 
As this is the first study of its type, there are no data available regarding the size of the 
effect on scotopic thresholds and ERG responses when people with AMD breathe a 
hypoxic or hyperoxic gas. However, threshold data and standard deviations have been 
reported from healthy controls under conditions of normoxia, hyperoxia and hypoxia for 
a centrally located stimulus under mesopic conditions (Connolly and Hosking. 2009b). 
These previously published data suggest that a study powered to detect a standardised 
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difference of 0.73 would identify an effect at least as big as that which is seen in healthy 
controls under a hypoxic condition. For the data collection in Chapters 4, 5 and 6 to allow 
detection of a standardized difference of 0.73 using a power level of 80% and a statistical 
significance of 0.05, a sample size of N=30 per group was aimed to be recruited per study.  
4.2.3 Baseline Measurements 
Patient history and baseline measurements were completed at the start of the visit after 
consent was obtained. They included distance corrected visual acuity (ETDRS LogMAR 
chart), intraocular pressures (Topcon CT 80 tonometer), D-15 saturated colour vision test, 
central 24-2 suprathreshold field examination using a Humphrey field analyser and slit 
lamp biomicroscope assessment of the anterior chamber angle using the Van Herick 
grading technique. If the participant met all of the inclusion criteria then 1% tropicamide 
was instilled into both eyes. Dilated binocular indirect ophthalmoscopy examination and 
retinal photographs were obtained for all participants (Topcon 3D OCT-1000) in order to 
allow fundus grading, along with OCT images. Fundus grading was carried out by 
assessment of the retinal photographs and binocular indirect ophthalmoscopy 
examination according to the AREDS simplified scale (Ferris et al. 2005) by TC.  
4.2.4 Equipment 
All stimuli for the psychophysical studies were presented on a gamma corrected high-
resolution monitor (Liyama LS902UT) driven by an 8-bit (nVIDIA Geforce 9) graphics board 
under the control of MATLAB. Scotopic thresholds were measured using the QUEST 
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Bayesian adaptive procedure (Watson et al. 1983) written with Psychophysics Toolbox 
extensions (Brainard, Pelli and Robson 2002). This psychometric measure determines final 
threshold using the maximum likelihood approach (Watson et al. 1983) as discussed in 
Section 1.5.2. The outputs of the programme were scotopic threshold and standard 
deviation. Gases were delivered via a 60% ventimask (intersurgical). A pulse oximeter 
(Crucial Medical Systems CMS 50E) was used to monitor the peripheral blood oxygen 
saturation (SpO2) in all experiments. See section 3.1.3 for details. 
4.3 Pilot Study  
A pilot study was conducted prior to commencing recruitment for the main part of the 
study, in order to evaluate the feasibility of the protocol. 
4.3.1 Methods 
Baseline tests were carried out, as outlined in section 4.2.3. A break of 10 minutes was 
then provided, during which time the study eye was patched and room lighting was 
dimmed. Following this, a 40-minute period of dark adaptation took place, with the test 
eye still patched and no room lighting. The psychophysical procedures used to measure 
scotopic thresholds are outlined in section 4.2.4. At the end of the dark adaptation 
period, the participant undertook a practice session that consisted of a shortened version 
(20 trials) of the QUEST psychophysical procedure. The first of two randomly assigned 
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gases, was then delivered to the participant providing either 21% or 60% oxygen for 
inhalation. The participant was masked to which gas was being inhaled. 
The first gas was inspired for 10 minutes and, within the last 5 minutes, scotopic 
threshold was determined using the QUEST 40 trial paradigm. There then followed a 5-
minute wash out period where no gas was given. After the wash out period, the second of 
the two gases was turned on for 10 minutes and the scotopic threshold was recorded 
again within the final 5 minutes. Threshold recording was conducted in the final 5 
minutes in order to ensure that an SpO2 plateau had been reached by the 8-10th minute 
where the paradigm converged on the threshold. The SpO2 of the participant was 
monitored throughout the duration of the experiment, and recorded every minute. A 
timeline of the experiment is shown in Figure 4-1. 
dark 
adaption 
50 mins 
20 trials 
practice 
5 mins 
Start 
gas 1 
5 mins 
Record 
thresholds 
5 mins 
Wash 
out 
5 mins 
Start 
gas 2 
5 mins 
Record 
thresholds 
5 mins 
Figure 4-1. Experimental timeline. Note that gas 1 and gas 2 were assigned randomly.  
To ward against hyperventilation, participants in all studies involving breathing air though 
a mask were coached on maintaining a regular breathing pattern. If it was felt by the 
examiner that the participant’s breathing pattern had changed then this was discussed 
wtih the participant. The participant was also distracted from thinking about breathing 
though the mask with conversation during any adaptation period. 
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4.3.2 Results 
Four individuals (three male) participated in the pilot study, with a mean age of 75 years 
(range 72-77 years). Three participants were classified as having early AMD (001JW, 
002MD, 003RC), and one (000RE) was an age similar control. Figure 4-2 displays the mean 
SpO2 readings per minute under both gas conditions. The graph shows that there was 
little variation over time in SpO2 readings when breathing 60% O2 or 21% O2, where the 
average readings all fell within a 1.25% range. It can be seen that the 95% confidence 
intervals do not overlap between 5-9 minutes, suggesting a significant difference in SpO2 
values during this time. 
Figure 4-2. Mean SpO2 per minute with 95% confidence intervals breathing 60% and 
21% oxygen. 
Sample scotopic threshold data obtained using the QUEST procedure under conditions of 
60% and 21% oxygen are displayed for the age similar control and one participant 
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classified as having early AMD in Figure 4-3. The solid line in each plot indicates the 
threshold, whilst the dotted lines show the QUEST standard deviation. Each data point 
represents one trial presentation. The plots show that the QUEST algorithm converged on 
the participant’s scotopic threshold after 40 trials. 
 
 
Figure 4-3. Sample scotopic threshold data from control participant 000RE (top row) 
and an individual with early AMD, participant 001JW (bottom row). The left column 
shows thresholds for 21% oxygen, the right column for 60% oxygen.  
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Table 4-1 summarises the scotopic thresholds of all four participants with confidence 
intervals whilst breathing each gas type.  The table shows that the differences in the 
scotopic thresholds between breathing 21% and 60% O2 were not significant for any 
participant as the confidence intervals for thresholds overlapped for all participants 
between the two gas conditions. However, it is of interest that the scotopic thresholds for 
all three participants with early AMD were lowest after breathing the second gas (see 
bold results in Table 2), regardless of whether this was 60% or 21% oxygen.  
Participant reference Threshold log cdm-2  +/- 
95% CI with 21% oxygen  
Threshold log cdm-2  +/- 
95% CI with 60% oxygen 
000RE (control) -3.11 +/- 0.21 -3.36 +/- 0.12  
001JW (AMD) -4.01 +/- 0.10 -3.90 +/- 0.14 
002MD (AMD) -3.32 +/- 0.11 -3.22 +/- 0.35 
003RC (AMD) -3.81 +/- 0.11 -3.85 +/- 0.11 
Table 4-1. Scotopic thresholds and 95% confidence intervals of all participants when 
breathing 21% and 60% oxygen. The bold threshold indicates the first presented gas.  
4.3.3 Discussion 
The 95% confidence intervals overlapping between scotopic thresholds when breathing 
21% and 60% oxygen for all participants suggests that there were no significant 
differences in threshold between the two gas conditions for any of the participants 
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included in the pilot. This was contrary to our hypothesis that individuals with early AMD 
would show a reduction in threshold when breathing 60% oxygen. However, as can be 
seen from the results, the scotopic thresholds in all three participants with early AMD 
were non-significantly higher with the first gas presented, regardless of whether it was 
the 21% or 60% oxygen. One explanation for this trend could be that the participants 
were still not fully dark adapted when the measurement of scotopic thresholds began, 
which may have led to an elevated scotopic threshold on the first trial, with the first gas. 
Dark adaptation takes approximately 50 minutes to complete, and the 50 minutes of 
reduced/no lighting and eye patching should have been sufficient to reach absolute 
threshold. However, just before dark adaptation commenced, fundus photography and 
VOLK retinal examination were conducted. These procedures use a bright light that would 
have resulted in significant photopigment bleaching. Furthermore, people with AMD are 
known to have prolonged kinetics of dark adaptation compared to age-matched controls 
(Dimitrov et al. 2011; Owsley et al. 2007). Therefore, the 50 minutes of dark adaptation 
that preceded the measurement of scotopic threshold in this protocol may not have been 
sufficient. Consequently, it was decided that for all further studies these fundus 
examination procedures would be undertaken after scotopic threshold recording was 
complete and the dark adaptation period would be increased to one hour. 
Although all participants undertook a shortened trial procedure as a training exercise, 
these findings could also be explained by a learning effect, or increasing confidence as the 
participant progressed though the repeated trials. To reduce the impact of the learning 
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effect, a new training protocol was implemented based on the pilot study data for all 
future data collection. From this point, all studies included a minimum of two practice 
trials, each consisting of 20 stimulus presentations. The main study only commenced 
when the thresholds obtained in two consecutive practice trials were within 1 standard 
deviation of each other. When necessary, a third training session was initiated. This 
ensured that for future data collection the participant understood the task. The results of 
these practice sessions were also used to estimate the final threshold, which was entered 
into the main MATLAB QUEST procedure. 
4.4 Main study 
4.4.1 Methods 
Twelve participants with early AMD and 11 age matched healthy controls were recruited 
to the main study. The participant selection criteria, baseline measurements, pupillary 
dilation and equipment used have been described in section 4.2. Procedures involving 
bright lights (i.e. VOLK examination and fundus photography) were undertaken at the end 
of the experiment.  
Following the initial work up, the participant had a 15-minute rest period, during which 
room lighting was reduced and the test eye was patched, then a further period of 45 
minutes of dark adaption with no room lighting and the test eye still patched. The 
protocol for the data collection was as described in section 4.3.1 for the pilot study. In 
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this study, before the main data collection took place the participants undertook 2 trial 
practice sessions and proceeded to the main trial if the thresholds of both trials were 
within 1 standard deviation of one another. If this was not the case then a third trial was 
undertaken, if this threshold was not within 1 standard deviation of the first two trials 
then the data collection was stopped at this point.  The timeline of the experiment is 
shown in Figure 4-4. 
 
Dark      
adaption 
60 mins 
20 trials 
practice 
5 mins 
20 trials 
practice 
5 mins 
Start 
gas 1 
5 mins 
Record 
thresholds 
5 mins 
Wash 
out 
5 mins 
Start 
gas 2 
5 mins 
Record 
thresholds 
5 mins 
Figure 4-4. Timeline showing the protocol of the main study investigating the effect of 
inhaling 60% oxygen on scotopic thresholds. Note that gas 1 and gas 2 were randomly 
assigned for each participant as 60% oxygen and 21% oxygen (medical air). 
4.4.2 Data Analysis 
The scripts driving the QUEST procedure used in this study were written by Watson and 
Pelli (1983) and implemented within the Matlab Psychophysics Tool box. Although the 
scripts came from a trustworthy source, it was decided to check the threshold data 
produced by the QUEST procedure independently. Hence, the data points for each 
participant were also fitted with a Weibull function (Equation 4-2) on a least squares basis 
using the solver function in Excel to determine threshold independently.  
Additional 20 trials to take place 
here if necessary 
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 F(x,α,β) = 1-e-(x/β)α 
Where α = scale parameter, β = shape parameter, x = luminance. 
Equation 4-2. Weibull cumulative distribution function. 
This results in a psychometric function and the 50% point on this graph should be 
comparable to the threshold given by the QUEST procedure. The psychometric function 
produced by this analysis and the corresponding QUEST outcomes were compared to 
identify any systematic differences in these approaches by conducting a Bland and 
Altman type analysis (Bland and Altman 1999).  
In both the AMD and the control groups, the distribution of scotopic thresholds and the 
SpO2 readings when breathing 60% oxygen and 21% oxygen were tested for normality 
using the Shapiro-Wilkes test. For within group comparisons where the distribution of the 
data was normal, paired t-tests were used. The Wilcoxon signed rank test was used if the 
data were not normally distributed. When comparing the data between groups the 
independent samples t test was used if the data were normally distributed, or the Mann 
Whitney test was used for data that were not normally distributed. 
4.4.3 Results 
Twenty-three participants took part in the study, 11 controls and 12 participants with 
early AMD.  50% of participants with AMD were female, and the group had a mean age of 
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73.9 years +/- 6.2SD. The control group comprised 36% females, and had a mean age of 
69.0 years +/- 5.5SD. Table 4-2 shows the characteristics of the early AMD group.
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Participant number Age Gender AMD status RE+ AMD status LE+ Combined status* VA RE VA LE 
001JW 75 M 0 
 
2- nAMD 2 -0.20 -0.08 
002MD 77 F 2- nAMD 1- Large drusen 
 
3 -0.20 -0.20 
003RC 77 M 2- nAMD 1- large drusen 3 0.70 0.00 
004JB 69 F 1- large drusen 2- aAMD 3 0.28 0.50 
005AD 71 M 2- nAMD 
 
0 2 0.12 -0.16 
006DW 67 F 2- nAMD 
 
1- large drusen 3 -0.14 0.12 
008ST 86 F 2- nAMD 0 
 
2 0.54 0.18 
009MR 66 M 1- large drusen 2- nAMD 3 -0.60 -0.20 
015AP 83 F 1- pigment changes 1- pigment changes 2 -0.20 -0.18 
018UH 78 F 1- large drusen 2- nAMD 
 
3 0.0 -0.10 
019LP 70 M 2- nAMD 0 
 
2 0.2 -0.14 
021RJ 68 M 2- nAMD 1- large drusen 
1- pigment changes  
3 1.0 -0.14 
Table 4-2. Characteristics of participants with early AMD; + the number given to the status of each eye reflects the number 
of risk points assigned according to the AREDS simplifed scale; * combined status reflects the AREDS simplified scale .
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4.4.4 Validation of Quest results 
The psychometric function produced by the Weibull analysis and the corresponding 
QUEST outcome are given below in Figure 4-5 for participant 015AP when breathing 60% 
oxygen. The points at 1 on the probabiity scale were seen points, and those at 0 were 
unseen. The scotopic threshold given by QUEST was 1.01 log cd/m2 and the 50% threshold 
produced by the psychometric function was 1 log cd/m2. Figure 4-6a indicates a strong 
positive correlation between the QUEST and Weibull scotopic thresholds across 
participants and Figure 4-6b shows that the limits of agreement between threshold 
techniques were small. Overall, the Weibull analysis verified that the QUEST procedure 
was reliable in assessing scotopic thresholds. 
(a) (b)      
Figure 4-5. Scotopic threshold results for participant 015ap by (a) psychometric function 
and (b) quest. 
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(a)  
Figure 4-6. (a) Thresholds obtained using the QUEST technique plotted against the 
Weibull function results and (b) Bland and Altman type agreement graph plotting mean 
threshold (QUEST and Weibull) against the difference between QUEST and Weibull 
thresholds for each individual. The solid blue line indicates the mean difference 
between techniques, with the red lines denoting the 95% limits of agreement i.e. mean 
difference between techniques+/- 1.96* the SD of the differences.  
4.4.5 SpO2 results 
Figure 4-7 shows the mean SpO2 levels per minute for all participants. The lack of overlap 
in the confidence intervals suggests that there was a statistically significant difference in 
SpO2 between the two gas conditions throughout the 5 minutes. Statistical analysis of the 
final 5 minutes of SpO2 values confirmed that the difference in mean SpO2 readings 
between breathing 60% and 21% oxygen over the 10 minutes was significant in people 
with early AMD (Wilcoxon signed rank p< 0.001) and in the control group (Wilcoxon 
signed rank p= 0.00). However, the absolute difference in mean SpO2 between the two 
gas conditions was small, reaching a maximum of ~2% at 7 minutes. As the accuracy of 
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the pulse oximeter is +/- 2% the findings should be interpreted with caution. It can also be 
seen that there was more between-subject variability when participants were breathing 
21%, as indicated by the larger confidence intervals.  
       
Figure 4-7. Mean SpO2 per minute with 95% confidence intervals for all participants, 
breathing 60% and 21% oxygen. 
A further observation which can be drawn from Figure 5-7  is that the group mean SpO2 
actually varied very little over the 10 minutes for either gas condition. When breathing 
21% oxygen the range of average SpO2 was between 97.2- 97.9%. When breathing 60%, 
the range of average SpO2 was between 98.7-99.0%. There was no significant difference 
in SpO2 between the early AMD group and the control group when breathing 60% oxygen 
(Mann-Whitney p= 0.144). There was, however, a statistically significant difference in 
SpO2 between the two groups when breathing 21% oxygen (Mann-Whitney p=0.006). 
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4.4.6 Scotopic Threshold results 
Scotopic threshold data were obtained for all 23 participants, under both gas conditions. 
As an example, the output of the QUEST procedure is shown in Figure 4-8 for the control 
participant 017DG alongside the SpO2 readings per minute over the 10 minutes of gas 
inhalation.      
  (a)      (b)    
     (c)       (d)    
Figure 4-8. Scotopic thresholds with standard deviations and SpO2 recordings over a full 
trial when breathing 21% oxygen (top panels) and breathing 60% oxygen (bottom 
panels) for control participant 017DG. 
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Figure 4-9 shows the group mean thresholds for each participant group, under each gas 
condition, with confidence intervals. The overlapping 95% confidence intervals suggest 
that there was no significant difference in scotopic thresholds when comparing breathing 
60% oxygen and 21% oxygen in either group. This was supported by the statistical 
analysis which demonstrated no significant difference between the scotopic thresholds 
for the AMD group when breathing 60% and 21% oxygen (-3.89 log cd/m2 ± 0.30 SD vs. -
3.89 log cd/m2 ± 0.31 SD; paired t-test p= 0.976), or the control group (-4.01 log cd/m2 ± 
0.27 SD vs. -3.95 log cd/m2 ± 0.38 SD; paired t test p= 0.249). 
(a)     (b) 
Figure 4-9. Group mean scotopic thresholds with 95% confidence intervals for 21% and 
60% oxygen conditions for (a) the AMD group and for (b) the control group. 
There were also no differences between the groups when breathing 60% oxygen 
(independent t-test p= 0.308) or 21% oxygen (independent t-test p=0.388). When the 
differences in scotopic threshold between gas conditions were calculated (threshold with 
21% oxygen subtracted from threshold with 60% oxygen for each individual), there was 
-4.7
-4.5
-4.3
-4.1
-3.9
-3.7
-3.5
0 20 40 60 80 100
Sc
o
to
p
ic
 t
h
re
so
ld
 (
 lo
g 
cd
m
2
)
Oxygen (%)
-4.7
-4.5
-4.3
-4.1
-3.9
-3.7
-3.5
0 20 40 60 80 100
Sc
o
to
p
ic
 t
h
re
sh
o
ld
 (
lo
g 
cd
m
2
)
Oxygen (%)
 
172 
also no statistical difference in the results between the AMD and control groups (Mann-
Whitney p= 0.413). 
Due to a lack of any evidence of a difference between gas conditions in the AMD group 
findings (-3.89 log cd/m2 ± 0.30 SD vs. -3.89 log cd/m2 ± 0.31 SD), and the evidence of a  
ceiling effect on the participants’ SpO2 it was decided that data collection for this study 
would cease, and the following studies would investigate the effect of breathing a 
hypoxic gas on scotopic thresholds and ERG parameters. 
4.4.7 Order effects 
To minimise the impact of any order effects, the randomisation of the gas order was 
balanced such that the same number of individuals received each gas type first. However, 
there was no statistically significant difference in the scotopic thresholds between the 
first and second gases (paired t test p= 0.872).  
4.5 Discussion 
This is the first study to investigate the effect of breathing 60% oxygen on scotopic 
thresholds in people with AMD. According to these results, there was no significant 
difference in scotopic thresholds between gas conditions. The results for the control 
group agree with the literature, where hyperoxia was not found to alter final scotopic 
thresholds (Connolly et al. 2006; Kent 1966).  
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There was no statistically significant difference between the scotopic thresholds recorded 
in the two groups when breathing 21% oxygen. This is in agreement with Jackson et al. 
(1998), where participants with early AMD (less than 5 small drusen to 1 large drusen 
and/or hyerpigmentation) showed no statistically signficant difference in scotopic 
threshold when compared to age-matched controls. However, the results are in contrast 
to previous work which has found that scotopic threshold is higher in participants with 
AMD when compared to age-matched controls (Owsley et al. 2000; Owsley et al. 2007; 
Chen et al. 2004; Steinmetz et al. 1993; Brown et al. 1986; Owsley et al. 2001). There are 
several explanations that may explain this. Firstly, our group of participants with early 
AMD included individuals with early macular changes. All participants who presented 
with soft drusen and/or focal pigmentary changes in the absence of signs of advanced 
AMD in the test eye were included (simplified AREDS grades 1-4), as were individuals who 
presented with nAMD in the non test-eye, even if the test eye showed minimal drusen or 
pigmentary changes (AREDS grade 2-4). This is because there is strong evidence to 
suggest that the presence of advanced AMD in one eye increases the 5-year risk of 
developing advanced AMD in the other eye, even if the other eye has no other clinical 
signs present (Ferris et al. 2005). This suggests that in these people the macula of the 
apparently healthy eye is likely to have macular changes, even if these are not clinically 
visible. As one aim of this study was to see if functional biomarkers of hypoxia could be 
used to diagnose and monitor patients at risk of developing AMD before clinical signs are 
present, these participants were included. The inclusion of early stage disease results in 
the profile of clinical signs in the AMD group in this study differing to the groups found in 
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the other studies. This can be seen from the comparison table of studies investigating the 
effect of early AMD on scotopic threshold (see Table 4-3). Notably, participants with late 
stage AMD were included by Brown et al. (1986), Owsley (2000) and Owsley et al. (2007) 
which may have influenced their results. Further analysis of the data of Owsley et al. 
(2007) comparing only the participant group with early AMD to the control group (by 
calculating the 95% confidence interval), demonstrated no statistically significant 
difference in scotopic thresholds between the two groups. 
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Study Early AMD participant 
details 
Period of dark 
adaptation 
used 
Results 
Steinmetz et al. 1993 N=12 all with discrete 
and/or confluent drusen. 
45 minutes Dark adapted foveal 
threshold ranged from 1-
24dB above normal values. 
Owsley et al. 2007 N=83 all with AMD 
classified by stages 1-12 of 
the AREDS (2005) scale. 12 
had CNV and 5 with GA. 
60 minutes 
after bleach 
Significant (p<0.0001) 
impairment in rod sensitivity 
Owsley et al. 2001 N=20 with < 5 small drusen 
or ≥ 1 large drusen, focal 
hyperpigmentation or both. 
30 minutes Reduced scotopic sensitivity 
in AMD group by 0.4 log 
units when compared to 
normals 
Owsley et al. 2000  N=71 with < 5 small drusen 
or ≥ 1 large drusen, focal 
hyperpigmentation or both. 
9 late AMD 
≥ 40 minutes Mean field dark-adapted 
sensitivity was statistically 
lower by 6.7dB in AMD than 
in normal subjects (p=0.006). 
Chen et al. 2004 N=24 drusen and 
hyper/hypo pigmentation. 
40 minutes Mean scotopic sensitivity of 
participants with early AMD 
was 2.73dB lower than in 
the control group. This was 
statistically significant (p < 
0.05) 
Brown et al. 1986 N=4. N=3 non- exudative 
AMD or drusen and n=1 
with confluent drusen and 
haemorrhages.   
20 minutes Participants with early AMD 
showed decreases in cone 
and rod sensitivity (0.5-1.5 
log units) 
Table 4-3. Comparison table of studies into the effect of early AMD on scotopic 
thresholds. 
 
176 
There were also differences in the study designs, with all of the studies using a shorter 
duration of dark adaptation than the 60 minutes used in this study. As discussed in 
section 1.5.3, AMD results in a prolongation of dark adaptation (Owsley et al. 2001; 
Steinmetz et al. 1993; Haimovici et al. 2002; Dimitrov et al. 2008; Dimitrov et al. 2011; 
Eisner et al. 1992; Eisner et al. 1991). The order effect demonstrated in the earlier pilot 
data suggested that the 50 minutes of dark adaptation originally used for the recording of 
scotopic thresholds was not long enough for participants with early AMD to reach a final 
scotopic threshold. If the period of dark adaptation used by previous studies was similarly 
too short to allow absolute scotopic threshold to be reached in people with AMD, then it 
is possible that an artificial elevation of the scotopic thresholds would have been present 
in this participant group. Some studies even applied a photopigment bleach before the 
period of dark adaptation (Steinmetz et al. 1993, Owsley et al. 2007), after which it can 
take around 60 minutes for absolute threshold to be reached (Lamb et al. 2004; Thomas 
and Lamb 1999). This would lead to a greater difference in final thresholds between the 
two groups. This may be a further explanation for the previously reported elevation of 
scotopic thresholds in people with early AMD. As no order effect was found in the main 
study reported in this chapter after the hour of dark adaptation, one may conclude that 
this duration of dark adaptation gave both participant groups time to reach their final 
scotopic threshold.  
One potential limitation of the study design was the use of a fixed termination rather 
than a dynamic termination in the QUEST procedure. The dynamic criterion continues the 
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procedure until the threshold can be estimated with a particular degree of confidence, 
however this can result in some participants not finishing the trials (Madigan and 
Williams 1987). Fixed termination after 40 presentations was used due to time 
constraints as each data set required completion between minutes 8 and 10 due to the 
dual requirements of gas adaptation and safety guidelines. Studies by Anderson (2003) 
and Madigan and Williams (1987) comparing dynamic and fixed stopping criterion in 
Bayesian procedures concluded that there was little evidence to recommend the use of 
the dynamic over a fixed criterion. 
The finding that thresholds were unaffected in people with early AMD by a transient 
period of systemic hyperoxia may be explained by the high levels of peripheral oxygen 
saturation at baseline. The results indicated that participants in neither group were 
systemically hypoxic i.e. both groups showed a SpO2 close to 100% at baseline. Therefore 
SpO2 was close to saturation in both groups, and an increase in SpO2 by breathing 60% 
oxygen was limited by the ceiling effect to only 1-2%. Therefore, the results from this 
study do not disprove the hypothesis that there is local retinal hypoxia in the participants 
with AMD i.e. caused by an impaired delivery of systemically circulating oxygen to the 
outer retina, but rather demonstrates that these participants do not suffer from a 
systemic reduction in blood oxygen saturation that can be reversed by breathing 60% 
oxygen. Furthermore, given the limited sample size, it is possible that the null findings 
may be attributable to a Type II error. 
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To overcome the limitations of this study, in further studies 14% oxygen was inhaled to 
create mild acute systemic hypoxia. Scotopic thresholds and dark adapted ERGs were 
recorded when inhaling 14% oxygen and medial air to test the hypothesis that, when 
breathing 14% oxygen, scotopic thresholds would increase in both groups but that the 
increase would be greater in the group with early AMD due to the compounding effect of 
the systemic hypoxic episode on a locally hypoxic retina. 
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5 The effect of breathing 14% oxygen on 
scotopic thresholds in people with 
early AMD 
 
5.1 Introduction 
The aim of chapter 5 was to study the effect of breathing 60% oxygen on scotopic 
thresholds of participants with early AMD. The hypothesis stated that if hypoxia was the 
cause of the rise in scotopic thresholds seen in early AMD, then the inhalation of 60% 
oxygen could temporarily decrease the scotopic thresholds in these participants. 
However, no statistically significant differences in scotopic thresholds were recorded 
between the normoxic and hyperoxic conditions. As discussed in section 4.5, it was 
hypothesised that this lack of effect was due to the lack of systemic hypoxia in these 
participants. The SpO2 was close to saturation under control conditions and thus it was 
not possible to further increase the SpO2 due to a ceiling effect. Therefore, this chapter 
presents the results of a modified study to investigate the effect of mild systemic hypoxia 
on the scotopic thresholds of participants with early AMD.  
It was aimed to test the hypothesis that all participants (control and AMD) would show a 
decrease in scotopic sensitivity when experiencing a mild hypoxic episode (as discussed in 
sections 2.2.6 and 2.3.5). However, it was also hypothesised that, due to the local retinal 
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hypoxia that may be present in participants with early AMD, these changes would be 
greater in participants with early AMD. 
5.2 General methods 
5.2.1 Participants 
Sixteen participants with early AMD, and 20 controls were recruited to take part in this 
study. The recruitment procedure, inclusion and exclusion criteria and baseline 
measurements followed the same methods as set out in section 4.2. As in the main study 
of chapter 4, procedures involving bright lights (e.g. VOLK fundal examination and fundus 
photography) were carried out after the scotopic threshold experiment to minimise 
photopigment bleaching effects. 
5.2.2 Equipment  
The apparatus and psychophysical methods for scotopic threshold measurement were as 
described in sections 3.1.3 and 4.4.1.  
5.2.3 Methods 
The methods for scotopic threshold data collection were as described in section 4.4.1 
except the 60% oxygen condition was substituted with a hypoxic 14% oxygen mixture. To 
summarise, following 60 minutes of dark adaptation and 2-3 practice QUEST sessions (20 
trials each), participants inhaled either medical air or 14% oxygen. Data collection then 
followed the timeline summarised in in Figure 5-1. 
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Figure 5-1. Timeline showing the protocol of the study investigating the effect of 
inhaling 14% oxygen on scotopic thresholds. Gases 1 and 2 were randomly assigned as 
either medical air (21% oxygen) or a hypoxic gas (14% oxygen). 
5.2.4 Data analysis 
In both the AMD and the control groups, the distribution of scotopic thresholds and the 
SpO2 readings when breathing 14% oxygen and 21% oxygen were tested for normality 
using the Shapiro-Wilkes test. For within group comparisons where the distribution of the 
data was normal, paired t-tests were used. The Wilcoxon signed rank test was used if the 
data were not normally distributed. When comparing the data between groups the 
independent samples t-test was used if the data were normally distributed, or the Mann 
Whitney test was used for data that were not normally distributed. 
5.3 Results 
Thirty-six participants took part in the study, 20 controls and 16 participants with early 
AMD. The AMD group contained 6 females and the control group 8 females. There was no 
significant age difference between the AMD group (mean age 72.9years +/- 4.9SD) and 
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the control group (mean age 68.3 years +/- 5.4SD). Data were not collected from one 
participant due to the participant’s SpO2 dropping below 85%. The participant felt fine 
and their SpO2 returned to a normal level once the 14% oxygen was turned off. Therefore, 
data were collected from 35 participants. Table 5-1 shows the characteristics of all 
participants who sat for the studies in Chapters 5 and 6.  
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Participant 
number 
Age Gender AMD 
status test 
eye+ 
AMD 
status 
fellow eye+ 
Combined 
status* 
VA test 
eye 
(LogMAR) 
VA fellow 
eye 
(LogMAR) 
Group 
001 77 M 1 2 3 0.00 0.02 AMD 
002 78 M 2 2 4 0.20 0.82 AMD 
003 61 M 0 0 0 0.00 0.00 CONTROL 
004 74 M 1 2 3 0.08 0.52 AMD 
005 76 M 1 2 3 -0.06 0.00 AMD 
006 70 F 0 0 0 0.00 -0.02 CONTROL 
007 69 F 1 2 3 0.02 0.48 AMD 
008 82 M 1 2 3 0.24 0.30 AMD 
009 65 M 0 0 0 0.02 0.06 CONTROL 
010 68 M 0 0 0 0.06 0.10 CONTROL 
011 69 M 1 2 3 0.02 1.40 AMD 
012 73 M 0 0 0 -0.08 0.02 CONTROL 
013 66 F 0 0 0 -0.16 0.24 CONTROL 
014 71 M 0 2 2 0.00 0.20 AMD 
015 78 F 1 2 3 0.00 0.00 AMD 
016 77 F 0 0 0 0.10 0.10 CONTROL 
017 72 F 1 1 2 0.00 0.06 AMD 
018 72 M 1 0 1 0.08 -0.10 CONTROL 
019 82 M 0 0 0 0.10 0.06 CONTROL 
020 68 F 0 0 0 0.06 0.30 CONTROL 
021 67 M 1 2 3 0.02 0.00 AMD 
022 66 F 0 0 0 0.1 0.2 CONTROL 
023 66 F 0 0 0 -0.16 -0.10 CONTROL 
024 69 F 1 2 3 0.20 1.00 AMD 
025 67 M 0 0 0 -0.10 0.00 CONTROL 
026 74 M 1 0 1 0.00 -0.08 AMD 
027 66 M 0 0 0 -0.20 0.00 CONTROL 
 
184 
 
Table 5-1. Characteristics of all participants; + the number given to the status of each eye reflects the number of risk points 
assigned according to the AREDS simplifed scale; * combined status reflects the AREDS simplified scale score.  
 
 
 
028 62 M 0 0 0 -0.08 0.10 CONTROL 
029 70 M 0 0 0 -0.18 0.00 CONTROL 
030 61 F 0 0 0 -0.16 0.02 CONTROL 
031 70 F 0 0 0 0.10 0.00 CONTROL 
032 68 F 1 2 3 -0.01 0.10 AMD 
033 61 M 0 0 0 0.08 0.08 CONTROL 
034 79 F 1 1 2 0.10 0.14 AMD 
035 64 M 0 2 2 -0.10 0.02 AMD 
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5.3.1 SpO2 Results 
The SpO2 for both groups fell when breathing 14% oxygen. This reached a plateau for 
the control group after 7 minutes and the AMD group after 8 minutes. There was a 
significant difference in SpO2 between the groups for the final 5 minutes when 
breathing 21% oxygen (Mann-Whitney p=0.01) and when breathing 14% oxygen 
(Mann-Whitney p=<0.0001). In both cases the control group had higher SpO2 values 
compared to the early AMD group (97.1 vs 96.8% 21% O2; 92.7% vs 91.4% 14% O2). 
All individuals showed a reduction in SpO2 when breathing the hypoxic gas compared 
to medical air. Figure 5-2(a) shows the mean SpO2 over 5 minutes for the AMD group 
when breathing 14% and 21% oxygen, the decrease in SpO2 was statistically significant 
(Wilcoxon signed rank p=<0.0001). Figure 5-2(b) shows the mean SpO2 over 10 
minutes when breathing 14% and 21% oxygen for the control group. In this group 
breathing 14% oxygen also resulted in a significant drop in SpO2 (Wilcoxon signed rank 
p<0.0001). 
(a)  (b)  
Figure 5-2. Mean group SpO2 readings with confidence intervals for the final 5 
minutes of breathing gas for (a) AMD group and (b) control group. 
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5.3.2 Scotopic threshold results 
Scotopic threshold data were analysed for 33 out of 35 participants for both visits, as 
one participant (015) did not proceed to the main trial after failing the requirement 
for the scotopic threshold from each of the practice trials to be within one standard 
deviation of each other. The data for one control participant (022) had to be removed 
from analysis due an abnormal OCT indicating a pre-existing ocular condition. 
An example of the psychophysical data is given in Figure 5-3, which shows a sample 
output of the QUEST procedure alongside the SpO2 readings per minute for both gas 
types for participant 011. It can be seen that, for this individual, SpO2 levels dropped 
by more than 5% when the hypoxic gas was provided. The scotopic threshold for this 
person with AMD was very similar under the two gas conditions. 
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Figure 5-3. Scotopic thresholds with standard deviations and SpO2 recordings over a 
full trial when breathing 21% oxygen (top panels) and breathing 14% oxygen 
(bottom panels) for early AMD participant 011. 
The differences in threshold for each individual when breathing 14% were compared 
with breathing 21% oxygen and are shown in Figure 5-4. Points above the line 
represent an increase in threshold (decrease in sensitivity) when breathing 14% 
oxygen, and points below the line represent a decrease in threshold (increase in 
sensitivity) when breathing 14% oxygen. The difference for all but one participant 
within the control group was less than 0.15 log cd/m2, whilst only 3 participants with 
AMD showed a change in threshold greater than this with the change in gas type. 44% 
(n=8) controls showed an increase in threshold when breathing 14% oxygen, whilst 
60% (n=9) participants with AMD showed an increase in threshold when breathing 
14% oxygen.  
0
0.5
1
1.5
2
0 20 40
T
h
re
sh
o
ld
 (
lo
g 
cd
/m
2
)
Trial number
89
91
93
95
97
99
0 2 4 6 8 10
Sp
O
2
Time (mins)
0
0.5
1
1.5
2
0 20 40
T
h
re
sh
o
ld
 (
lo
g 
cd
/m
2
)
Trial number
89
91
93
95
97
99
0 2 4 6 8 10
Sp
O
2
Time (mins)
 
188 
These plots indicate that there is no evidence of an effect of breathing the hypoxic gas 
on scotopic thresholds.  
(a)     (b)                                                                                                                                                             
Figure 5-4. Change in threshold when breathing 14% oxygen compared to breathing 
21% oxygen for (a) the AMD group and (b) the control group.  
There was no significant difference in mean scotopic thresholds when breathing 14% 
oxygen compared to when breathing 21% oxygen within the early AMD (paired t-test 
p=0.781) or the control group (paired t-test p= 0.950); this can be seen in Figure 5-5, 
where the confidence intervals are clearly overlapping. There was also no significant 
difference in the change in thresholds between groups when values were compared 
under 14% and 21% oxygen conditions (Mann-Whitney AMD differences mean = -
0.015, control differences mean = -0.001; p= 0.509). 
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 Figure 5-5. Group mean scotopic thresholds with 95% confidence intervals for 14% 
and 21% oxygen conditions for the AMD group (left panel) and for the control group 
(right panel). 
There was, however, a statistically significant difference in mean scotopic threshold 
between the two groups when breathing 21% oxygen (independent t-test p=0.049) 
but not when breathing 14% oxygen (independent t test p= 0.130), with the AMD 
group showing a significantly higher threshold than the control group under normoxic 
conditions. 
5.3.3 Order effects 
Randomisation of the gas order was such that 16 participants received 14% oxygen 
first and 17 received 21% oxygen first. There was no effect of the order of presented 
gas (pair samples t-test p=0.196). 
5.4 Discussion 
This is the first study to investigate the effect of breathing 14% oxygen on scotopic 
thresholds in people with early AMD. The first hypothesis was that all participants 
(AMD and control) would show an increase in scotopic thresholds in hypoxic 
conditions. The results show that there was no statistically significant increase in 
-4.3
-4.2
-4.1
-4
-3.9
-3.8
10 15 20 25
T
h
re
sh
o
ld
 (
lo
g 
cd
/m
2
Oxygen (%)
-4.3
-4.2
-4.1
-4
-3.9
-3.8
10 15 20 25
T
h
re
sh
o
ld
 (
lo
g 
cd
/m
2
Oxygen (%)
 
190 
scotopic thresholds in either group when breathing 14% oxygen when compared to 
21% oxygen. This finding is in contrast to previous studies which have suggested that 
hypoxia raises scotopic thresholds in normal participants (McFarland et al. 1940; 
McDonald et al. 1939; Wald and Harper 1942b; Kobrick, L et al. 1984; Ernest et al. 
1971; Hecht et al. 1946). Table 5-2 details other studies that have examined the effect 
of hypoxia on the scotopic thresholds of healthy controls. It can be seen that in all 
studies the oxygen concentration supplied to create a hypoxic episode was lower than 
that used in this study, and the duration of breathing the air was longer. Whilst 
preliminary studies presented in this thesis have found that SpO2 stabilises after 8-
11mins of breathing air with an altered oxygen concentration (see section 3.2), there 
could be a compounding effect of an increased duration of inhalation and a lower 
level of oxygen inhaled in previous studies. It is also worth noting that all the previous 
studies had small participant numbers. 
There was a statistically significant difference in scotopic thresholds between the 
groups when breathing 21% oxygen (p=0.049) suggesting that under normoxic 
conditions scotopic thresholds are reduced in people with early AMD. This finding is in 
agreement with the literature (Owsley et al. 2000; Owsley et al. 2007; Scholl et al. 
2004) but not in agreement with Jackson et al. (1998) or the results from the 
investigation in Section 5, into the effect of breathing 60% oxygen and scotopic 
thresholds. The reason for this disparity is unclear as there were no significant outliers 
for any group which affected the statistical significance and there were no 
fundamental differences in the methods or equipment used between chapters 5 and 
6. Whilst 9 control participants and 6 participants with early AMD sat for both studies, 
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there was a larger sample size for this study, compared to the study described in 
Chapter 5. It is also worth noting that the difference in the recorded mean threshold 
when breathing 21% for both the AMD and control group was not significant between 
studies, demonstrated by overlapping confidence intervals. 
Study Participant 
details 
Period of dark 
adaptation 
used 
Period of 
hypoxia 
Percentage 
oxygen 
used 
Results Other details 
McFarland 
and Forbes 
(1932) 
N=6 32 mins 30 mins 13.3/11.4/ 
10/7.3 
Raised ST with 
reducing oxygen 
No stats analysis 
Pressure constant 
Full DA curve 
McDonald 
and Adler 
(1939) 
N=1 60 mins 20 mins 10.4 ST rise of 0.6 log units No stats analysis 
Normal pressure 
Wald and 
Harper 
(1942) 
N=4 uknown 30 mins 8-11 ST rise of 0.35 log 
units 
Rise and fall in 
thresholds noted- 
related to breathing 
patterns 
Kobrick 
(1984)  
N=12 None- testing 
continued for 
20 mins after 
bleach 
16 days  Sig impairment of ST 
to green stimulus 
Participants studied 
at altitude 
Full DA curve 
Ernest and 
Krill (1971) 
N=3 30mins 15mins 10 Increase in ST more in 
peripheral retina and 
had a greater effect 
on cones when 
compared to rods 
Stats conducted 
between rod and 
cones and not rods 
and control. 
Hecht and 
Hendley 
(1946) 
N=8 Unknown Unknown 9-16 Increase in 
threshold of 0.11 
log microlamberts 
when breathing 
14.9% oxygen 
Studied contrast 
discrimination 
 
Table 5-2. Comparison table of studies into the effect of a hypoxic episode on 
scotopic thresholds in normal participants. 
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The second hypothesis of this study was that the scotopic threshold would be 
selectively reduced in participants with early AMD in hypoxic conditions, due to the 
local retinal and choroidal changes that are present in early AMD. The results did not 
support this hypothesis i.e. there was no significant difference in the change in 
threshold between the two groups. This suggests that the retinas of people with AMD 
are, like age-matched controls, insensitive to hypoxia.  
The absence of a significant finding could be explained by the lack of a stable 
reduction in oxygen at a retinal level for a duration long enough to alter the scotopic 
thresholds of patients with early AMD. It could be that short periods of hypoxia are 
insufficient to induce localized retinal hypoxia to an extent which will affect retinal 
function. It is also noteworthy that a greater proportion of individuals with AMD 
showed an increase in threshold under the hypoxic condition than the proportion in 
the control group showing a similar change. It could be that certain individuals with 
AMD are more susceptible to localised changes to retinal oxygenation.  
A limitation of this study was that the effects of breathing reduced levels of oxygen 
were measured by changes in SpO2, which is a systemic measure. It may be that it 
takes longer to create localised retinal hypoxia than it does to induce systemic 
changes. A further limitation of this study was that, for pragmatic reasons, it was not 
possible to achieve the sample size of n=30 per group which was the aim, based on 
the sample size calculations (see section 4.2.2). This introduces the possibility of a 
type II error in the negative findings of this study. However, the findings of this study 
may also suggest that hypoxia is less implicated in visual dysfunction in early AMD 
than hypothesized. This will be further explored by evaluating a different aspect of 
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visual function. The ERG has been shown to be affected by hypoxia (as discussed in 
chapter 2) and by AMD (as discussed in chapter 2). The next chapter of this thesis will 
investigate the effect of breathing 14% oxygen on global and focal ERG parameters. It 
is hypothesised that, whilst the ERGs for both the early AMD and the control groups 
will be affected by hypoxia, due to the altered choroidal and retinal structure in early 
AMD the effect will be greater in the early AMD group. 
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6 The effect of breathing 14% oxygen 
on the electroretinogram of 
participants with AMD. 
6.1 Background and aims 
As discussed in section 1.5.4, electroretinography is an objective technique, which is 
able to detect and localise subtle changes in retinal function. Section 1.5.4.6 
concluded that both the amplitude and implicit times of focal ERGs are affected by 
early and intermediate AMD (Sandberg et al. 1993; Sandberg et al. 1998; Binns et al. 
2007; Falsini et al. 1999). Significantly reduced full field a and b-wave amplitudes have 
also been found in participants with nAMD and GA (Walter et al. 1999).  Implicit time 
delays of 1ms to the ERG have also been found in the fellow eye of participants with 
unilateral nAMD, which were associated with areas of choroidal perfusion defects 
(Remulla et al. 1995). This finding of a choroidal perfusion defect in the high-risk 
fellow eyes of participants with unilateral nAMD suggests that an altered retinal 
circulation is present before clinical signs of early AMD, and may predict the onset of 
nAMD. Furthermore, the study suggests that this circulatory abnormality can be 
detected with ERG recording. The ERG has also been found to be affected in healthy 
participants placed under a hypoxic episode, including significantly reduced OP and b-
wave amplitudes (Schmeisser et al. 1997; Tinjust et al. 2002; Janáky et al. 2007). As 
changes to the ERG are also seen during hypoxia as discussed in section 2.2.5, 
including reductions in both the a and b-wave amplitude (Schatz et al. 2014), it could 
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be that hypoxia is the cause of the changes in the ERG seen in AMD. This evidence not 
only supports the potential role of hypoxia in AMD, but also suggests that the ERG 
may be a sensitive tool for the investigation of ischaemia and hypoxia in AMD. 
This study aimed to investigate the effect of hypoxia on the focal flicker ERG and full-
field scotopic ERG in participants with early AMD. Both ERGs were recorded under 
scotopic conditions to maximise the dark current and retinal oxygen demands. The 
focal flicker response was employed to probe dark-adapted macular cone function 
under different states of oxygenation, whilst the full-field rod response assessed pan-
retinal rod photoreceptor function. The rationale for the inclusion of the focal ERG 
was that the macula is the primary locus of AMD related pathogenesis, and so is most 
likely to show signs of retinal hypoxia at an early stage. A cone response was chosen 
for the focal test as rods are highly directionally sensitive, and it is not possible to 
record a focal rod response within a short timeframe without the use of a 
desensitising surround (Binns and Margrain 2006). This would have resulted in a state 
of light adaptation which would minimise the oxygen demand of the tested retinal 
area.  The full-field rod response was also included on the basis that rod 
photoreceptor loss precedes cone loss in early AMD (Jackson et al. 2002). It was also 
of interest to include a full-field response to determine whether there were any 
indicators of a global state of retinal hypoxia in participants with AMD. Full field 
testing also has the advantage that the measured response is larger than that seen in 
focal responses, which may decrease the effect of noise in a group of older 
participants with pathology. 
 
196 
It was hypothesised that breathing 14% oxygen would result in a reduction in 
amplitude and delay in the implicit time of the first harmonic of the focal flicker ERG 
both in participants with early AMD and in the control group. A reduction in amplitude 
of the scotopic full field ERG a-wave and a reduction in amplitude and increase in 
implicit time of the b-wave in participants with early AMD and in the control group 
was also proposed. It was further hypothesised that the effects of the transient 
systemic hypoxia on both ERGs would be greater in the group with early AMD, due to 
the local retinal hypoxia which is hypothesised to be associated with the disease 
onset.  
6.2  General ERG recording methods 
A silver-silver chloride electrode, filled with an electrolyte gel (TECA) was used as a 
ground electrode. This was positioned in the mid-frontal forehead position, after skin 
was prepared using an abrasive gel (Nuprep, Weaver and Company), and affixed with 
surgical tape (Blenderm). DTL fibre electrodes (Unimed electrode supplies) were 
positioned in the lower fornix of the test eye as an active electrode and the 
contralateral eye as a reference. Surgical tape was applied first to any area where the 
DTL electrode may have contact with the skin. The electrode set up can be seen in 
Figure 6-1. 
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Figure 6-1. Participant set up for ERG recording. 
All ERGs were recorded under dark adapted conditions. In the pilot study, a period of 
35 minutes of dark adaptation was employed for the healthy controls, and 50 minutes 
for the participants with early AMD (reflecting the anticipated longer time required to 
reach absolute threshold in those with the condition (Owsley et al. 2007)). For the 
main study all participants underwent a total of 60 minutes dark adaptation to ensure 
that all individuals were at or close to absolute threshold. Following dark adaptation, 
the contralateral eye was occluded and ERGs recorded on the Medelec Synergy 
Evoked Potential Monitoring System (Oxford Instruments PLC, Old Woking, Surrey, 
UK) using a miniature Ganzfeld light emitting diode (LED) stimulator (CH electronics, 
Kent, UK). All ERGs were averaged and bandpass filtered from 1-100Hz. Artefact reject 
settings were applied to all traces to avoid any trace contamination by blinking or eye 
movements, for focal ERGs these were set to 50µV and for full field testing this was 
set to 500µV. 
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For the recording of focal ERGs a focal (20° diameter) red stimulus (peak wavelength 
666nm) was used, with an average luminance of 40 cd/m2, flickering with a square 
wave profile at a temporal frequency of 41Hz on a 50ms time base. A red stimulus was 
chosen to minimise light adaptation. For the recording of full field ERGs, traces were 
recorded to a blue 0.5Hz full field stimulus (0.00125cd.s.m-2) stimulus averaged on a 
200ms time base. 
The miniature Ganzfeld (LED) stimulator consists of a 5cm diameter tube which 
houses a collection of LEDs that can be used as a full field stimulus (when held close to 
the eye) or as a focal stimulus when viewed at a distance (in this study, held at 13.5 
cm to stimulate a region subtending 20 degrees at the retina). A peripheral surround 
may be used to desensitise the non-stimulated retina, in order to minimise the effect 
of scattered light on the focal response (Binns et al. 2007). In this study, however, we 
wished to maximise the state of dark adaptation and the peripheral surround was not 
employed. The equipment can be seen in Figure 6-2. 
        
Figure 6-2. Equipment used for ERG recording. 
Medelec 
 synergy 
 
Miniture 
Ganzfeld LED 
stimulator in 
peripheral 
surround   
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6.3 ERG signal analysis 
Data collected for all participants were exported to Excel Microsoft 2010 for Fourier 
analysis. For the focal ERG data the amplitude and implicit time of the first harmonic 
were analysed. In order to reduce high frequency noise, harmonics higher than the 
first twelve (i.e. above 60Hz) were removed from the full field data (preliminary 
analysis indicated that the signal contribution to harmonics above this frequency was 
negligible). The parameters chosen for full field analysis were the amplitude of the a-
wave (measured from from baseline), and the b-wave (measured from the a-wave 
trough to the peak of the b-wave), and the implicit time of the b-wave. The a-wave 
and the b-wave were objectively identified within fixed time windows (the minimum 
amplitude between 0-6ms for the a-wave and the maximum amplitude between 180-
200ms for the b-wave). 
6.4 Pilot study optimising stimulus parameters for the ERG 
protocol 
A pilot study was carried out to determine the optimum stimulus parameters to be 
used in the main study. As hypoxia in AMD is hypothesised to be greatest under dark 
adapted conditions, the optimal protocol for this study would employ the lowest 
possible stimulus luminance. The pilot study therefore had 3 aims: 
 To establish the dimmest focal stimulus that could elicit recordable traces. 
 To determine if any light adaptation occurred over a two minute period when 
a red 41Hz square wave flickering focal stimulus at the maximum luminance 
was used (average luminance 40 cd/m2). 
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 To determine if any light adaptation occurred over a one minute period when 
a blue 0.5 Hz full field stimulus (0.01cd.s.m2) was used to stimulate rod 
photoreceptors. 0.01cd.s.m2 was chosen as it corresponds to the ISCEV 
standard for the dark adapted rod 0.01 ERG recording (McCulloch et al. 2014). 
 
To establish the optimum stimulus parameters, three studies were designed to 
address these aims, which are described below. 
6.4.1 Methods 
Participants for this pilot study were recruited from the School of Optometry and 
Vision Sciences, Cardiff University and from the Medical Retina clinics at the University 
Hospital Wales. Distance corrected visual acuity (ETDRS LogMAR chart) and 
intraocular pressures were measured (Topcon CT 80 tonometer) and participants 
were excluded if they had a VA less than 6/7.5 (0.1 logMAR) or an IOP >21mmHg 
(average of three readings). Retinal photographs were taken to assign participants to 
one of three groups, younger normals (ages 26-37 years), older normals (ages 59-72 
years) or participants with early AMD. One percent tropicamide was then installed 
into the eye used for recording, this was the right eye or, in the case of the 
participants with AMD, it was the eye diagnosed with early AMD. All procedures 
adhered to the tenets of the declaration of Helsinki. The study was approved by South 
East Wales Research Ethics Committee.  
The ERGs were recorded according to the method described in section 6.2. 
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6.4.1.1 Stimulus intensity study 
This study aimed to determine the lowest stimulus luminance that would elicit 
recordable traces in both normal participants and participants with early AMD. 
Neutral density filters (0.3, 0.6 and 0.9 log units) were used to attenuate the focal 
stimulus luminance to 20 cd/m2, 10 cd/m2 and 5 cd/m2, respectively. 200 sweeps were 
averaged at each luminance level, starting with the lowest intensity stimulus. 
Responses were Fourier analysed to obtain the amplitude of the first harmonic. 
6.4.1.2 Focal cone ERG stimulus adaptation study  
The aim of this study was to see if any light adaptation occurred when a focal (20°) red 
stimulus at the maximum time-averaged luminance of 40 cd/m2, flickering with a 
temporal frequency of 41Hz, was used for recording. Traces were averaged in sets of 
25 sweeps, on a 50ms time base, continuously for a period of 2 minutes, with every 
third trace Fourier analysed to obtain the amplitude of the first harmonic. On average, 
this resulted in 33 traces (range 28-36) being obtained for each participant. A 
comparison was made between the amplitude of the first two and the final two 
responses analysed, on the basis that a significant difference in amplitude of the first 
harmonic would indicate that light adaptation had occurred during the recording 
period. Statistical significance was tested using a paired t test or Wilcoxon signed rank 
test if the data were not normally distributed. 
6.4.1.3 Full-field rod ERG stimulus adaptation study  
To record a full field response, the participant held the miniature Ganzfeld (LED) 
stimulator as close to the eye as possible. Three single responses were averaged on a 
200ms time base to a full field blue 0.5 Hz stimulus (0.01cd.s.m2). The stimulus was 
then viewed continuously for 1 minute, after which a second set of 3 responses was 
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averaged. For some participants additional data were collected with neutral density 
filters attenuating the light to luminances of 0.0025 cd.s.m2 (6 participants) and 
0.000625 cd.s.m2 (4 participants). All traces were then Fourier analysed and the 
amplitude of the b-wave evaluated. To investigate if there was a statistical significance 
between the amplitude of the b-wave after 1 minute a paired t-test (or Wilcoxon 
signed rank test if the data was not normally distributed) was run. 
6.4.2 Results 
Participants were chosen to represent a diverse range of ages and included healthy 
controls and individuals with early AMD. Eleven participants took part, and their 
details can be seen in Table 6-1. Datasets were recorded for all participants for the 
stimulus intensity study and the focal cone ERG stimulus adaptation study, except for 
participant AB.  Data sets were collected for all participants for the full field ERG 
stimulus adaptation study, except for CJ. Four participants also participated in the 
collection of full-field adaptation data at lower stimulus intensities. The participants 
were split into three sets which included 5 younger normals (mean age 29.4 years), 
three older normals (mean age 63.67) and three participants graded as 0-2 in the test 
eye on the simplified severity AREDS scale (Ferris et al. 2005) (mean age 72 years). 
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Participant Age Disease status Studies 
participated in. 
CJ 26 No Disease 1,2 
VN 27 No Disease 1,2,3 
GR 27 No Disease 1,2,3 
LR 30 No Disease 1,2,3 
AB 37 No Disease 3,4 
RN 60 No Disease 1,2,3 
RE 72 No Disease 1,2,3,4,5 
SH 59 No Disease 1,2,3,4 
LP 70 Early AMD 1,2,3,4,5 
JB 69 Early AMD 1,2,3,4,5 
MD 77 Early AMD 1,2,3,4,5 
Table 6-1. Participant details and the studies they participated in. study 1= Stimulus 
intensity study, 2= focal stimulus adaptation study, 3= full field stimulus adaptation 
study, 4= full field stimulus adaptation study to 0.0025cd.s.m2 5= full field stimulus 
adaptation study to 0.000625cd.s.m2. 
6.4.2.1 Stimulus intensity study 
In all control participants apart from RE, data were reliably collected at all stimulus 
luminances. As expected, the amplitude of the traces reduced as stimulus luminance 
was reduced (see sample data from control LR in Figure 6-3, top panel). For 
participant RE (a member of the older control group), the lower luminances did not 
elicit a response distinguishable from noise levels (see sample data from RE in Figure 
6-3, lower panel). For the participants with early AMD, clear responses were not 
obtained at any stimulus luminance for any participant, apart from JB, who showed a 
clear response at 40 cd/m2 and 20 cd/m2. 
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Figure 6-3. Results from focal cone stimulus intensity study from participant LR (top 
panel) and participant RE (bottom panel). The traces shown are each the average of 
800 responses, before Fourier analysis.  
Figure 6-4 shows the mean averaged amplitude of the first harmonic from all 
participants at all four luminances. It can be seen that there is an increase in the 
amplitude of the first harmonic with increasing luminance of the stimulus. Increasing 
CI bars indicate that the intersubject variability is greatest for the highest luminance. 
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 Figure 6-4. Mean amplitude of the first harmonic recorded at different luminance’s 
with 95% confidence intervals. 
6.4.2.2 Stimulus adaptation study focal cone ERG 
Figure 6-5 shows every third trace for sample participant RN (older control group) 
over a period of 2 minutes. An average time of approximately 2 seconds elapsed 
between the beginning of each of these recordings. There was no clear systematic 
reduction in the response amplitude with increasing time after stimulus onset. This 
was the case for all participants where a clear response was obtained before Fourier 
analysis. However, the signals from all three participants with AMD were too small to 
produce a response above the level of background noise when only 25 responses 
were averaged.   
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Figure 6-5. Results from focal cone stimulus adaptation study for participant RN. 
For the group mean data, the results from the AMD group were not included in the 
analysis due to the data being contaminated with noise. The group mean amplitudes 
of the first harmonic for the first and final two waves with confidence intervals can be 
seen in Figure 6-6. There was no statistically significant difference between the 
amplitudes of the first and last traces (p=0.647) suggesting that there is no light 
adaptation to a stimulus averaging 40 cd/m2 over a two minute period. 
 
Figure 6-6. Group mean amplitude of the 1st harmonic at 0 minute (blue diamonds) 
and 2 minute (red diamonds) with confidence intervals. 
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6.4.2.3 Stimulus adaptation study full field rod ERG 
Table 6-1 shows which data was collected for each participant for this study. Figure 6-
7 shows the raw traces for participant RE when the luminance was attenuated to 
0.000625 cd.s.m2. 
 
Figure 6-7. Recording before blue light adaptation (blue trace) and after 1 minute 
blue light adaptation (red trace) for participant RE with a stimulus luminance of 
0.000625 cd.s.m-2. 
After Fourier smoothing had taken place, and b-wave amplitudes evaluated, the group 
mean of the b-wave amplitudes for each luminance before and after the 1 minute 
adaptation period were plotted and can be seen in Figure 6-8. In every case, the mean 
amplitude was lower after adaptation. However, there is an overlap of the confidence 
intervals for the first and last b-wave amplitudes for all luminances, suggesting that 
that there is no significant effect of light adaptation on ERG amplitude after viewing 
the stimulus for one minute at any luminance. This was confirmed with statistical 
analysis (paired t-tests, luminance 0.01 cd.s.m2 p=0.139, luminance 0.0025 cd.s.m2 
p=0.946, luminance 0.000625 cd.s.m2 p=0.180). 
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Figure 6-8. Mean group b-wave amplitudes with confidence intervals. 
 
6.4.3 Pilot discussion 
This pilot study aimed to determine the optimum stimulus parameters for a study into 
the effect of hypoxia on ERG parameters in participants with early AMD. The purpose 
of this optimisation was to identify the stimulus luminance that would allow clear 
responses to be recorded from all participants, whilst minimising the state of light 
adaptation. 
The first pilot study suggested that a stimulus luminance averaging 40cd/m2 is 
required to reliably elicit a focal flicker response from all individuals above the level of 
noise. Clear responses were not obtained from all participants at the lower 
luminances. Also, as signal sizes are reduced with age and with retinal disease a higher 
luminance stimulus will increase the chance of a recordable signal being obtained in 
all participants.  
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The results of the second study suggest that there was little light adaptation to the 
focal stimulus, even when viewing the highest available stimulus luminance of 40 
cd/m2. This finding is important for two reasons. Firstly, the effect of hypoxia in AMD 
is thought to be greatest under conditions of dark adaptation, hence ongoing light 
adaptation of the retina is undesirable in this study of dark-adapted cone function; 
secondly, when comparing responses before and after gas inhalation, it is vital that 
adaptation effects are not influencing responses. The red stimulus was used in order 
to minimise the effect of light adaptation as rod photoreceptors are relatively 
insensitive to red light. 
For the full field testing, although there was no statistically significant effect of light 
adaptation on the ERG amplitude at any stimulus luminance there was a trend for the 
amplitude of the b-wave to be smaller after viewing the stimulus for 1 minute. 
Therefore to minimise the effect of light adaptation, for the main study the test 
stimulus used for full field ERG recording was 0.00125cd.s.m-2, an intensity which fell 
between the two lower stimulus levels.   
6.5 Main Study 
The aims and hypotheses of this study are described in section 6.1. Dark–adapted 
cone function (focal flicker ERG) and rod function (full-field rod ERG) were assessed in 
participants with AMD and age matched controls when breathing medical air and 14% 
O2.  
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6.5.1 Methods 
The main study followed the basic methods set out in section 6.2.  All participants had 
previously taken part in the scotopic thresholds 14% oxygen study described in 
Chapter 5, and the inclusion and exclusion criteria are as previously described (see 
section 4.2.1). Baseline measurements were recorded as described in section 4.2.3. 
Participants that had been seen for the psychophysical testing within the past 4 weeks 
continued straight to the main ERG study data collection after consent and patient 
history were taken, without repeating baseline tests.  Once 60 minutes of dark 
adaptation were complete, participants undertook up to 10 minutes of practice ERG 
recording, then the data collection followed the timeline set out in Figure 6-9. To 
summarise, the first of two randomly assigned gases (either air containing 14% oxygen 
or medical air containing 21% oxygen) was turned on and, after 8 minutes, the 
participant undertook 7 minutes of ERG recordings. In this period, the data collection 
for both the focal and the full field recordings took place. Focal ERG traces were 
recorded to a red (peak wavelength 660nm) stimulus of 20◦ diameter, with an average 
luminance of 40 cd/m2, at a temporal frequency of 41Hz (50% duty cycle), averaged in 
blocks of 25 responses on a 50ms time base.  Full field ERGs were recorded to a blue 
(peak wavelength 469nm) stimulus of 0.005cd.s.m-2, duration 5ms, at a temporal 
frequency of 0.5Hz, averaged in blocks of 5 responses on a 200ms time base. The 
amount of data collected depended on the participant, but on average 20 blocks of 
focal data and 10 blocks of full field data per gas were collected. There was then a 5 
minute washout period, before the second gas was turned on and the process 
repeated. Throughout the study the participant’s SpO2 was recorded at 1 minute 
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intervals using a finger pulse oximeter (CMS-50E) and the study was terminated if the 
participant’s SpO2 fell below 85%. Details of the 60% ventimask used for the gas 
inhalation and the finger pulse oximeter are provided in section 3.1.3.   
Dark adaptation 
  
60 mins 
Practice 
 
 10 mins 
Breathing 
gas 1 
8 mins 
Recording 
of ERGs 
7 mins 
Washout 
period 
5 mins 
 
Breathing 
gas 2 
8 mins 
 
Recording 
of ERGs 
7 mins 
 
Figure 6-9. Timeline showing the protocol of the study investigating the effect of 
inhaling 14% oxygen on ERG parameters. 
 
6.5.2 ERG signal analysis 
For all participants the raw traces were exported to an Excel spreadsheet for analysis. 
All of the individual traces (an average of 25 responses for the focal data and an 
average of 5 responses for the full field) were then grouped by the stimulus presented 
and the air type breathed and were then plotted on 4 graphs (14% focal, 14% full field, 
21% focal, 21% full field). The data were then made anonymous and reviewed by eye 
by the author.  Traces which were contaminated by noise or were outliers were 
removed. The remaining data were then averaged for each condition, with confidence 
intervals. The mean traces with confidence intervals, as well as the individual 
component traces for each individual participant were then reviewed by supervisor 
AB, who was masked to the participant group and air type breathed. Data that were 
still considered unreliable were removed from any further analysis. ‘Unreliable’ data 
was identified as that where the component traces were not reproducible, suggesting 
contamination by extraneous noise such as eye movements. Data containing an 
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obvious blink artefact or traces showing a gradient associated with a slow eye 
movement were also excluded. 
Fourier analysis and the objective evaluation of the amplitude and implicit time of the 
first harmonic of the flicker ERG, and the a- and b-waves of the full-field ERG was 
carried out as described in Section 6.3 
6.5.3 Data analysis 
Comparisons were made for each parameter between gas types within each group, 
and between groups for each gas type. Data were tested for normality using the 
Shapiro-Wilkes test. For within group comparisons where the distribution of the data 
was normal, paired t-tests were used. The Wilcoxon signed rank test was used if the 
data were not normally distributed. When comparing the data between groups the 
independent samples t-test was used if the data were normally distributed, or the 
Mann Whitney test for data that were not normally distributed. Data were tested for 
order effects by running independent samples t tests if the data were normally 
distributed or the Mann Whitney test for data that were not normally distributed. 
6.5.4 Results 
Datasets were collected from all of the 35 participants who participated in the 
investigation into the effect of breathing 14% oxygen on scotopic thresholds in AMD 
(see chapter 5). Their details are shown in Table 5-1. Retinal imaging was repeated 
and no participant showed a change in disease status between the two visits. 
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The visual evaluation of the data by TC and AB resulted in the datasets for 4 
participants being removed for the full field analysis (participants 009, 010, 017 and 
026). The datasets for 7 participants were also removed from the analysis of the focal 
ERG (participants 002, 012, 015, 021, 024, 034, and 035). Examples of this excluded 
data are shown below in Figure 6-10 and in Figure 6-11. 
(a)         (b)  
Figure 6-10. Examples of excluded focal ERG datasets. Mean of focal data with 
confidence intervals after the removal of contaminated data for participant (a) 
034EF when breathing 21% oxygen and (b) 021MR when breathing 14% oxygen. 
(a) (b)  
 
Figure 6-11. Examples of excluded full-field datasets. Mean of full field data with 
confidence intervals after the removal of contaminated data for participant (a) 009DG 
when breathing 21% oxygen and (b) 010RE when breathing 21% oxygen. 
 There were no order effects for any of the parameters measured [focal amplitude 
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full field amplitude of the a-wave (Wilcoxon signed rank p= 0.739), amplitude (Wilcoxon 
signed rank p=0.814) and implicit time (paired t-test p= 0.950) of the b-wave] 
6.5.4.1 SpO2 results 
Figure 6-12 shows the mean SpO2 readings for each group under each gas condition. It 
is apparent that the peripheral blood oxygenation dropped by a significant amount for 
both groups (Wilcoxon signed rank, early AMD group p<0.001, control group<0.001) 
when breathing 14% oxygen. The SpO2 values were significantly different between the 
two groups when breathing 14% gas (Mann Whitney p= 0.031), but there was no 
significant difference when breathing 21% oxygen (Mann Whitney p= 0.174). Both 
groups reached a plateau by the ninth minute.  
 
Figure 6-12. Mean SpO2 for the AMD group and the control group when breathing 
14% and 21% oxygen with confidence intervals. 
6.5.4.2 Focal ERG results  
Figure 6-13 shows sample data collected for participant 022 when breathing 21% 
oxygen, in order to demonstrate the data analysis stream. Traces which fell 
substantially outside the confidence intervals of the mean (dashed black) were 
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treated as outliers and excluded (red traces). Figure 6-14 shows the new average trace 
with outlying data excluded, and the Fourier analysis of the response.  
Figure 6-13. Data for the focal ERG recording for participant 022 when breathing 
21% oxygen. Mean trace (black) with confidence intervals (black dotted). Rejected 
traces shown in red.   
 
Figure 6-14. Mean (black trace) and Fourier analysed data (blue trace) for the focal 
ERG recording for participant 022 when breathing 21% oxygen. 
The mean amplitude and implicit time of the first harmonic data are presented in 
Table 6-2. There was no statistically significant difference in the amplitude of the first 
harmonic when breathing 14% oxygen, when compared to breathing 21% oxygen 
within either the AMD group or the control group (paired t-tests AMD p= 0.592; 
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Control p= 0.990). However, there was a statistically significant difference in 
amplitude between groups when breathing 14% oxygen (independent t-test p= 0.006) 
and 21% oxygen (independent t-test p= 0.002), in both cases the control group had a 
greater mean amplitude than the early AMD group. Statistical testing showed that 
there was no significant difference in the implicit times of the first harmonic either 
within groups when comparing gas types (AMD group p=0.457, control group p= 
0.349) or between groups when breathing 14% oxygen (Mann-Whitney p= 0.145) or 
when breathing 21% oxygen (Mann-Whitney p=0.668). 
The differences between the amplitude and implicit time of the first harmonic when 
breathing 14% oxygen compared to 21% oxygen were calculated within each group 
and compared between the AMD and control groups (this can be seen in Figure 6-15). 
There were no significant differences in the change in amplitudes (independent t-test 
p=0.692) or implicit time (Mann-Whitney p=0.095) between gas conditions in the two 
groups.  
 First harmonic 
amplitude 
First harmonic 
implicit time 
AMD group 14%  mean +/- CI 0.82 +/- 0.29 -0.37 +/- 0.61 
AMD group 21%  mean +/- CI 0.65 +/- 0.23 -0.12 +/- 0.71 
AMD group  mean difference +/- CI -0.10 +/- 0.23 0.31 +/- 0.73 
Control group 14%  mean +/- CI 1.25 +/- 0.18 -0.02 +/- 0.59 
Control  group 21%  mean +/- CI 1.24 +/- 0.18 -0.36 +/- 0.55 
Control group mean difference +/- CI 0.04 +/- 0.23 -0.30 +/- 0.55 
Table 6-2. Focal mean amplitude and implicit time of the first harmonic for AMD and 
control groups with 95% confidence intervals. 
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 (a) (b)  
Figure 6-15. Mean difference in (a) amplitude of the first harmonic and (b) implicit 
time of the first harmonic between gas conditions for each group with 95% 
confidence intervals. 
The change in SpO2 when each participant was breathing 14% oxygen was calculated 
for each individual and compared with the change in ERG parameter, these results are 
displayed graphically in Figure 6-16. Whilst all participants became hypoxic when 
breathing the 14% oxygen, there was no association between the change in SpO2 and 
any parameter for either group for both the focal parameters tested.  
 
(a)   (b)  
Figure 6-16. Change in SpO2  compared to change in (a) amplitude of the first 
harmonic and (b) implicit time of the first harmonic. 
 
6.5.4.3 Full field ERG results 
Figure 6-17 shows an example of the full-field data collected for participant 028 when 
breathing 14% oxygen. The mean trace can be seen in black, with confidence intervals 
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in dashed black. Traces that were rejected from analysis are shown in red. Figure 6-18 
shows the mean of the data after the rejection of contaminated traces, and the trace 
after Fourier removal of high frequency noise. 
      
Figure 6-17. Data for the full field ERG recording for participant 028 when breathing 
14% oxygen. Mean trace (black) with confidence intervals (black dotted). Rejected 
traces shown in red. 
               
Figure 6-18. Mean (black trace) and Fourier analysed data (blue trace) for participant 
028 when breathing 14% oxygen. The red dots represent the objectively determined 
b-wave 
amplitude 
a-wave 
amplitude 
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locations of the a-wave and b-waves. The arrows represent the amplitudes of the a- 
and b-waves. 
The mean amplitudes of both the a-wave and the b-waves and the implicit times for 
the b-wave for both groups are presented in Table 6-3.  Statistical analysis of the 
amplitude of the a-wave showed that there was no significant difference either within 
the groups when comparing the effect of breathing 14% oxygen to breathing 21% 
oxygen (Wilcoxon signed rank AMD group p= 0.594, paired t-test control group p= 
0.222) or between the AMD and control groups when breathing 14% oxygen (Mann-
Whitney p= 0.161) or when breathing 21% oxygen (independent t-test p= 0.155).  
There was also no significant difference in the amplitude of the b-wave between the 
groups when breathing 14% oxygen (Mann-Whitney p= 0.830) or when breathing 21% 
oxygen (Mann-Whitney p= 0.421). Within groups, there was no significant difference 
in the amplitude of the b-wave when breathing 14% compared to breathing 21% 
oxygen in the AMD group (Wilcoxon signed rank p= 0.272). There was, however a 
statistically significant decrease in the amplitude of the b-wave when breathing 14% 
oxygen when compared to breathing 21% oxygen within the control group (Wilcoxon 
signed rank p= 0.028). There was no significant difference in the implicit time of the b-
wave when breathing 14% compared to breathing 21% oxygen either within the 
groups (paired t-test AMD group p= 0.925, Wilcoxon signed rank control group p= 
0.570) or between groups when breathing 14% oxygen (independent t-test p= 0.764) 
or when breathing 21% oxygen (Mann-Whitney p= 0.625). 
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 a-wave amplitude b-wave 
amplitude 
b-wave 
implicit time 
AMD group 14%  mean +/- CI -3.63 +/- 3.12 80.26 +/- 19.62 95.14 +/- 5.16 
AMD group 21%  mean +/- CI -4.46 +/- 1.78 84.05 +/- 18.02 94.91 +/- 3.54 
AMD group  mean difference +/- CI -0.83 +/- 3.43 3.79 +/- 14.92 -0.21 +/- 4.49 
Control group 14%  mean +/- CI -6.07 +/- 1.79 73.69 +/- 11.93 96.09 +/- 3.65 
Control group 21%  mean +/- CI -7.63 +/- 2.73 89.62 +/- 14.65 96.42 +/- 4.80 
Control group mean difference +/- CI -1.57+/- 2.34 15.93+/- 11.25 0.33 +/- 3.53 
Table 6-3. Full field mean amplitude of the a-wave for the AMD and control groups 
with confidence intervals. 
Figure 6-19 and Figure 6-20 show graphs comparing the mean differences in all the 
parameters between gas conditions. There were no significant differences in the 
change in amplitude of the a-wave (Mann-Whitney p=0.356) or the change in 
amplitude (independent t-test p=0.211) or implicit time (independent t-test p=0.850) 
of the b-wave between gas conditions in the two groups.  
                          
Figure 6-19. Mean difference in a-wave amplitude when breathing 14% oxygen for 
AMD and control groups with 95% confidence intervals. 
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(a)  (b)   
Figure 6-20. Mean difference in (a) b-wave implicit time and (b) b-wave amplitude 
between gas conditions in the two groups, with 95% confidence intervals.  
 
No relationship was seen between the individual change in SpO2 and the change in 
any of the ERG parameters between gas conditions, this can be seen in Figure 6-21.  
 
(a)       (b)     
(c)  
Figure 6-21. Change in SpO2 compared to the change in (a) a-wave amplitude, (b) b-
wave amplitude and (c) b-wave implicit time. 
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6.5.5 Discussion. 
This study is the first to investigate the effect of breathing 14% oxygen on rod and 
cone scotopic ERG parameters in participants with early AMD. However, previous 
studies have shown that certain parameters of both the focal (Binns et al. 2007; Falsini 
et al. 1999) and full field ERG (Jackson et al. 2006; Walter et al. 1999) are affected by 
AMD when compared with control participants.  
In this study, the amplitude of the first harmonic was reduced in AMD participants in 
comparison to control participants when breathing 21% and 14% oxygen, but there 
was no difference in the implicit time of the first harmonic. This is in agreement with 
Falsini et al. (1999) who studied 25 participants with bilateral GA, and reported a 
reduction in the amplitude of the focal ERG with no phase changes. Our findings are in 
contrast to those of Remulla et al. (1995) and Sandberg et al. (1993) who found a 
preserved amplitude, but delayed implicit time in the fellow eye of participants who 
had unilateral nAMD. Binns and Margrain (2007) studying the effect of early AMD on 
the focal flicker ERG, likewise found an increase in implicit time in participants with 
early AMD, but also measured a decrease in amplitude similar to that reported here. 
One key difference in methodology is that the protocol reported here was unique in 
involving participants being dark adapted before recording the flicker response at the 
minimum luminance possible (with no adapting surround employed). Whilst the 
flicker ERG is by nature a cone response, the characteristics of the cone signal may be 
different under these conditions e.g. due to the increased metabolic demand 
presented by the maintenance of the rod dark current under dark adapted conditions 
(Wangsa-Wirawan et al. 2003). We can be confident that the focal ERG recordings in 
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this study were predominantly focal, despite the lack of an adapting surround, due to 
the use of a red stimulus which is not prone to scatter by the optical media. 
Although there are no studies comparing the effect of breathing 14% oxygen on focal 
ERG parameters between participants with early AMD and controls, it follows that if 
the amplitude of the first harmonic is reduced when breathing 21% in participants 
with early AMD when compared to controls, that it would also be reduced between 
the groups when breathing 14%, as found in this study. 
The results from this study are in agreement with the literature regarding the effect of 
AMD on full field ERGs (Jackson et al. 2004; Sunness et al. 1985). Jackson et al. (2004) 
found that early AMD did not alter the amplitude of the a-wave and Sunness et al. 
(1985) concluded that the full field ERG b-wave was not affected by either early or late 
AMD. Walter et al. (1999) concluded that AMD resulted in reduced a-wave and b-
wave amplitudes, however, no early AMD participants were included in that study, 
with all being graded as having either nAMD or GA.  
The results from the control group in this study are in agreement with the literature, 
in that the amplitudes but not the implicit times of the b-wave are affected by hypoxia 
(Schatz et al. 2014; Schatz et al. 2013). However these same studies also recorded a 
significant decrease in the a-wave amplitude, which was not repeated in this study. 
This discrepancy may be explained by the fact that the reduction in a-wave amplitude 
in a hypoxic condition was only reported in the literature when brighter stimuli were 
used (3 cd.s/m2 and 10 cd.s/m2), compared to the dim flash employed in this study 
(0.00125cd.s/m2). 
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Crucially, our results show that the change in ERG parameters when hypoxia is 
induced is not significantly greater in the AMD group than the control group for either 
the focal or the full-field response. Indeed, there were no significant differences 
between gas conditions for any of the parameters within either group, apart from the 
amplitude of the b-wave which was significantly reduced by the hypoxic episode for 
the control group. This finding was not in agreement with our hypothesis that stated 
that there would be a difference in the ERG parameters between gas conditions in 
both groups, and that the difference would be greater in the group with early AMD. 
The validity of recording full field ERG parameters to assess changes due to AMD has 
been challenged, due to the possibility of any focal rod and cone changes being 
obscured by the summed response from the peripheral rods (Curcio et al. 1990) which 
are relatively unaffected by AMD. This was reflected in our study by the lack of a 
significant difference in full-field ERG parameters between groups. However, our 
rationale for including this ERG in the protocol was to determine whether there was 
evidence of global retinal hypoxia in people with AMD. Our findings suggested that 
this was not the case. Similarly, the use of a flickering stimulus to evaluate dark-
adapted central retinal cone function might be contested in this study, given our 
hypothesis that any hypoxia will be maximal in the dark adapted eye. However, a 
rapidly repeating stimulus presented to the dark adapted eye might be expected to 
exacerbate hypoxia by further raising metabolic activity (Feigl et al. 2011), and it has 
the added benefit of allowing the substantial averaging of data within a limited 
timeframe. This maximises the signal to noise ratio of the response, which was vital in 
this study where the hypoxic conditions could only be applied for a limited time. The 
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pilot study also ensured that the luminance of the flickering stimulus was not 
sufficient to induce progressive retinal light adaptation.  
There are several limitations to this study. The first was the use of inexperienced 
participants for ERG recording. The amplitude of the waveform recorded to focal ERG 
parameters is small and subject to contamination by noise and therefore requires 
excellent compliance from the participant. Although training was conducted before 
data collection took place, due to time restrictions this was for 10 minutes only. The 
use of experienced participants may have resulted in more reliable data collection.  
Another limitation was the time constraint in the protocol due to safety when 
breathing 14% oxygen (i.e. this could not continue for a prolonged period). This led to 
a relatively short time window in which to average data, resulting in the collection of 
more variable data. It also meant that traces could not be reviewed until after data 
collection was complete. Ideally, review of the data at the time of collection would 
have enabled the removal of traces contaminated by eye movements, and the 
recording of replacements, allowing the collection of higher quality data. The 
combination of both these limitations resulted in more individual traces being 
rejected at the time of analysis. This particularly affected the focal results as even 
after Fourier analysis the data from 7 participants were excluded from analysis due to 
contamination by noise. 
A further limitation was that, for pragmatic reasons, the sample size included in this 
study did not meet the original aim of n=30 per group (section 4.2.2). This increases 
the possibility of a type II error i.e. missing a small difference between groups which 
would become apparent if the sample size had been larger.  
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Finally, although the SpO2 values in both groups decreased significantly during the 
hypoxic episode, it could not be proven that in this study this resulted in a significant 
decrease in oxygenation at a retinal level. Therefore, although a systemic hypoxic 
episode was created, it may be that this did not result in a local retinal hypoxia. 
To summarise, these limitations notwithstanding, it may be concluded from the 
findings of this study that there was no evidence of focal or global retinal hypoxia in 
the participants used in this study, when compared to healthy age-similar controls. 
The next chapter of this thesis will discuss the findings of chapters 4, 5 and 6 and 
consider the future of this research area. 
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7 General discussion and future 
directions. 
7.1 Discussion 
Age-related macular degeneration is the leading cause of blindness in the devloped 
world (Congdon et al. 2004), and currently there is treatment available for less than 
10% of those affected by the condition. A greater understanding of the pathogenesis 
is required to facilitate the development of new treatments at all stages of the 
disease, particularly in the early stages of the condition. An enhanced understanding 
of the disease mechanism would also help to develop improved tests for the early 
diagnosis and sensitive monitoring of AMD. The primary aim of this theisis was to gain 
a greater understanding of the role of hypoxia in the pathogenesis of early AMD, and 
to assess whether measures of dark adapted visual function could be used as 
functional biomarkers of disease-related hypoxia.  
Two reviews of current literature in Chapter 2 were carried out as part of this PhD, 
which aimed to investigate the effect of hypoxia on visual function, and to review the 
evidence that hypoxia plays a role in the pathogenesis of AMD. These reviews 
indicated that there is substantial evidence that a transient period of induced hypoxia 
affects various aspects of visual function, including scotopic thresholds and ERG 
parameters in normal participants. In people with AMD a reduction in scotopic 
sensitivity and changes to ERG parameters are also seen, which are comparable to 
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those reported under a hypoxic episode in normals. However, direct evidence that 
this visual dysfunction in AMD is attributable to hypoxia is absent. The experimental 
work reported in this thesis aimed to probe the relationship between hypoxia and 
scotopic visual function in AMD by recording scotopic thresholds and ERGs during 
transient periods of induced hypoxia and hyperoxia.  
In order to evaluate the effect of periods of transient hyperoxia and hypoxia on visual 
function in people with AMD, it was first necessary to evaluate the effect of these 
conditions in healthy controls. The studies carried out in Chapter 3 of this thesis 
looked at the effect of breathing 14% and 60% oxygen on the scotopic thresholds of 
normal participants for 5 minutes compared to a control medical air condition (21%). 
It was hypothesised that breathing 14% oxygen would result in an increase in scotopic 
thresholds, but that breathing 60% oxygen would not alter thresholds significantly. 
The study concluded that there were no significant differences in thresholds when 
inhaling 14%, 21% or 60% oxygen at any of the three retinal locations tested. This 
finding was unexpected, given the published evidence that a transient period of 
systemic hypoxia causes an elevation in dark adapted thresholds (McFarland et al. 
1939; McDonald et al. 1939; Wald et al. 1942b). However, it appeared from 
examination of the data that SpO2 was still decreasing after 5 minutes. This would 
suggest that a steady state of blood oxygenation had not been reached, and therefore 
that hypoxia was not at a level which would result in altered visual function. A follow 
up study found that a minimum of 8 minutes were required to reach this steady state 
plateau in SpO2 when breathing 14% oxygen.  
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A further aim of the preliminary studies was to determine whether a particular 
macular region was likely to be more susceptible to the effects of hypoxia. When the 
intensity of the hypoxic episode was increased (by breathing 10% oxygen), the 
stimulus presented at 7 degrees eccentricity showed the greatest deficit in scotopic 
visual function, indicating a possible increased vulnerability to the oxygen deficiency 
at the location. This result is in agreement with Feigl et al. 2011 and Connolly et al. 
2008b who found that visual function in the mesopic range is reduced between 1-15 
degrees and at 9 degrees, respectively. As the fovea is free from rods (Nag et al. 2012) 
it is not suprising that it was not as sensitive to hypoxia in the dark as the area at 7 
degrees. Retinal ganglion cell density peaks at 1.5-7 degrees from the fovea (Dacey 
and Petersen 1992) and these cells have also been found to have a high energy 
requirement (Wong-Riley 2010). It could be that the combined high density of RGCs 
and rods at this location increases its sensitivity to hypoxia.  
These pilot studies provided important information regarding i) the necessary 
duration of the hypoxic/hyperoxic episode and ii) the optimal location to test for 
retinal hypoxia. This information informed the development of an optimised protocol, 
which was then applied to a wider cohort of people with AMD and age-matched 
controls in order to test the hypothesis that temporarily reducing the level of retinal 
hyopxia by breathing 60% oxygen would result in a decrease in scotopic thresholds in 
people with AMD (see chapter 4). Interestingly, there was no reduction in threshold in 
either control or AMD group associated with the transient hyperoxic condition. 
However, the results of this study indicated that participants with early AMD were not 
systemically hypoxic under control conditions (their SpO2 levels were close to 100% at 
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baseline), therefore there appeared to be a ceiling effect at play whereby inhalation of 
60% could not increase participants’ SpO2 significantly beyond the baseline level. It is 
therefore not surprising that the systemic hyperoxia did not affect the scotopic 
thresholds of pariticipants. Also, an increase in SpO2 will not necessary result in a 
reduction in local retinal hypoxia as changes in the choroid and Bruch’s membrane 
would still impede transportation of metabolites to the photoreceptors (Goldberg et 
al. 1998; Staurenghi et al. 1992).  
The remaining experimental studies in this PhD, therefore, approached the problem 
from a different angle, testing the hypothesis that a transient hypoxic (rather than 
hyperoxic) event would have a greater effect on visual function in people with AMD 
than in healthy controls.   
Surprisingly, as reported in chapter 5, there was no significant increase in scotopic 
thresholds in either controls or people with early AMD when breathing 14% oxygen 
compared to medical air. There is evidence in the literature that a hypoxic episode 
results in a tempory increase in scotopic thresholds in control participants (McFarland 
et al. 1939; McDonald et al. 1939; Wald et al. 1942b). This discrepency may be due to 
the hypoxic conditions employed in this PhD, as previous studies used both a lower 
concentration of oxygen and an increased duration of hypoxia. The effect of a hypoxic 
episode on the scotopic visual function of participants with early AMD has not been 
studied before, however it would be expected that participants with AMD would be 
preferentially suseptable to the effects of a hypoxic episode due to changes in the 
structure of the choroid and Bruch’s membrane in AMD (Goldberg et al. 1998; Xu et 
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al. 2010) resulting in a possible localised retinal hypoxia already present in these 
participants. 
Chapter 6 assessed another aspect of scotopic visual function; the ERG. Specifically 
the latency and amplitude of the first harmonic of the focal ERG and the amplitude of 
the a-wave and amplitude and latency of the b-wave of the full field ERG. It was 
hypothesised that the effect of a hypoxic episode would be to increase the implicit 
time and reduce the amplitude of the first harmonic of the focal ERG and to cause a 
decrease in the amplitude of the a-wave and an increase in the implicit time and 
decrease in the amplitude of the b-wave of the full field ERG in both participant 
groups. This effect was expected in to be greater in participants with early AMD. 
Whilst the amplitude of the first harmonic was reduced in the group of particiapnts 
with early AMD, no other parameter of the focal or full field ERG was affected by early 
AMD, this was in line with the literature for the full field ERG (Sunness et al. 1985; 
Jackson et al. 2004). With respect to the focal ERG results, the findings were in 
agreement with Falsini et al. (1999) and Binns and Margrain (2007) who also found a 
amplitude of the first harmonic to be reduced in AMD, however some studies have 
also found a delay in the implicit time of the first harmonic (Binns et al. 2007; Remulla 
et al. 1995; Sandberg et al. 1993), which was not evident in this study. There was also 
no effect of breathing 14% oxygen on any of the tested parameters in participants 
with early AMD and within the age-matched controls, the only parameter to be 
affected was the amplitude of the b-wave which was significantly reduced in the 
control group. 
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The combined findings of chapters 4-6 provide no supporting evidence for the role of 
hypoxia in the pathogenesis of early AMD. This finding could be due to the profile of 
the participants recruited to the study. None of the participants in these studies were 
current smokers. People who smoke are at an increased risk of tissue hypoxia (Jensen 
et al. 1991) and therefore may have been more affected by systemic hypoxia. 
Therefore the participants in this study could require a longer duration and/or greater 
reduction in SpO2 to elicit a retinal hypoxic effect.  It may also be that the role of 
hypoxia in AMD is not as influential at the early stages of AMD seen in the participants 
in this study. The presence of drusen has been associated with choroidal filling defects 
(Staurenghi et al. 1992; Zhao et al. 1995). Some participants in this study had no age-
related changes in the test eye, and therefore may not have been affected by hypoxia 
at this stage in the disease process. However, the overall findings of this PhD suggest 
that hypoxia is implicated to a lesser degree in the pathogenesis of AMD than had 
been hypothesised.  
One of the main limitations of all of the studies included in this thesis is the sample 
size, which may not have been adequate to detect a small difference between groups 
or gas conditions. The sample size calculation described in section 4.2.2 was based on 
a study which looked at the effect of breathing different gas types on mesopic 
thresholds in healthy controls (Connolly and Hosking 2009b). These data are of limited 
relevance to the research presented in this thesis, which relates to the effect of the 
gas inhalation on scotopic visual function in people with early AMD. Hence, the  prior 
sample size calculation which suggested that a sample of 30 would be required per 
group was not regarded as reliable. In practice, the main constraint on participant 
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numbers was the difficulty encountered in recruiting volunteers who satisfied the 
inclusion criteria, particularly given the high prevalence of co-morbidities such as 
diabetes in individuals of this age-group. The exclusion of participants who were 
currently smokers was also a constraint. The sample size achieved for the main studies 
in this thesis was actually n=12 (early AMD group) and n=11 (age matched healthy 
controls) for Chapter 4, and n=15 (early AMD group) and n=20 (age matched healthy 
controls) (Chapters 5 and 6). As such the studies would only have been able to detect 
a relatively large standardised difference of about 0.97 with 80% power at the 5% 
level. This means that, whilst there was no evidence of any effect of either gas type on 
visual function in the participants with AMD, there is the possibility that the apparent 
lack of significant findings is actually attributable to the studies being underpowered. 
The data presented in this thesis may prove to be valuable to any future researchers 
wishing to carry out further work in this field, as they provide data which will allow for 
more appropriate sample size calculations to be conducted for future studies.  
A further limitation of this research was that there were no reliability studies carried 
out on the clinical measures assessed. As scotopic threshold measurements and the 
electroretinogram can be affected by extraneous factors such as electrical and neural 
noise, an estimate of reliability would have been valuable in determining that a true 
difference was not masked by poor test reliability. As the psychophysical and 
electrophysical methods used for data collection were unique to this study, there are 
no reliability studies from other sources. However two studies have evaluated the 
between session repeatability of measures of dark adapted visual function (Patryas et 
al. 2013; Kiser et al. 2006). Patryas et al. (2013) studied the repeatability of the dark 
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adaptation curve with data collected from stimuli presented on a Cathode ray tube 
screen. They concluded that cathode ray tube based dark adaptometry was highly 
repeatable with a coefficient of repeatability of 0.35 log cd.m-2 for the final threshold. 
Kiser et al. (2006) assessed the reliability of dilated dark adaptometry, dark adapted 
perimetry and dark adapted full field flash threshold testing in participants who were 
registered as having severe vision loss and in participants with normal vision as 
assessed with VA. They reported that over a period of three or more visits all of these 
tests were repeatable, with a coefficient of repeatability of +/-12.5 dB for the control 
group using full field flash testing and concluded that these tests could be used for 
monitoring outcomes in clinical trials.  
However, the data collection within the studies contained in this thesis was conducted 
within a single session, therefore a between session repeatability measure may not 
have been directly applicable. Perhaps more relevant is the within subject 
reproducibility of scotopic ERG measurements by Gillan (2012) who recorded scotopic 
flash ERGs in 6 participants over 10 recordings. They showed that there was variation 
in amplitude of the b-wave both within (coefficient of variation varied from 0.02-0.41 
µV for individual participants) and between participants (mean b-wave amplitudes 
ranged from 56.15-207.07µV for dilated recordings), and cautioned that the biological 
variation needs to be considered in both clinical and research settings. It is possible 
that this variability may have masked a small effect of gas type  in the current study.  
However, the difference in methodology between these previous studies and our own 
means that such a conclusion should be treated with caution. 
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The studies contained in this thesis tested the hypothesis that there would be a 
greater effect of systemic hypoxia / hyperoxia on visual function in people with early 
AMD than healthy controls. It would have been interesting to include further 
subanalysis of the data based on other structural parameters, for example the 
presence of RPD and choroidal thickness, however this fell outside the remit of the 
present study. Furthermore, although an OCT scan was run on both eyes of every 
participant at all visits, the imaging system used employed a laser of wavelength 
850nm unlike longer wavelength OCTs (1040nm and above), this is unable to reliably 
image the full thickness of the choroid in all participants (Unterhuber et al. 2005). 
Hence, a reliable measurement of choroidal thickness was not available for analysis. 
A further limitation of this study was the lack of a second grader for assigning all 
participants into age-matched control or AMD groups. A second grader was only 
consulted when TC considered the grading to be ambiguous. As can be seen in Table 
5-1 all apart from 3 participants had been assigned a grade of 2 in the fellow eye, 
these participants were undergoing treatment for nAMD and were therefore assigned 
to the AMD participant group. These individuals had already been classified as having 
unilateral nAMD by the Medical Retina team at UHW. In the 3 cases that required 
grading it was clear that they had at least one druse of larger than 125um or RPE 
changes and hence clearly had early AMD. However, a second, masked grader for 
grading participant images for those who had been classified as age-matched controls 
would have potentially improved grading reliability.  Although grading could have 
been improved by using a scale with more resolution, this was not considered 
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necessary as the scale was only used to classify participants as normal or as having 
early AMD in the test eye. 
In summary the main findings of this research indicate that: 
 That hypoxia is not responsible for the elevation of scotopic thresholds 
reported in early AMD. 
 That hypoxia is not responsible for the changes in ERG parameters found in 
early AMD. 
 That scotopic thresholds and scotopic ERGs cannot be used as functional 
biomarkers of hypoxia in early AMD. 
 The findings of this thesis do not support the role of hypoxia in the 
pathogenesis of early AMD, however the possibility cannot be excluded that a 
type II error was introduced due to the limited sample size.  
 The data presented in this thesis may be valuable in providing the means of 
conducting accurate sample size calculations for future research. 
7.2 Future directions 
Further analysis on participant characteristics, including the presence of RPD and a 
measurement of choroidal thickness would have allowed for potential sub analysis on 
the data collected. For example, was there a difference in scotopic thresholds or ERG 
parameters between participants with or without RPD? Further studies, if undertaken 
using a similar protocol, could include a measurement of these parameters. 
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The findings of studies in this thesis concluded that ERG parameters were not affected 
by early AMD or by hypoxia. However there is evidence that the full field ERG is 
affected by late stage AMD (Walter et al. 1999; Binns et al. 2007) and that there is a 
reduction in the amplitude of the first harmonic (Falsini et al. 1999) and a delayed 
implicit time (Remulla et al. 1995; Sandberg et al. 1993; Binns et al. 2007) in the focal 
ERG with early and late AMD. 
As the amplitude of the first harmonic was significantly affected by early AMD in this 
study, an extension of this work would be to measure this parameter on a selection of 
patients at different stages of the disease process, from early AMD to nAMD and GA. 
This research could lead to a better understanding of when the ERG is affected by 
AMD. Collecting data under a hypoxic episode from these individuals, as per the 
protocol in Chapter 6, could also determine if the role of hypoxia in the pathogenesis 
of AMD could occur at a later stage than that studied in this thesis.  
A limitation of the studies in chapters 4-6 was the exclusion of participant groups 
which may be at a higher risk of systematic hypoxia. Tissue hypoxia is a result of 
cigarette smoking (Jensen et al. 1991) and smokers are also at an increased risk of 
AMD (Klein, Klein and Moss 1998; Evans 2001; Chakravarthy et al. 2010b). To assess 
the effect of hypoxia on the scotopic visual function of smokers, data would be 
collected as per the protocols in chapters 6 and 7, in the following 4 cohorts 
 Participants with AMD- non smokers 
 Participants with AMD- current smokers 
 Age-matched control- non smokers 
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 Age-matched contol- current smokers 
The hypothesis of this study would be that any effect of breathing 14% oxygen on the 
scotopic thresholds and ERG parameters would be greatest in the group containing 
participants with early AMD who are current smokers. If this was confirmed then it 
would strength to the role of hypoxia in the pathogenesis of AMD. 
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Study 
 
 
Participants methods  results conclusions 
RGC sensitivity to mild 
systemic hypoxia. 
Kergoat 2006 
* 20 healthy adults * pERG conducted under 21% O2, carbogen or 
12% o2 
* amplitude and implicit time of 
P50 were not modified significantly 
with systemic hypoxia, they were 
depressed and delayed, respectively, 
for N95. 
 
* Inner neuroretinal function remained 
unchanged during increased blood O2 
and carbon dioxide levels known to 
alter retinal blood flow, but it was 
altered during decreased blood O2 
levels 
* The generators of N95, namely the 
retinal ganglion cells, are particularly 
sensitive to transient, mild systemic 
hypoxia. 
Spatial Contrast 
Sensitivity at Twilight: 
Luminance, Monocularity, 
and Oxygenation 
Connolly 2010 
 
*6 men mean age 32. 
6 women mean age 
32. 
*foveal cs at 7 spatial freq measured c 14.1% 
and 21% at luminances28.0 cd  m- 2  v, and at 
2.1 cd  m -2   and ; 0.26 cd m- 2 . 
*then mesopic luminances tested again c 100% 
o2 & 14.1% 
*cs- raised thresholds c reducing 
luminance. 
* More effect and reduced light & 
higher freq 
*respiratory changes= no effect  
*gender = no effct 
*spatial contrast sensitivity exhibits 
greater resistance to respiratory 
disturbance than do foveal measures of 
low-contrast acuity, chromatic 
sensitivity or dynamic contrast 
sensitivity at comparable mesopic 
luminance 
*supports binocular summation 
Low Contrast Acuity at 
Photopic and Mesopic 
Luminance Under Mild 
Hypoxia, Normoxia, and 
Hyperoxia conolly 2009 
*6 men 6 women 
mean age 28.3 
*non smokers 
*binocular contrast acuity assessment test 
(landolt c) at fovea & locations up to 5* from 
fixation under 14.1%, air & 100% o2 
 
* Statistically significant effects of 
breathing gas at 12 cd m- 2, 1 cd m- 
2, and 0.1 cd m-2 
*At 12 cd m-2 the younger subjects 
in the this study show greater 
sensitivity than ‘photopic standard’. 
Hypoxia elevated CAT relative to 
performance under hyperoxia 
* Hypoxia caused the contrast 
thresholds to increase at all light levels, 
but particularly at mesopic luminance. 
Hyperoxia decreased contrast 
thresholds, but only at the lowest light 
level. 
* 14.1%  req 26% more stimulus 
contrast at low photopic (12 cd m-2 ) 
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*Relative to normoxia, low contrast 
acuity was impaired by hypoxia and 
enhanced by hyperoxia, both effects 
maximal at the fovea. 
and upper mesopic (1 cd m-2 ) 
luminance to maintain the same level of 
VA. 
 * At 0.1 cd m-2 hypoxia necessitates 
50% more contrast to maintain acuity in 
the mid-mesopic range, relative to the 
sensitivity that is achievable with 100% 
o2. 
Evaluation of visual field 
parameters in patients 
with chronic obstructive 
pulmonary disease Demir 
2012 
*29 healthy controls 
*38 COPD pxs 
*11 COPD current 
smokers 
 
*Visual evoked potentials (VEPS), visual fields 
central 30-2 standard (SAP) & short wavelength 
(SWAP) 
*Bino testing but only 1 reliable field assessed 
*No sig effect of tobacco and visual 
field parameters in COPD pxs. 
*optic nerve VEP P100 latency to 
be prolonged in COPD group. 
*SWAP and SAP mean deviation, 
pattern standard devition & 
corrected pattern st dev all stat 
different between COPD and 
controls. 
*Hypoxia in COPD seems to effect 
retina and optic nerve 
Color discrimination 
under chronic hypoxic 
conditions (simulated 
climb "Everest-Comex 
97"). 
Bouquet 2000 
*8 healthy males 
mean age 26.5 
*24 pairs of identical or different coloured 
squares. Colour matching task. 
. Luminance & saturation were constant and set 
up to 127 units and 255 units. 
*pxs acclimatised to confinement (phase 1), rest 
and acclimatisation to hypoxia (phase 2),  
bought to 8,848 m over a 31-day period (phase 
3) 
Experiments performed in phase 1 and 3. 
  
*Data collected in terms of errors  
*alterations in color discrimination 
increased slightly, but significantly, 
as altitude increased Independent of 
color, hypoxia led to significant 
alterations in color discrimination at 
altitudes of 8,000 m and 8,848 m. 
*For the entire duration of the 
experiment, I1 and 3 errors were 
found in the red and blue 
discrimination, respectively. No 
impairments were found in the 
green discrimination. 
*impairments in color 
discrimination only occurred at 
8,000 and 8,848 m altitude in the 
blue discrimination. 
*Although color discrimination was 
affected only slightly by our hypoxic 
experimental conditions, our results 
clearly evidence impairments of color 
discrimination in both the red and blue 
ranges that increased significantly as 
altitude increased. In contrast, no 
alteration of color discrimination was 
found in the green range.  
*red and green range results show the 
percentage of subjects showing 
alterations in color 
discrimination and the index of 
impairment increased significantly as 
altitude increased 
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Effect of Hypoxia on 
Simultaneous Visual 
Contrast. Bridges 1964 
*7 healthy subjects 
age 19-35 
 
 Instrument provides gray test targets on back- 
grounds of variable luminance to induce contrast 
phenomena, subjects asked to match the 
brightness of the R spot with that of the L spot. 
*This was done with 20%o2/ 10% o2 then 20% 
again 
 
*During pre-hypoxia the threshold 
gradually decreases 
*During hypoxia and gradual 
increase in luminance is req to 
subjectively match R with L. 
*The posthypoxia period showed 
the greatest elevation of threshold. 
significant (p=0.02) when compared 
with hypoxia mean 
* the difference in luminance between 
left and right gray spot can be used as a 
measure for the inhibitory effect 
occuring during hypoxia. 
*assumption- during hypoxia the 
subject has decreased sensitivity to 
luminance differences of the spots and 
their respective backgrounds. A 
luminance increase is req to maintain 
subjective brightness match of the two 
spots. An increase in the contrast 
threshold in conditions of lowered 
oxygen partial pressure has occurred. 
Oxygenation State and 
Twilight Vision at 2438 m. 
Connolly 2011 
*6 men mean age 
30.6 
6 women mean age 
26.8 
 
*3 experiments- bino contrast Acuity 
Assessment test (lanolt c, low contrast) stimuli 
at the fovea, 6 1.25°, 6 2.5°, and 6 5°, the mono 
FDT & bino CAD test. Experiments were 
conducted near sea level breathing 15.2% 
oxygen & 100% o2 
*all carried out at at 0.1 cd m-2 and 12 cd m-2 
* Oxygenation state was a 
statistically significant determinant 
of visual performance on all three 
visual parameters at mesopic, but 
not photopic luminance. 
 
* The results indicate that twilight 
vision may be susceptible to conditions 
of altered oxygenation at upper-to-mid 
mesopic luminance 
Mild hypoxia impairs 
chromatic sensitivity in the 
mesopic range. Connolly 
2008 
* 6 men mean 
age31.7 
6 women mean age 
26.1. 
 
 *CAD test was used to measure binocular and 
monocular R-G and Y-B chromatic sensitivity 
by using dynamic luminance contrast noise to 
isolate the use of color signals at 14.1% o2, 
21%o2 (study 1) and then 14.1% and 100% o2 
(study 2) 
 * Light level, number of viewing 
eyes, and oxygenation state were 
significant determinants of 
chromatic sensitivity. 
 * In the mesopic range, mild hypoxia 
impairs chromatic sensitivity 
progressively with reducing luminance. 
Binocular summation of chromatic 
signals is consistent and independent of 
the luminance channel 
Color vision at very high 
altitude 
Leid 2001 
*5 subjects over 2 
expeditions both 
eyes- all seasoned 
climbers  
*desaturated D15 used monocularly on first 
expedition (1997) yielded results at 5,300, 
5,700, 6,450, and 7,000 m, on 2nd 
 Data collected at 5,200 m 
*10 eyes were tested at 6,500 m. 
Two tetartan abnormalities were 
observed. 
*In the trained individuals, and after 
sufficient acclimation, severe hypoxia 
due to very high altitude and 
exacerbated by physical effort does not 
lead to major disturbances of colour 
perception detected by the desaturated 
D15 test. 
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*Oxygenation state and 
mesopic sensitivity to 
dynamic contrast stimuli. 
Connolly 2009 
*6 men 6 women 
mean ages 30 yrs 
 
* Mono threshold sensitivity to frequency-
doubled contrast stimuli assessed after bleach 
and dark adaptation, breathing 14.1% o2, 100% 
o2, and air viewing at background fields of 10 
cd/m2 and 1 cd/m2.  
*At low photopic luminance (10 
cd/m2), sensitivity was marginally 
enhanced when breathing 100% 
oxygen. At mesopic luminance (1 
cd/m2), sensitivity was consistently 
worse with hypoxia and greatest 
with o2 at all eccentricities and in 
all field quadrants,  
 * supports outer retinal (photoreceptor) 
susceptibility to hypoxia under twilight 
viewing 
*Oxygenation and gender 
effects on photopic 
frequency-doubled 
contrast sensitivity. 
Connolly 2008 
*6 men 6 women 
mean ages 30 yrs 
*All 6/6 va c 
correction if req 
* 
 
*mono threshold sensitivity measured breathing 
14.1% o2, 100% o2, air and under 
hyperventilation to induce hypercapnia using 
frequency doubling perimetry (random gas 
order) 2 min washout 
* The effect of hypoxia was 
statistically significant for the 
‘inner’data (p = .001) and almost 
statistical significance for the 
‘outer’ data (p = .051). The apparent 
slight effect of hypocapnia to 
enhance sensitivity at the ‘fovea’ 
was not statistically significant. 
*For field quadrant anaylsis- a 
reduction in threshold sensitivity 
under mild hypoxia, no sig of 
hypercapnia. 
* greatest overall sensitivity during 
the experiments in which exposure 
to 100% oxygen immediately 
preceded exposure to hypoxia, and 
poorest sensitivity when hypoxia 
immediately preceded 100% 
oxygen,  
* clear effect of exposure order to 
influence the overall sensitivities 
achieved with each breathing gas-prior 
hypoxia diminishes the benefit of 
subsequent oxygen & prior 100% 
oxygen mitigates the impairment of 
subsequent hypoxia 
* male sensitivity greater than female 
sensitivity over the nasal hemifield.  
* relative to normoxia, female 
sensitivity is slightly but consistently 
enhanced by 100% oxygen in all 
quadrants, male sensitivity is not. 
Hypocapnia appears to enhance male 
and female sensitivity on the nasal side 
of the field, but not the temporal, in 
comparison to the normoxic, 
normocapnic control exposures. 
* Mild hypoxia, equivalent to breathing 
air at only 
3048 m, degrades temporal contrast 
sensitivity beyond the fovea under good 
viewing conditions 
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The effect of hypoxia on 
visual function. 
Psychophysical studies.  
Ernst 1971 
*3 subjects 24-34 yrs 
old  
 *The fixation target was a projected circular red 
light which subtended one- third degree on the 
retina.  
*Test target sizes12’ ½ deg, l° 3°, and 5° of arc 
on the subject's retina. Nasal field eccentricities 
at 5° or 45° from foveal fixation on the 
horizontal midline used. 
*The color of the test light was either white, 
yellow, red, or blue 
*measured under 10% o2 
*mean percentage increase in the 
absolute visual threshold secondary 
to hypoxia greater at (45° 
eccentricity) than at (5° eccentricity) 
for all four (12’, 1, 3, 5 deg) target 
sizes. 
*Red target threshold (cones) was 
affected by hypoxia to a greater 
extent than was the blue target 
threshold at 5 deg. 
*Hypoxia elevated cone seg of dark 
adaptation after 4 mins, rod-cone 
break time unaffected. During the 
early four minutes there was no 
change, but hypoxia elevated the 
later curve. 
*hypoxia has a greater effect on 
peripheral rod thresholds than on central 
rod thresholds therefore hypoxia may 
cause a greater ischemia of the 
peripheral retina than of the central 
retina. 
*Red-light absolute thresholds thought 
to relate mostly to cone function at 5° 
retinal eccentricity, were affected more 
by hypoxia than blue-light absolute 
thresholds, thought to relate mostly to 
rod function in this area- why this is the 
case is not clear. 
*1st 4 mins of rod and cone adaption not 
effected by hypoxia- thought to be due 
to different processes- in early thought 
to be due to neural processes, later, 
photochemical processes 
Effect of simulated altitude 
on the visual-fields of 
glaucoma patients and the 
elderly Falk 1991 
*3 subject groups 
6 glaucoma, 12 age 
matched normals, 
6 normals under 36. 
* Humprey central 24-2 in each 3 groups at 
ground level and 3000m. 
*1 eye – for glau  eye with more clearly 
delineated depression. 
*hypobaric chamber used 
50% tested ground then 3000m 50%  3000m 
then ground. 
*Older subjects had lower 
sensitivity than younger- altitude 
had no effect on these sensitivities. 
*For glau group altitiude did not 
effect mean sensitivity for any type 
of point.  
 *No increase in regulations of the FAA 
medical standards req. 
Local neuroretinal 
function during acute 
hypoxia in healthy older 
people. 
Feigl 2008 
12 participants 
2 groups,  
Younger group mean 
age 28+/- 4 
Older group 55+/-5 
 
mfERG slow flash to measure bipolar cells 50 
degrees retinal field at 35 s 
cm (c rx if req) 
monocular c medical air and 12% o2 
Effect of hypoxia on amplitude n1-
p1 greater in older group at all 
locations. 
Effected p1 implicit times more than 
n1 (longer in older group) but no 
effect c o2 
Amplitudes effected more centrally 
than peripherally c o2 in younger 
group 
Central neuroretinal function was sig 
reduced during hypoxia at all ages 
Was a sig reduction amplitude and an 
increased implicit time in ops c age but 
not hypoxia but this was not the case in 
all areas  
Frequency of ops not effected c age 
therefore c age neurons can maintain 
temporal precision but req a greater 
stimulus energy to generate a response 
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All locations effected by o2 in older 
group 
Age caused change in ops c age but 
not hypoxia 
Color vision changes in 
young subjects acutely 
exposed to 3,000 m 
altitude. 
Karakucuk 
2004 
 
*Sixteen students, 
ages ranging between 
14 and 17 yr, 
 
*Farnsworth- Munsell 100-Hue (FM-100 Hue) 
test conducted at 1060 and 3000 m above sea 
level under photopic conditions 
*Total number of errors (all 4 
sectors together) was 132 at 1060 m 
and 194 at 3000 m out of 1344 
possible correct. 
*significant increase in error 
numbers in sectors 1 and 3 indicated 
that the deterioration was significant 
in the blue-yellow range. 
*moderate altitude can adversely affect 
the total number of errors in an 
acclimatized group of young people in 
an ideal photopic environment (3000 m) 
on FM-100 Hue testing 
Hypobaric hypoxia 
reduces the amplitude of 
oscillatory potentials in the 
human ERG. 
Janáky 2007 
 
*14 males mean age 
39.7 yrs  
  
* rod-(scotopic) ERGs, cone-(photopic) ERGs, 
maximal responses and oscillatory potentials 
(OPs)) and 30-Hz flicker ERGs were recorded 
*recorded after 20 mins dark adaptation, then 
during 15 min hypoxic experience equivalent to  
5500m 
* No significant changes in a or b 
waves 
* The OPs of the ERG, revealed a 
significant decrease in amplitude 
during hypoxic exposure. Both OP1 
and OP2 amplitudes were 
significantly different. OP3 and 
OP4 not effected 
*From the initial mean ± SD value 
of 98.12 ± 0.83% it decreased to 
82.75 ± 2.81%  
* results suggest that the OPs are the 
most sensitive indicators of an acute, 
mild hypoxic challenge.  
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The effect of acute hypoxia 
and hyperoxia on the slow 
multifocal 
electroretinogram in 
healthy subjects. 
Klemp 2007 
 
* 10 subjects  
 
*Pupils were dilated to 7 mm. 
*Stimulus array contained 61 hexagons scaled 
by eccentricity (scaling factor 12.857) displayed 
at a frame rate of 75 Hz.  
*Mean P1 amplitudes were 
significantly reduced during 
hypoxia compared with normoxia. 
*the amplitude reduction of first-
order N2 decreased from 33.0% 
centrally to 18.3% at the highest 
eccentricity  
*hypoxia reduced the average first-
order N1 amplitude by 9.5%. 
Hypoxia also reduced mfOP 
amplitudes, by 16.6% to 34.8%, but 
no effect of eccentricity. Hyperoxia 
had no significant effect on 
amplitude. 
* hypoxia nor hyperoxia had any 
effect on the latency of the P1 
implicit times. 
* with the mfERG, we have 
demonstrated profound regional 
variations in the sensitivity of the retina 
to hypoxia under photopic conditions in 
healthy subjects, the fovea being by far 
most sensitive and the amplitude 
reduction being prominent, while the 
implicit time is very nearly un-changed. 
Multifocal 
electroretinography 
changes in the macula at 
high altitude: a report of 
three cases. 
Pavlidis 2005 
*3 healthy climbers 
aged 31, 52 and 67 
years. 
 
 
*MF ERG 61 hexagonal elements displayed on 
a color monitor driven at a frame rate of 75 Hz.,  
*Physiological parameters indicative of 
acclimatization were compared daily during the 
expedition at altitudes between 500 m and 5,050 
m: hemoglobin, oxygen saturation,  
*The central macula MF ERG 
responses were significantly 
reduced 1 week after high-alitude 
exposure, and had recovered by the 
follow-up examination performed 
during the following week 
*MF ERG was found to be more 
susceptible to hypoxia-induced changes 
in the nonlinear dynamics of the eye 
than standard ERG. 
*High-altitude hypobaric hypoxia 
effects retinal function before clinical 
signs. 
Mild systemic hypoxia and 
photopic visual field 
sensitivity. 
Feigl 2011 
 
* 7 men 7 women 
mean age 20.9 
 
*Medmont M700 Perimeter flicker perimetry 
used 61 locations concentrically arranged at 
1°,3°,6°,10°,15°,22° and 30°. 
*Two static and two flicker tests were 
performed during normoxic and 12% o2, in a 
randomized order.  
*Under photopic illumination, 
flicker and static visual field 
sensitivities at all eccentricities were 
not significantly different between 
hypoxia and normoxia conditions. 
The mean defect and pattern defect 
were not significantly different for 
either test between the two 
oxygenation conditions 
*Preliminary visual field data from a 
small sample of healthy participants (n 
= 3) measured under mesopic 
illuminations suggests that perimetric 
sensitivity is significantly reduced at all 
eccentricities during hypoxia.  
*Although metabolic demand increased 
c flicker, under photopic conditions it is 
not altered by hypoxia 
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Visual Fields During Acute 
Exposure to a Simulated 
Altitude of 7620 m 
Horng 2008 
*15 males mean age 
31.4 
 
*visual fields in 3 different zones 
 central zone (0° – 10°), the moderate peripheral 
zone (10° – 20°), and the peripheral zone (20° – 
30°) 
*Sao2 % dropped to 64.0 6 5.4% 
within 3 min. 
*Mean visual sensitivity was 
significantly reduced by 7.2 6 1.6 
dB. Furthermore, peripheral 
sensitivity was significantly more 
diminished than central sensitivity. 
*Reduction in periphery may be due to 
rod demands as this testing tested rods 
and cones. 
The effect of high- to low-
altitude adaptation on the 
multifocal 
electroretinogram. 
Kofoed 2009 
*8 healthy residents 
3600 m above sea 
level were examined 
over 72 days after 
arriving at sea level. 
Control group of 8 
healthy lowlanders. 
*mfERG pupil dilation to a diameter of 7mm  
*An array of 103 eccentricity-scaled hexagons 
was displayed at a frame rate of 75 Hz. 
*The highlanders’ summed mfERG 
amplitude was 43.1% larger than the 
lowlander reference for N1, 47.1% 
for P1, and 59.9% for N2. On day 
72, the differences between the two 
groups were increased to 73.2%, 
76.0%, and 87.0% for the three 
amplitudes. 
*These observations were consistent 
throughout the stimulated field, 
when tested by eccentricity. 
*Implicit times were comparable 
between highlanders and lowlanders 
throughout the study. 
*hematologic responses were observed 
in our study, with a decrease in 
hemoglobin (10.6%) 
erythrocytes(13.6%), and hematocrit 
(14.6%). 
*The nearly identical mfERG 
waveforms throughout study suggest 
the effect of relative hyperoxia and 
acclimatization was the same on all 
components of the mfERG. 
*Future studies should extend to 1 year 
and include baseline examinations, inc 
examinations of retinal structure. 
Effects of hypoxemia on 
the a- and b-waves of the 
electroretinogram in the 
cat retina. 
Kang 2000 
 
*Cats *Responses to bright flashes of diffuse white 
light were recorded at 3-minute intervals during 
hypoxemic episodes lasting 15 minutes to 2 
hours, flash intensity was varied over 6 log units 
by means of neutral density filter. 
*To test for a cone contribution, responses were 
obtained to short-wavelength flashes and long-
wavelength flashes 
*During mild hypoxemia small 
changes in the a wave amplitude 
were detected but did not increase 
with further hypoxemia 
*The a-wave is more resistant to 
severe hypoxemia than the b-wave. 
This implies that photoreceptor 
transduction works almost normally 
during hypoxemia and that failure of 
inner retinal PO2 causes a decrease 
in the b wave (35%) 
*Both a- and b-waves were resistant to 
hypoxemia, but the b-wave was more 
affected by low PaO2. Poss when the b-
wave decreases, it is from a failure of 
the retinal circulation to maintain 
oxygenation of the inner retina.  
*It now seems necessary to postulate 
that when oxidative metabolism is 
affected, the photoreceptors switch 
more to glycolysis for energy 
production 
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Hyperoxia improves 
contrast sensitivity in early 
diabetic retinopathy 
Harris 1996 
 
*12 insulin dependent 
dia (diag at least 5 
yrs) (23 mean age) no 
or grade 1 dr. 
*12 normals (mean 
age 26)  
*contrast sensitivity tested using CSV 
equiptment 3 6 12 18 cpd spatial freq tested, 
under normal conditions and breathing 100% o2 
*also measured blood flow dynamics using 
scanning lazer ophthalmology 
*diabetics had reduced sensitivity at 
12 & 18 cpd c room air, when 
breathing o2 the reduction at 12 cpd 
was improved to normal values, 
there was improvement at 18 but 
less than 12. 
 
 
*result suggests that some factor linked 
to retinal tissue hypoxia (or 
pseudohypoxia) causes the contrast 
sensitivity decline seen early type 1 
diabetes 
* when healthy tissue is perfused with 
blood with an increased o2 content 
vasoconstriction ensures constant o2 
delivery, in dia this constriction did not 
occur 
Hypoxia, color vision 
deficiencies, and blood 
oxygen saturation. 
Hovis 2012 
*All male,  
*Colour normal 
group- mean age 
33.3. 
*Colour defective 
group mean age 37.6 
*Cambridge colour test (CCT), Colour 
assessment and diagnosis (CAD) test and cone 
specific contrast test (CSCT, mono) performed 
at ground level and 3780m. 
*CCT-no sig effect of altitude of sig 
interaction involving altitude 
*CAD- stat. sig altitude effects and 
interactions involving altitude, NCV 
group had increase in red-green 
threshold. Dichromats, larger 
change in blue-yellow compared to 
red-green. Anomalous trichromats 
increases in both  
*CSCT- no stat. sig altitude main 
effect involving altitude. 
*No relationship between results of 
CAD, CSCT or for grey or yellow 
background of CCT, but blue-
yellow CAD effected by age 
(positive) time in chamber and 
SaO2 (neg) 
 
*Any change in chromatic threshold at 
low photopic light levels at 3700 is 
likely to be small (10% increase) - 
consistent with the hypothesis that mild 
hypoxia is equivalent to a slight 
reduction in retinal illumination. 
*For CAD blue-yellow thresholds, for 
unexpected finding that a higher SaO2 
resulting in a larger change in threshold 
poss accounted for by subects with 
lower SaO2 having lower blue-yellow 
thresholds relative to the ground 
condition. 
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Diurnal-variations of acute 
mountain-sickness, color-
vision, and plasma-cortisol 
and acth at high-altitude. 
Richalet 1989 
*8 healthy male 
lowland inhabitants. 
*mean age 31 
*All normal cv 
* 2 anomaloscopes- red-green axis. 
Chromotest- mono, using flickering mixed light. 
*CV testing and AMS scores  preformed every 
2/24 between 8-20:00hrs. 
*Experiments performed and normoxia (N) and 
4350m. Hypoxia days H1,H1, H2 H3. 
*No sig difference in any parameter 
between any hypoxic day. 
*Between N and H days- sig 
difference for both tests. Decrease 
in sensitivity to green in favour of 
red was found. 
*In H both tests showed sig diurnal 
variations with highest scores in am 
compared to pm, also a sl increase 
at 18:00 and 20:00. 
*both anomoloscopes are practice for 
field studies, to explore cv in red-green 
axis- it is a simple and objectable way 
to quantify AMS symptoms. 
*with hypoxia- both showed a decrease 
in sensitivity to green compared to red 
*Alterations in CV were clearer in am 
and values tended to reach normoxic 
levels during the day. 
Contrast sensitivity as an 
early indicator of acute 
mountain sickness. 
Nordmann 1991. 
*12 healthy subjects, 
age 29-41.  
*bino contrast sensitivity at 7 freq from 1.5-40 
cycles per degree. 
*tested at 5400m on arrival to base camp and 
also at base camp after trekking up to 8000m 
*Decrease of cs seen constantly in 
all subjects after arrival at base 
camp 
*Impairment  most evident in low 
and med spatial freq (-2.0 to -4.9db) 
Rtned to normal values after 36/24. 
*No changes from 5400m to 
8000m. 
*1 subject suffered ams- these cs 
measurements didn’t rtn to normal 
until 10mg pred administered.  
*Cs measurements could give a 
quantitative evaluation of brain and 
retinal disturbances caused by hypoxia. 
The contrast sensitivity of 
cat retinal ganglion cells at 
reduced oxygen tensions. 
Enroth 1980 
* 31 adult cats- 19 for 
RGC recordings, 7 
for retinal oxygen 
tension and 5 for both 
 
*Extensive- see text *Centre and surround of ganglion 
cells very resistant to hypoxia, 
maintaining a normal sensitivity 
until the arterial oxygen tension was 
35mmHg or less. 
 
*Retinal O2 tension well regulated over 
a wide range of arterial O2 tensions, 
corresponding well to the range over 
which ganglion sensitivity is normal 
*Ganglion cells resistant to hypoxa 
Effect of hypoxia on FM 
100-Hue test performance. 
Smith 1976 
* 5 subjects 
(3 for 1670 lux, all 5 
for 37 lux) 
*All normal colour 
vision 
*Bino FM100 testing under 1670 lux and 37 lux, 
each test lamination run twice- once  breathing 
air and once with 10% O2. (starting gas varied) 
 
*Under standard illumination 1670 
lux hypoxia caused no increase in 
total error scores. 
*Under 37 lux 2 subjects showed 
tritan axis  
*Inter-observer variability 
emphasized with 37 lux. 
*Stable oxyhemoglobin may not have 
been reached at beging of hypoxic 
testing as errors increased slightly on 
end run with hypoxic gas at 37 lux. 
*All errors showed along tritan axis. 
*considerable inter-observer variability 
in the errors on the tritan axis under 
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*All subjects showed an increase in 
errors with 10% O2 t 37 lux. 
reduced illumination, inc further by 
hypoxia. 
*attributes results of tritan defect to 
hypoxia being an insult to inner retina. 
Color vision in the tritan 
axis is predominantly 
affected at high altitude. 
Tekavcic-Pompe 2009 
*14 climbers- 1 
female mean age 
52.4. 
*All no cv defects. 
* CV testing with Mollon-Reffin Minimalist test 
at 300m (28 eyes) 
1300m (28 eyes), 4000m (28 eyes), 5400m (8 
eyes) and 300m 3 days later (24 eyes) and 
at300m 1 yr later (24 eyes) 
All tests performed under good conditions 
* at 300 m, all eyes had normal 
color vision in all 3 axes. At 1,300 
m, 100% of eyes showed normal 
color vision in the protan and deutan 
axes, while 25% showed minimally 
reduced discrimination in the tritan 
axis. At 4,000 m, 100% showed 
normal deutan axis, 4% minimally 
reduced protan axis, & 72% 
minimally reduced tritan axis 
discrimination. At 5,400 m 100% 
eyes tested showed normal protan & 
deutan axis discrimination, 75% 
showed minimally and 25% 
moderately reduced tritan axis 
discrimination. At 300 m 3 days 
after rtn, 100% showed normal 
deutan, 4% minimally reduced 
protan, & 38% minimally reduced 
tritan axis discrimination.  
*Tritan colour axis predominantly 
affected at high altitude- but this is 
transient. 
*Changes in tritan axis discrimination 
correlated well with decreased O2 
saturation.  
Effects on colour 
discrimination during long 
term exposure to high 
altitudes on Mt Everest. 
Willmann 2010 
* 2 healthy male 
subjects age 32 and 
46. 
 
*mono Cambridge color 
test after 30 mins dark adaptation, tests 
performed under mesopic conditions. 
* Control measurements were taken 1/52 prior 
to and 6/12 after the expedition. Measurements 
were taken in Kathmandu (1300 m) at 3450 m, 
* With increasing altitude, colour 
discrimination thresholds were 
found to rise, predominantly for the 
tritan axes in both observers. Deutan 
(green) thresholds were minimally 
elevated at high altitude, whereas 
protan (red) was altered in one 
* effect of chronic hypoxia on 
discrimination along the tritan axis 
suggests a selective vulnerability of S 
cone compared with L or M cone 
pathways, S cones may be particularly 
sensitive because of their relatively low 
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4410 m, 5060 m, 5300 m, 6450 m, 7200m and 
8000m over a period of 54 days 
observer. Tritan colour 
discrimination thresholds decreased 
as a function of time spent at a 
given altitude. 
 
abundance: only 5-10% of all cones are 
S cones. 
* Hypoxia decreases the maximum 
response rate of all cone pathways 
equally; however, as the number of S 
cones is limited, their absolute 
responses might become undetectable at 
earlier stages. 
Dark adaptation during 
systemic hypoxia induced 
by chronic respiratory 
insufficiency. 
Thylefors 2009 
*13 subjects- 6m 
men, 7 women mean 
age 68.7 yrs 
*All on long term O2 
therapy for at least 
4/12 
*Dark adaptation measured in 3 visits, visits 1 
and 3 with pxs normal O2 supplied, visit 2 with 
no O2 for 30mins to 8 hrs. 
* No significant differences were 
observed between the three visits for 
the right eye, the left eye, or both 
eyes 
*Sig differences between visits 1 
and 2 for Pao2, arterial o2 saturation 
and pulse oxymetry 
* dark adaptation was normal for 
their age and unchanged in all pxs 
* oxygen treatment made no 
difference, despite a significant 
difference of at least 5.8% in arterial 
blood oxygen saturation 
*pxs had normal dark adaptation for 
their age. 
* The result may partly reflect the 
influence of PaCO2 on the lumen of 
choroidal & retinal vessels. At high 
altitudes, with hypocapnic 
vasoconstriction the o2 supply to the 
retina is further compromised, resulting 
in reduced dark adaptation. The authors 
hypothesize that respiratory 
insufficiency with hypercapnia or 
normocapnia will have larger choroidal 
and retinal vessel lumens, added to by 
further dilation of retinal vessels during 
hypoxia. The tentative net effect would 
be preserved dark adaptation 
The effects of hypoxia on 
contrast sensitivity. 
Rossi 1985 
Not reported *Cs measured at 1.5,3,6,1,218 cycles per degree 
at 45 cd/m2  
*measured pre, at and post 15,000ft altitude 
using a hypobaric chamber. 
*No losses in cs  which would be 
expected to produce sig 
performance  related loss in visual 
capability. 
*Small individual differences in loss 
patterns for cs and spatial freq   
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Effects of exposure to 
simulated altitudes on 
visual fields, contrast 
sensitivity, and dazzle 
recovery. 
Yap 2005 
*12 males, age 19-30 
*All no 
ocular/medical 
history 
*All vas 20/15 
*Decompression chamber used to simulate 
altitudes sea level, 7000 ft, 12000 ft in random 
order. 
*At each altitude visual fields for 60 degrees, 
spatial CS  (1.5,3,6,12 cpd), temporal CS 
(2,4,8,16,32 cps) (all re) and macular photostress 
test (le) performed.  
*haemoglobin sat 99.5 at sea level, 
96.8 at 7000ft, 91.2 at 12000ft. 
*no change in visual fields with 
altitude 
*No sig difference in spatial freq for 
any altitudes at 3,6,12, but sig 
difference at 1.5at 7000 (not 
relevant) 
*no sig difference in temp contrast 
sensitivity. 
**no sig difference in dazzle 
recovery. 
* Results in line with other papers, in 
which va is uneffected up to 12000 ft, 
and fields to 26,240 
Modification of color-
vsiosn in the red green axis 
in acute and chronic 
hypoxia explored with a 
portable anomaloscope 
Rcihalet 1988 
*8 subjects, mean age 
35. 
*All normal cv  
*chromotest conducted at sea level, in acute 
hypoxia after 2/7 at 4350 (h1), subacute hypoxia 
after 7/7 between 1000-4800m and 3/7 at 4800m 
(h2) and chronic hypoxia after 3/52 at 4800m. 
*2 measurements each eye.- result is mean 
*Sig decrease in g sensitivity and 
increase in g  were found in all 
hypoxic conditions. 
*No sig difference between hypoxic 
conditions 
*No correlation between age and 
variation in g,r or g/r values. 
*Variation in sensitivity related to 
arterial o2 saturation 
*Decrease in green sensitivity related to 
hypoxia. 
Operation Everest 2: Lack 
of an effect of extreme 
altitude on visual contrast 
sensitivity. Kobrick 1988. 
 
*8 males, ages 21-31 
yrs. 
* All no 
ocular/medical 
history. 
*decompression chamber used to an altitude of 
25000ft over 40/7 (all external factors controlled 
ie cold, dehydration). 
CS measured by Vistech test, testing 
1.5,3,6,12,18 cpd daily  
*Highest cs sensitivities for the 
midrange freq 3,6,12. 
*Altitude exposure had neither an 
overall;l effect on cs, nor separate 
effects within the respective spatial 
freq ranges. 
*Performances for individual 
subjects were all similar and had 
good continuity.   
* CS was affected only slightly, if all, 
by the hypoxic conditions of this study. 
*All subjects were acclimatised which 
may have effect on results. 
*Small number of subjects 
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Short-term hypobaric 
hypoxia enhances visual 
contrast sensitivity. 
Benedek 2002 
*14 healthy males 
*Mean age 32 
*CS measured after 5,10,15 mins of hypoxia in a 
hyperbaric chamber at 5500m 
*CS measured at 
0.5,1.2,1.9,2.9,3.6,4.8,5.7,7.2,14.3 cpd 
*temporal cs also measured at 8hHz 
*for both static and dynamic cs 
there were negative correlations 
with blood o2 saturation at low and 
med spatial freq 
*sig increased cs values in 
hypobaric hypoxic conditions 
*early visual processes may be 
enhanced during a short hypoxic 
challenge, a marked inc was observed 
after only 5 mins of altitude exposure, 
which was sustained over the 15 mins.  
*it may be that mild transient hypoxia 
increases sensitivity, whereas prolonged 
choric leads to visual loss. 
Respiratory effects upon 
the visual threshold 
Wald 1942 
* Not noted *Monocular dark adaptation with artificial 
pupils 
*anoxia of short and long duration (8-11%o2) 
*hyperventilation by breathing to beat of a 
metronome 
*anoxia threshold rose within 1 to 
10 minutes of anoxia to new levels 
0.2 to 0.5 log unit above normal 
0.35 ave. 
*On increasing the rate of breathing 
room air by 50 to 100 per cent the 
threshold fell, usually within 5 to 10 
minutes, to about half its normal 
value 
*Due to variations in breathing 
patterns subjects yield 
characteristically different responses 
on sudden exposure to low oxygen 
tensions with breathing 
uncontrolled. The threshold may 
either rise or fall; and on release 
from anoxia it may rise, or fall to 
normal or subnormal levels. 
*alkalosis induced by  hyperventilation, 
can be abolished or reversed by adding 
carbon dioxide to the inspired mixtures. 
*The threshold adjusts to anoxia 
rapidly; exposures lasting 5 to 6 hours 
do not produce greater or more 
persistent changes than those of much 
shorter duration. 
*The speed of rod and cone dark 
adaptation appears to be entirely 
unaffected by anoxia  
The effect of a moderate 
level of hypoxia on human 
color vision 
Vingrys 1987 
* 2  subjects age 23 & 
46 familiar with 
decompression. 
 
*FM-100 hue, American optical 
HRR and Pickford-Nicolson anomaloscope used 
*Photostress 
*all tests conducted at sea level and 12000 ft  
 
*no error on HRR plates 
*FM-100 hue change in error score 
of 75% with altitude- sl more red 
green errors  
*anomaloscope- cv depressed at 
12000 ft- grerater loss for blue 
*No sig change in photostress 
recovery for altitude 
*concluded rod and cones equally 
affected by mild-mod hypoxia. 
*Hypoxia effects inner retinal layer- 
prob ganglions 
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Effects of hypoxia and 
acetazolamide on color 
sensitivity zones in the 
visual field . Effects of 
hypoxia sensitivity and 
acetazolamide field on 
color zones in the visual 
Kobrick 1970 
*24 males 18-30 yrs 
old c normal vision 
*randomised 2 groups 
acetazolamide or not 
*red, green and blue stimulus, threshold 
determinations at 30 deg intervals 
*mono c natural pupil 
*sea level (20.93% O2) 13000ft (12.8%) 
15000ft (11.8%) 17000ft (10.9%) 
* No sig effect of drugs 
*Effect of hypoxia was strong and 
cumulative- constricting zones of 
colour sensitivity in the visual field. 
(intense inverse relationship) 
*reduction in fields with longer 
exposure duration. 
*sensitivity reduced more for red 
than green or blue 
* results match what was expected from 
purkinje law- selective desensitization 
to the perception of colour would occur 
under hypoxia with red affected 1st 
The Effects of Variations 
in the Concentration of 
Oxygen and of Glucose on 
Dark Adaptation. 
McFarland and Forbes 
1940 
* Normal fasting 
subjects aged 25-37. 
*concentrations of 
oxygen changed by 
dilution with nitrogen 
or by inhaling oxygen 
from a cylinder. 
*Low oxygen series in 13.3, 11.4, and 10.0 per 
cent oxygen corresponding to altitudes of 
12,000, 16,000, and 19,000 feet, respectively (6 
subjects).  
II. Control tests in air followed by tests during 
the inhalation of decreasing concentrations of 
oxygen going as low as 7.3 per cent oxygen in 
one case (5 subjects). 
*Other experiments with glucose 
* In 10.1 per cent O, five of the six 
subjects were poorer in both the rod 
and cone sections of the curve 
varying from 0.15 to 0.40 of a log 
unit.  
*Dark adaptation curves elevated 
with increasing hypoxia- but all 
similar shaped and rate of 
adaptation unchanged. (rods and 
cones equally effected) 
 
* extent of the impairment in light 
sensitivity under low oxygen might 
serve as a reliable objective test of one's 
ability to tolerate anoxia 
* In our opinion, the changes may be 
attributed directly to the effects on the 
nervous tissue of the visual mechanism 
and the brain rather than on the 
photochemical processes of the retina. 
Anoxia and brightness 
discrimination 
Hecht 1946 
* 7 men 1 women 
aged 17 and 25 years, 
apart from 1 aged 51. 
*Brightness discrimination measured at 3 field 
intensities, approx. 1/1000, 1/100, and 1/10 
millilambert, (actually 0.00085, 0.0102, and 
0.12 millilambert), when breathing gas mixtures 
between 9 and 16 per cent oxygen 
corresponding to 7 altitudes (cones only) 
*Threshold after dark adaptation measured in 2 
subjects. 
*The thresholds of night (rod) 
vision and day (cone) vision are 
equally affected by anoxia 
*brightness discrimination begins to 
deteriorate at fairly low altitudes. It 
is obvious at 8,000 feet, and 
becomes marked at 15,000 feet, 
where at low brightness, the contrast 
must be increased 100 per cent over 
the sea level value before it can be 
recognized. 
 
*The impairment of brightness 
discrimination with increase in altitude 
is greater at higher altitudes than at 
lower. The impairment starts slowly and 
becomes increasingly rapid the higher 
the altitude. 
*Impairment of brightness 
discrimination varies inversely with the 
light intensity. It is most evident under 
the lowest light intensities studied 
* Since anoxia causes only a shift in log 
I it is shown that the photochemical 
receptor system cannot be affected. 
Instead the conversion of photochemical 
 
293 
change into visual function is impaired 
in such a way that the conversion factor 
varies as the fourth power of the arterial 
oxygen saturation. 
Alterations in dark 
adaptation under reduced 
oxygen tensions 
McFarland 1939. 
* 20 subjects 2 
female 
*aged 20-30 one was 
42 
* biophotometer measured threshold of light 
sensitivity at 15.7 per cent 02 (7,400 ft.), 13.7 
per cent 02 (11,000 
ft.) and 11.7 per cent 02 (15,000 ft.). 
*quincunx used with 5 lights of various 
luminances 
*Dark adaptation curves elevated c 
reduced o2. 7400ft=0.10 log unit 
change, 11000ft 0.22, 15000=0.40. 
* 
 
 
 
 
 
294 
 
10 Appendix II Systematic literature 
review into the role of hypoxia in the 
pathogenesis of age-related macular 
degeneration; Table of included 
studies. 
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study 
 
 
Participants methods  results conclusions 
Foveolar chorodial 
circulation and choroidal 
neovascularisation in age-
related macular 
degeneration 
Metelitsina et al 2008 
135 px c AMD but 
no cnv 
 (193 eyes) 
Follow up yearly to 
5 yrs  
28 developed cnv 
during experiment 
Longditudinal, observational, 
prospective study. 
Relative foveolar choroidal blood 
flow. (ChBflow), volume (ChBvol, 
velocity (ChBvel) vel calculation 
using laser Doppler flowmetry 
Eyes in which cnv (19) developed 
had a 24% lower ChBvol & 20% 
less flow. 
No stat diff in vel between 2 
groups. 
In 14 of 19 cnv eyes was yrly 
deceases in flow (3-54%) & ave 
yrly decease of 11.5% 
Vol decreased in these eyes yrly by 
9.6% before formation of cnv. 
Eyes with no cnv increased flow 
6.7% & vol 2.8% 
Foveolar vol and flow were sig 
lower in eyes which developed 
cnv and the affected eyes chowed 
a marked chorodial circulatory 
decreases in the fovea- this was 
not observed in eyes which did 
not develop cnv. Therefore these 
changes preceed the formation of 
cnv. 
Eyes with lower flow at baseline 
are 3* higher risk of 3+ lines of 
visual loss than eyes with a higher 
circulatory parameters. 
Choroidal blood flow  & 
progression  of age-related 
macular degeneration in 
the fellow eye in patients 
with unilateral choroidal 
neovascularisation Boltz et 
al 2010) 
41 subjects with 
AMD (18 female)  
26 had 
hypertension, 18 
current smokers, 9 
past smokers. 
3 yr study, screening visit + 7 
study visits every 6/12. BP, pulse 
rate (PR)  hemodynamic 
parameters & IOPs measured. 
 
Stage of ARM (higher value 
worse), subfoveal choroidal  blood 
flow, fundus pulsation amplitude 
(all lower value worse) all stat sig 
influence on development CNV. 
Group which developed CNV- 
decline of hemodynamic values 
over time, non CNV group showed 
no changes to flow or FPA. 
 
Lower the chorodial perfusion, 
higher the risk for CNV 
Dark adaptation in age-
related maculopathuy 
Brown et al (1986) 
4 pxs c ARM  
5 normals  
 
0*/5*/10*/15*/ 25* target red or 
green lights flashing at 1Hz. 
 
*Sig longer time constants for rods 
in ARM, but no diff in cone 
recovery time. 
*Deficiencies in final thresholds for 
rods and cones.  
Time constants of rods portions 
of recovery curves. 
Depression of rod sensitivities out 
to 25*  
 
296 
The association between 
drusen extent and foveolar 
choroidal blood flow in age-
related macular 
degeneration. 
Berenberg 2012. 
*239 eyes of 157 
pxs c amd but no 
neovasc 
 
*ChBVel (measured) ChBVol 
(measured) and ChBFlow (calc) 
* no of drusen, individual druse 
area and total druse area 
meaused c combination of 
software and human readings, 
with good repeatability 
*A significant inverse relationship 
between total drusen area and 
ChBVol was found. Larger average 
druse area sig associated with 
decreased ChBVol 
* Average druse area was also 
significantly inversely related to 
ChBVol  
* No of drusen did not effect 
circulatory measurements 
 
 
* eyes with a larger extent of 
drusen, as measured by total 
drusen area & average druse 
area, tend to have decreased 
ChBVol & ChBFlow. 
* association between total 
drusen area & choroidal blood 
flow and vol was strong after age 
adjustment less strong for  
choroidal blood flow and volume. 
*Cannot conclude if decrease in 
choroidal blood flow causes the 
development of drusen or if the 
presence of drusen leads to 
decreased blood flow  
Color Doppler Imaging 
Discloses Reduced 
Ocular Blood Flow 
Velocities in Nonexudative 
Age-related Macular 
Degeneration. 
Ciulla et al 1999 
*25 normals mean 
age 70.2, 3 pxs c 
non-exudative 
amd mean age 73. 
 
*Ophthalmic artery measured at 
25mm behind globe. 
*short posterior ciliary arteries 
examined 10-20mm behind globe. 
*Central retinal artery examined 
10mm behind globe. 
* Peak systolic velocity is the 
highest blood velocity achieved 
during systole, and it is calculated 
from the frequency of the peak in 
the Doppler-shifted waveform. 
End diastolic velocity refers to 
the lowest velocity occurring 
during diastole, and it is 
calculated for the frequency of 
the trough in the waveform. 
* Post ciliary arteries in subjects 
with ARMD showed a consistent 
trend toward lower peak systolic 
velocity and end diastolic velocity. 
Especially in nasal posterior ciliary 
artery highly statistically significant 
almost sig for systolic. 
*Temp artery, nearly sig lowering 
diastolic, no sig change in systolic, 
no change in resistance. 
*No correlation between these 
changes and % macula area 
affected by macula changes. 
* In the ophthalmic artery, no 
affect AMD peak systolic velocity, 
end diastolic velocity, or resistance 
* Central retinal artery showed 
highly sig lower end diastolic 
* A primary perfusion defect in 
choroid could account for some 
of the physiologic and pathologic 
changes in AMD.  
* Reduced blood flow in the nasal 
and temporal posterior ciliary 
arteries. Specifically, in subjects 
with AMD these changes, along 
with no change in resistance is 
consistent with reduced bulk flow 
in these ciliary vessels, suggesting 
that choroidal perfusion is 
abnormal in this form of AMD. 
* Was a perfusion deficit in the 
central retinal artery of the AMD 
group. Poss due to a generalised 
perfusion abnormality, or a 
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velocity & the resistive index was 
higher in the ARMD group, no sig 
difference in systolic. 
2ndary autoregulatory response 
to a primary change elsewhere. 
 
Choroidal perfusion 
perturbations in non-
neovascular 
age related macular 
degeneration. 
Ciulla et al 2002 
*21 non-exudative 
AMD subjects, 21 
normals  
 
*Scanning laser ophthalmoscope 
indocyanine green (ICG) 
angiograms analysed by a new 
area dilution analysis technique. 
Four areas in the perifoveal region 
and two areas in the temporal 
peripapillary retina were 
evaluated by producing a graph of 
intensity of fluorescence of each 
area over time. The mean of the 
filling times and the heterogeneity 
of the filling times were assessed.  
 
*Means of the filling times within 
the perifoveal regions and the 
hetereogeneity of the filling times 
between regions within the same 
eyes were significantly greater in 
the AMD patients. 
* The spread of 10% filling times  
was greater in AMD patients than 
in normal subjects for the four 
perifoveal regions.  
 
* Objectively demonstrates 
delayed and heterogeneous filling 
of the choroid in patients with 
non-neovascular AMD with some 
perifoveal region specificity. 
*The haemodynamic 
heterogeneity is measured within 
each eye and not between 
subjects; consequently, this stat 
sig result does not originate from 
differences in AMD 
manifestations between subjects, 
but from increased haemo- 
dynamic heterogeneity between 
the analysed regions of the 
choroid in an AMD subject 
compared with a control subject. 
*These differences were most 
pronounced in the perifoveal 
regions 
Hypothermia reduces 
secretion of vascular 
endothelial growth factor 
by cultured retinal 
pigment epithelial cells. 
Coassin et al 2010 
Cell cultures *ARPE-19 cells were grown in 
culture for up to 5 days under 
normoxic (20% O2) and hypoxic 
(1% O2) conditions at 
temperatures ranging from 
27Cto40C. VEGF levels in the 
media were measured by ELISA 
and cell metabolic activity was 
* ARPE-19 cell VEGF secretion was 
reduced by 38% at 34C compared 
37C & ARPE-19 cell VEGF secretion 
was increased by 32% at 40C 
compared with 37C. Hypoxia 
increased ARPE-19 cell VEGF 
secretion by 84% at 37C. However, 
hypothermia decreased the 
hypoxia-induced increase of ARPE-
*Hypothermia decreases VEGF 
secretion and cellular metabolism 
in ARPE-19 cells in temperature-
dependent fashion. Effects of 
hypothermia are cannot be 
obtained by pharmacological 
agents that slow cellular 
metabolism. 
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measured by a fluorescent cell 
metabolic assay 
19 cell VEGF secretion by 30%. 
Thiopental and nicotinamide were 
able to reduce RPE cell 
metabolism but not VEGF 
secretion. 
*Hypothermia may have 
therapeutic effects by reducing 
the metabolic activity of the RPE 
and the energy req by the PRS, 
and by reducing VEGF secretion  
Vascular cell-adhesion 
molecule-1 plays a central 
role 
in the proangiogenic effects 
of oxidative stress 
Dong et al 2011 
*Mice deficient in 
superoxiude 
dismutase (which 
have inc oxidative 
stress) and 
compared with 
wild mice with 
ischemic 
retinopathy 
See article- extensive  *The addition of excess oxidative 
stress to ischemia increased 
capillary non- perfusion which was 
blocked by VCAM-1 antibody.  
*Of six HIF-1–regulated genes 
examined, all except EPO showed 
a significant increase in expression 
when oxidative stress and 
ischemia were combined and the 
increase was blocked by treatment 
with anti- oxidants  
*NV by oxidative stress is 
mediated primarily by factors 
other than VEGF. 
*Of six hypoxia-regulated genes 
tested, only VEGF was not up-
regulated by the addition of 
excess oxidative stress to 
ischemia.  
*VCAM-1 plays an important role 
in this increased susceptibility to 
severe NV and neutralization of 
VCAM-1 may provide an adjunct 
to VEGF antagonists for 
treatment of retinal and choroidal 
NV 
 Quantifiying changes in 
RPE and choroidal 
vasculature in eyes with 
Age-related macular 
degeneration. 
McLeod et al 2002. 
*6 eyes of 3 
postmortem 
subjects. 2 with 
non-exudative 
AMD, 1 control 
with no AMD 
signs. 
*The choroid, with the RPE was 
dissected from the sclera and 
incubated for APase activity. 
Pigment was partial bleached with 
H2O2. 
The choroid was then flat 
embedded and sectioned after 
image and morphometric 
analyses. 
Quantitative computer assisted 
morphometric analyses of all 
samples were compared.   
* In normal eye 99-100% of RPE 
intact. 
* correlation between % surviving 
RPE in a given region with % 
vascular area decline with GA. 
*Regions of GA with complete RPE 
atrophy had substantial loss of 
choroidal BVs.  
* Significant linear relationship 
between the % of RPE covering an 
area and the density of choroidal 
bvs in that region. 
*Vascular density decreased in 
the area of atrophy. 
*Areas of choroid devoid of RPE 
remained spome what well 
vascularised. 
*suggests that degeneration of 
the RPE is more advanced than 
the loss of choriocappilaris, but 
these results cant be used to 
draw conclusion about sequence 
in degeneration of 2 cell types.  
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* remaining capillaries had stat sig 
severely constricted lumens 
smallest in areas of total RPE 
atrophy. 
Genetic and 
pharmacological inhibition 
of JNK ameliorates hypoxia-
induced retinopathy 
through 
interference with VEGF 
expression. 
Guma et al 2009 
Mice exposed to 
hyperoxia (75% 
oxygen) from 
postnatal day 7 to 
postnatal day 12 
then in normoxia 
until wk 17. 
Control mice kept 
in  ambient o2 
*Mice killed at wk 17 and retinas 
dissected and stained 
*Quantification with analysis 
softwear. 
*Different assays used- see paper  
*Hypoxia enhanced JNK activity 
and also created ROIs which can 
lead to JNK activation  
*JNK1 Does Not Regulate HIF-1 
Expression. 
*These data show that hypoxia 
can induce VEGF transcription 
through activation of the JNK1-c-
Jun pathway in addition to the 
well- established HIF-1 pathway. 
 
*Intravitreal Injection of a JNK 
Inhibitor Prevents Retinal 
Neovascularization. 
* JNK1 is a critical factor in 
hypoxia-driven pathological 
angiogenesis in the retina.  
*JNK1 is critical for hypoxia-
induced VEGF production. Retinal 
JNK-dependent VEGF expression 
occurs independently of HIF 
activation, and hypoxia stimulates 
JNK activity though ROS 
production 
Postreceptoral adaptation 
abnormalities in early age-
related maculopathy. 
Feigl et al 2006 
*32 eyes of 32 
participants were 
examined. 20 pxs 
in  healthy control 
group and 12 
participants in 
early ARM group  
*Fast flicker mfERG stimulation- 
and slow flash mfERG paradigm  
total recording time of about 7 
min per eye. 
 
* Neither the fast flicker nor the 
slow flash mfERG paradigm itself 
discriminated significantly 
between two groups.  
*There were no significant 
differences in the N1P1 response 
densities between the 2 groups. 
*ARM pxs have a reduced ability 
to adapt under photopic 
conditions compared to controls. 
 
*results give better insight into 
possible retinal mechanisms in 
early ARM- postreceptoral, 
hypothesis.  
* propose that the difference 
waveform component we 
extracted detects impaired fast 
adaptation abnormalities in the 
early course of ARM.-could reflect 
ischemic conditions that possibly 
trigger the genetic predisposition 
in ARM  
Hypoxia/reoxygenation 
induces CTGF and PAI-1 in 
cultured human retinal 
6 human donor 
eyes processed 
within 4 to 16 h 
after death. The 
*RPE cells isolated and 
immunohistochemistry/ northern 
blot analysis/ western blot 
analysis performed 
*There were no detectable cell 
varations in morphology at a 
microscopic level between cells 
* Likely that hypoxic conditions 
are responsible for the observed 
CTGF expression in the underlying 
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pigment epithelium cells. 
Fuchshofer et al 2009 
donors ranged in 
age between 18 
and 71 years.  
exposed to ambient air and cells 
maintained in hypoxic conditions. 
*Western blot analyses showed 
increased expression of CTGF 
protein after 12/ 24’ 36 h of 
hypoxia compared to normoxia. 
* Cells kept for 12 h under hypoxic 
conditions showed an increase in 
extracellular matrix associated 
PAI-1 expression. 
*Following hypoxic conditions, 
there was an increase of HIF-1a 
mRNA compared to untreated 
control cells. 
*Hypoxia for 12 hrs followed by 
reoxygenation for 24 hrs increased 
mRNA expression of CTGF and 
increases the expression of 
fibronectin and collagen type IV. 
 
RPE of choroidal 
neovascularization membranes. 
*Immunohistochemical studies 
demonstrated elevated 
extracellular matrix-associated 
PAI-1 staining after hypoxic 
conditions, supporting the 
involvement of HIF-1a in hypoxia-
induced PAI- 1 gene expression in 
RPE cells. 
*Antioxidants had no influence 
on the hypoxia-mediated increase 
of CTGF and PAI-1, but did block 
the hypoxia/ 
reoxygenation-mediated up 
regulation. 
* Hypoxia & 
hypoxia/reoxygenation 
increased profibrinogenic factors 
and ECM components in cultured 
RPE cells.  
*Hypoxia and hypoxia/ 
reoxygenation might be involved 
in ECM accumulation in the RPE 
as seen in early AMD 
Antioxidant N-Acetyl 
Cysteine Protects Retinal 
Pigmented Epithelial Cells 
from Long-Term Hypoxia 
Changes in Gene 
Expression. 
Gerona et al 2010 
*6 eyes from 6 
donor cows- RPE  
isolated using 
standard 
techniques for 
cellular dislocation 
and isolation. 
 
*Total RNA was extracted using 
the GenElute Mammalian Total 
RNA Miniprep Kit. 
8Exposed to 3% o2 for 72 hrs. 
*Controls without treatment were 
maintained in hypoxic and 
normoxic conditions. 
*After 72 hrs hypoxia p53 
expression levels increased, 
suggests p53 dependant apoptosis 
induced by long term hypoxia in 
the RPE. 
* no significant expression found 
in either hypoxia or NAC-treated 
cells for p53 effector gene bax,. 
* p53 causes cell death by directly 
inducing mitochondrial 
permeability and apoptosis, 
independent of the 
transcriptional up-regulation of 
proapoptotic genes  
*Cell death produced by hypoxia 
in RPE may be mediated by 
 
301 
*10mM NAC added to culture 
before induction of hypoxia and 
maintained during hypoxic 
stimulus. 
* CASP8 mRNA showed a sig 
higher expression level in hypoxia- 
but not in NAC-treated cells.  
 
initiator caspase 8, as values for 
CASP8 were also increased under 
hypoxia conditions and normal in 
NAC-treated cells. 
Topographic variation of 
the choroidal watershed 
zone and its relationship to 
neovascularization in 
patients with age-related 
macular degeneration. 
Mendrinos 2009 
*50 ICG video-
retinograms of 50 
pxs with wet AMD 
and watershed 
zones (retinl 
angiomatous 
proliferation inc) 
* 20 men/30 
women,  
*Videos reviewed  *  60% pxs had stellate wz- in 
these pxs the cnv occured In the 
centre of the wz 
*vertical wz 36% pxs- 3 subgroups 
 (50%) had a vertical zone through 
the ONH with a portion extending 
into the fovea. In these cases, CNV 
occurred at the part extending into 
the fovea. In (33.3%) patients, the 
vertical zone coursed through the 
ONH with-out extending into the 
fovea 
In these cases CNV occurred at the 
temporal margin of the WZ and 
extended away from it towards 
the fovea. In 16.7% patients the 
vertical zone coursed through the 
fovea without involving the ONH- 
In these cases CNV occurred within 
the wz 
* An angle-shaped WZ coursing 
through the ONH and the fovea in 
4% patients in both cases, CNV 
occurred within the WZ. 
* Choroidal neovascularization 
occurred within the WZ in 44 of 
50 (88%) patients (whenever it 
coursed through or extended into 
the fovea). 
* Even when the WZ did not 
involve the fovea, a portion of it 
always involved at least part of 
the macular region (i.e. either the 
temporal peripapillary choroid or 
the maculopapillary bundle). 
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Geldanamycin, a HSP90 
inhibitor, attenuates the 
hypoxia-induced vascular 
endothelial growth factor 
expression in retinal 
pigment epithelium cells in 
vitro. 
Wu et al 2007 
*A human RPE cell 
line was primarily 
isolated from a 
donor eye. 
* For details on method for 
hypoxic treatment/heat shock 
treatment/assays and analysis see 
text  
*1% O2 of hypoxic tension 
increased the VEGF gene 
expression 3.4-fold.  
*VEGF levels in hypoxia-
conditioned media after 24 h are 
sig higher. 
*VEGF165, but not VEGF121 could 
be induced by HS treatment under 
both normoxia and hypoxia. 
*Hypoxia can stimulate RPE cell 
proliferation and prime cells to 
respond to exogenous growth 
factors. 
*HSP induction either facilitates 
the VEGF165 transcription or 
enhances transcript stability, 
promoting VEGF production. 
*First report that a pretreatment 
with GA can significantly suppress 
the VEGF gene expression in 
cultured RPE cells 
*We only tested the short-term 
GA effect in this in vitro study; 
whether GA treatment for longer 
periods generates a deleterious 
side effect deserves to be further 
investigated. 
*Pretreatment with HSP90 
inhibitor significantly attenuates 
the de novo VEGF production in 
RPE cells under hypoxia. 
Association of Risk Factors 
for Choroidal 
Neovascularization in Age-
Related Macular 
Degeneration With 
Decreased Foveolar 
Choroidal Circulation 
Grunwald et al 2010. 
*273 study eyes of 
204 AMD patients 
investigated.  
*No exudative 
AMD or other 
ocular pathology 
*Laser Doppler flowmetry 
measurements of relative 
choroidal blood velocity, choroidal 
blood volume (ChBVol), and 
choroidal blood flow (ChBFlow) 
obtained. 
*Choroidal blood flow was 
calculated. 
 
*A significant inverse correlation 
was observed between ChBVol 
and ChBFlow and age. 
*A significant inverse correlation 
was observed between spherical 
equivalent and ChBflow and 
ChBVol. 
 
* AMD patients showed 
decreasing choroidal blood flow 
and volume, but not velocity, 
with increasing age are consistent 
with those of our previous study 
in normal subjects. 
* The presence of 
decreased choroidal blood 
volume and choroidal blood 
flow in the patients with history 
of SHTN suggests that an ischemic 
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mechanism may be involved in 
the cause of this disease. 
Choroidal filling in age-
related macular 
degeneration: indocyanine 
green angiographic 
findings. 
Giovanni 1994 
*145 AMD eyes * abstract only *a correspondence in 71% of cases 
between the site of the CNV and 
watershed areas and in 59% of 
cases between the CNV and areas 
of 'delayed choroidal filling'. 
*These data support the 
hypothesis of a relationship 
between areas of presumed 
choroidal ischemia and evolution 
of AMD complicated with CNV. 
**Possibly, choroidal blood flow 
decreases may lead to imbalances 
in choroidal watershed vascular 
filling zones, the areas most 
prone to develop ischemia and 
hypoxia. 
 
Reduced Foveolar 
Choroidal Blood Flow in 
Eyes with Increasing AMD 
Severity 
Grunwald 2005 
* 26 control eyes 
of 17 normal 
subjects and 163 
eyes with early 
AMD. 
*AMD study eyes 
were divided into 
three groups 
according to 
increasing risk for 
development of 
CNV 
*Laser Doppler flowmetry was 
used to assess relative foveolar 
choroidal blood velocity (ChBVel), 
volume (ChBVol), and flow 
(ChBFlow). 
*Mean ChBVel, ChBVol, and 
ChBFlow decreased with increased 
risk for CNV 
*There is a systematic decrease in 
choroidal circulatory parameters 
with an increase in the severity of 
AMD features associated with risk 
for the development of CNV, 
suggesting a role for ischemia in 
the development of CNV. 
Deep retinal vascular 
anomalous complexes in 
advanced age-related 
macular degeneration. 
Hartnett 1996 
*11 patients (14 
eyes) with AMD 
*clinical and fluorescein 
angiography descriptions, infrared 
imaging and indocyanine green 
angiography 
*Each study eye had a clearly 
defined anastomosis connecting 
the retinal circulation to a vascular 
complex in the deep retina 
*In seven eyes with RVACs, there 
were clinically recognizable 
retinovascular findings: 
*These results indicate that 
retinovascular changes can be 
associated with nondisciform 
AMD. The authors speculate that 
neurodegenerative changes and 
hypoxia may lead to such changes 
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intraretinal hemorrhages, 
telangiectasia, or microaneurysms 
Role of hypoxia and 
extracellular matrix-
integrin binding in the 
modulation of angiogenic 
growth factors secretion by 
retinal pigmented epithelial 
cells. 
Mousa 1999 
* Human RPE cells 
were cultured 
from post-mortem 
eyes 
* Extensive- see paper- antibody 
blocking experiments 
*Hypoxia Increases Levels of VEGF  
*FGF2 decreased with hypoxia 
*RPE cells under hypoxic 
conditions demonstrated time-
dependent linear increase in VEGF 
in their media, 
*Deposition of TSP1 and/or other 
ECM proteins in drusen or 
thickened Bruch’s membrane in- 
patients with AMD could 
potentially modulate the 
secretion of angiogenic growth 
factors by RPE cells and could 
play a role in the development of 
choroidal neovascularization. 
 
Synthesis and secretion of 
hemoglobin by retinal 
pigment epithelium. 
Tezel 2009 
* 10 donor eyes * Proteomic analysis *Immunohistochemistry revealed 
the presence of haemoglobin 
within RPE and Bruch’s 
membrane. The haemoglobin 
release rate was calculated to be 
1.9  1.2 attomoles per cell per 
hour. 
*Hemoglobin expression by 
human RPE brings a new 
perspective to the understanding 
of oxygen transport to the outer 
retina. Malfunction of RPE-
hemoglobin production may 
underlie the pathophysiology of 
ocular diseases characterized by 
subfoveal hypoxia and VEGF 
upregulation, 
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Hypoxia specific SDF-1 
expression by retinal 
pigment epithelium 
initiates bone marrow-
derived cells to participate 
in Choroidal 
neovascularization in a 
laser-induced mouse 
model. 
Zhang 2011 
* 1-mice 
2- Human RPE cells 
cultured under 
chemical hypoxia 
* 1-Lazer CNV induced then tissue 
processed for 
immunofluorescence 
* RNAi technique was used to 
knock down HIF-1α gene to 
observe the expression of HIF-1α 
and SDF-1 in hRPE cells 
*2- hypoxia specific-HIF-1α 
influenced SDF-1 expression in 
hRPE cells.  
* suggests that hypoxia-induced 
SDF-1 expression in RPE might be 
a critical initiator for recruitment 
of BMCs in CNV. SDF-1 might be 
another important factor in 
BMCs’ differentiation into 
endothelial cells to participate in 
the CNV 
Ocular rigidity in patients 
with age-related macular 
degeneration. 
Pallikaris 2006 
* AMD group: 16 
with neovascular 
and 16 with non 
neovascular AMD 
and 44 age-
matched control 
patients 
* Ocular rigidity measurement 
device used 
* No statistically significant 
difference in ocular rigidity 
measurements between patients 
with AMD and control subjects. 
* When examined separately the 
two subgroups of patients with 
AMD, the average ocular rigidity 
measurements were higher in 
patients with neovascular AMD vs 
both control subjects and patients 
with non neovascular AMD 
* increasing ocular rigidity could 
be an important component of 
the pathophysiologic cascade of 
neovascular AMD. It still remains 
to be elucidated whether 
hampered ocular rigidity is 
causative or reflects an event that 
results from the treatment or the 
changes that occur with aging and 
is accentuated in AMD 
Pulsatile ocular blood flow 
study: decreases in 
exudative age related 
macular degeneration 
Mori 2001 
* 10 patients with 
non-exudative 
AMD, 11 patients 
with exudative 
AMD, and 69 age 
matched controls. 
* POBF, pulse amplitude (PA), 
systolic and diastolic blood 
pressures, intraocular pressure 
(IOP), refractive error, and axial 
length were compared 
* No significant differences were 
found in age, systolic and diastolic 
blood pressures, IOP, or refractive 
error between patients with 
exudative and non- exudative 
AMD and control subjects. 
* In the patients with exudative 
AMD the POBF and PA were 
significantly lower than in the 
*These data show that the POBF 
and PA exudative AMD pxs are 
lower than in the px with non-
exudative AMD and normal 
subjects. Decreased choroidal 
blood flow may have a role in the 
development of 
choroidal neovascularisation in 
AMD 
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patients with non- exudative AMD 
and control subjects  
Pulsatile ocular blood flow 
in asymmetric exudative 
age related macular 
degeneration. 
Chen 2001 
* 37 patients with 
asymmetric 
exudative AMD 
* pulsatile ocular blood flow 
measured in both eyes of each 
subject. 
* Adjusted for ocular perfusion 
pressure, IOPs, and pulse rate 
* POBF was significantly higher in 
eyes with CNV than the 
contralateral eyes with drusen  
* Eyes with disciform scar had 
lower POBF than the contralateral 
eyes with drusen 
* There was no significant 
correlation between the POBF and 
the lesion size of the CNV 
* The POBF in eyes with drusen 
was lower than their fellow eyes 
with CNV, but higher than their 
fellow eyes with disciform scar. 
This finding suggests that 
haemodynamic differences 
between fellow eyes in 
individuals are relevant to the 
development of CNV and the 
formation of disciform scar 
Retinal haemodynamics in 
patients with age-related 
macular degeneration 
Sato 2006 
* 25 eyes of 25 
patients with AMD 
and nine eyes of 
nine age-matched 
control subjects 
* retinal laser Doppler system 
measured  pulsatility ratio (PR), 
the pulsatility index (PI), 
and the resistivity index (RI)  
* PR, PI, and RI in the patients with 
AMD were each significantly 
higher than in the control group, 
and increased monotonically with 
increasing severity of AMD 
* no differences in mean blood 
velocity, arterial diameter, or 
blood flow rate among the groups 
* This suggests that the increased 
blood flow pulsatility in the 
retinal arteries of the eyes with 
AMD is not due to increased 
distal vascular resistance, but 
instead is likely due to a loss of 
compliance in the arterial 
vasculature leading to the eye. 
* increasing vascular rigidity in 
the systemic arterial circulation is 
directly associated with an 
increasing severity of AMD. 
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Color Doppler Imaging of 
Choroidal Circulation in 
Patients with Asymmetric 
Age-Related Macular 
Degeneration 
Üretmen 2003 
* 26 patients who 
had non-exudative 
AMD in the first 
eye and CNV 
secondary to AMD 
in the fellow eye 
* Blood flow velocities, vessel 
pulsatilities and resistivities were 
measured from ophthalmic artery, 
nasal and temporal posterior 
ciliary arteries using colour 
Doppler imaging 
* Systolic and diastolic velocities 
were lower in eyes with CNV for all 
vessels, except for the systolic 
velocity of the nasal posterior 
ciliary artery. 
* Pulsatility and resistivity indices 
were higher in eyes with CNV for 
all vessels.  
* Impaired choroidal blood flow 
in AMD 
*choroidal blood flow is more 
impaired in eyes with AMD in 
CNV eyes than in fellow eyes. 
 
Expression of hypoxia-
inducible factor-1alpha and 
-2alpha in human choroidal 
neovascular membranes. 
Sheridan 2009 
 
 
 
 
 
 
 
 
*12 surgically 
excised subfoveal 
CNV secondary to 
AMD (n=9) or 
punctate inner 
choroidopathy 
(PIC) were 
obtained during 
pars plana 
microsurgery. 26 
Normal human 
eyes  
* samples immunohistochemically 
probed with monoclonal 
antibodies against HIF−1α and 
−2α and compared to that for cell 
markers specific for vascular 
endothelial cells (CD34), 
macrophages (CD68), retinal 
pigment epithelial cells (RPE; 
panel cytokeratins/CK18) and 
VEGF. Following secondary 
antibody amplification, reactions 
were visualized with fast red 
chromogen 
*Cellular immunoreactivity of 
membranes for HIF−2α was strong 
in eight out of nine AMD 
specimens but it was only weakly 
positive for HIF−1α in 
fivespecimens. In contrast, two 
out of three PIC specimens were 
weakly positive for HIF−1α but 
demonstrated no staining for 
HIF−2α. 
*Immunohistochemical analysis 
revealed areas within the CNV 
membranes that were 
predominantly immunopositive for 
CD68 and cytokeratin indicating 
the presence of RPE and/or 
macrophages and that these cells 
strongly co-localized with the 
presence of HIF and VEGF. 
*The localization of HIF 
expression supports the concept 
that hypoxia is a major stimulus 
for the development of 
submacular wound healing and 
within this context CNV is but one 
component of this process. 
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The role of the p53 protein 
in the selective 
vulnerability of the inner 
retina to transient 
ischemia. 
Rosenbaum et al. 1998 
*Sprague-Dawley 
rat. 
*Transient retinal ischemia was 
induced using a high intraocular 
pressure (HIOP) model for 60 
minutes. *Histopathologic 
outcome 7 days after ischemia.  
* analysis for evidence for 
apoptosis (TdT-dUTP terminal 
nick-end label [TUNEL] staining) 
and p53 protein expression 
performed at several points 
during reperfusion period. 
*Also wild-type mice, one 
homozygous and the other 
heterozygous for the p53 null 
gene, subjected to HIOP for 60 
minutes, and histopathology 7 
days later. 
* marked thinning of inner retinal 
layers 7 days after ischemia.  
* p53 immunochemistry- elevated 
protein levels within the inner 
retina peaking 24 to 48 hours but 
was no longer present at 4 days 
after ischemia.  
*7 days subsequent to 60 minutes 
of ischemia in wild-type and 
transgenic mice, histopathologic 
evaluation demonstrated 
preservation of the retinal 
histoarchitecture in the 
heterozygous group compared 
with the wild-type or homozygous 
animals 
* Supports the hypothesis that 
the delayed cell death that occurs 
after transient retinal ischemia is, 
in part, apoptotic.  
*Suggest a role for the p53 
protein in the selective 
vulnerability of the inner retina to 
transient ischemia. p53 protein 
may be a target for future 
therapeutic agents. 
Foveal electroretinograms 
and choroidal perfusion 
characteristics in fellow 
eyes of patients with 
unilateral neovascular age-
related macular 
degeneration. 
Remula et al 1995 
 
Fellow eyes of 67 
patients with 
unilateral nAMD.  
Fluorescein angiograms and foveal 
cone ERGs recorded in  
*42% of the eyes had choroidal 
perfusion defect. ERG implicit 
times averaged 1 ms slower 
(p=0O0167) in eyes with abnormal 
choroidal perfusion  
delayed ERG implicit time with 
prolonged choroidal filling 
remained after controlling for age, 
acuity & drusen.  
*there is prolinged choroidal 
filling in fellow eyes of nAMD. 
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Functional loss in age-
related Bruch's membrane 
change with choroidal 
perfusion defect. 
Chen et al (1992) 
* eyes which had 
delayed and 
prolonged 
choroidal filling, 6 
controls 
Scotopic thresholds measured 
with Humprey perimeter and 
compared with area of perfusion 
defect. 
* In eyes without delayed 
choroidal perfusion, no discrete 
areas of increased ST.  
*In 7/8 eyes with prolonged 
choroidal filling, discrete areas of 
scotopic threshold elevation of up 
to 3.4 log units were recorded and 
these corresponded to regions of 
choroidal perfusion abnormality.  
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11 Appendix III Matlab code for 
scotopic threshold program. 
% Annulus THRESHOLD: YES/NO, QUEST 
% 
% This programme uses a YES/NO, QUEST driven staircase to determine 
contrast  
% thresholds for an annulus.  
% The code is adapted from Gaboiumdemo, kbDemo and QuestDemo. 
% Ver. 1: Tom Margrain on 28-11-12. This was a 2 IFC version.MattTom 
QUEST 
% results 
% Issues: the frame refresh rate is 60Hz on the laptop but for some 
reason 
% it reduces significantly from time to time; I guess other programmes 
% running the background are stealing resources. If this happens the 
% stimulus will be flickering more slowly than expected. The main 
problem 
% seems to be for the first presentation, after that things are 
generally 
% better. 
% Ver. 8 - Fully working 2 IFC programme. Only altered to Ver. 9 
because 2 
% IFC may be tricky for patients 
% Ver. 9 - Here the programme is altered from 2 IFC to a Yes/No 
% Ver. 10 - Now pushing the response key during the presentation 
should 
% work too + keep track of false positives + improve the 'feel' by 
altering 
% the timing of presentations 
% Ver. 11 - implements a 'simple gamma correction' using code from the 
online 
% AdditiveBlendingForLinearSuperpositionTutorial. The important lines 
of 
% code that were not used before include  
% PsychImaging('AddTask', 'General', 'EnablePseudoGrayOutput') - this 
line 
% lets us call up all screen output in the range 0-1 (0-100%) rather 
than 
% grey scale.  
% PsychImaging('AddTask', 'FinalFormatting', 'DisplayColorCorrection', 
'SimpleGamma'); 
% This line sets up simple gamma correction in the video output 
'pipeline' 
% PsychColorCorrection('SetEncodingGamma', win, gamma); So, all output 
is 
% gamma corrected automatically. 
% This version also allows the 'blob' to occupy a 0-1 range rather 
than 
% 0-0.5 (line 130). It also changes the slightly misleading variable 
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% "contrast" to the more accurate "luminance" i.e. the output is 
threshold 
% luminance (lines 167, 173). The final output (threshold) is log 
luminance  
% as a fraction of the max screen luminance in cd/m2. 
% Ver. 12 - This version is a modification of the 14Hz flicker code I 
wrote 
% for Claire. It produces an annulus and fixation cross. There is some 
% redundant code. This programme is only to show how to do these 
things it 
% is not a calibrated programme to be used in experiments.  
% Ver. 13 - the output (i.e. final threshold) is the log of the 
normalised 
% stimulus intensity without any adjustment for the number of filters 
over 
% the top. 
% Ver. 14 - the print out to Excel now included a conversion back to 
cdm-2, 
% it should also print out the SD for the threshold but, I think i 
have a 
% mistake in here the SD is way too large!  
  
% INSTRUCTIONS 
% 1)This programme needs to write to an Excel file. 
% 2)Tell subject the expt last 3.5 minutes (40 trials). 
% 3)The task is to push any button when a flickering stimulus is seen. 
  
% First, set up all the relevant parameters 
trialsDesired = 40; % number of times a choise is offered 
wrongRight={'wrong','right'}; % this is used at the end of each trail 
to identify the response 
stimFreq = 14; % temporal frequency of flickering gabor in Hz 
screenMax = 122; % this it the measured maximum luminance of the 
screen in cdm-2 
KbName('UnifyKeyNames'); 
escapeKey = KbName('ESCAPE'); 
format compact 
avgfps = []; 
contrastPresent = [];    
falsePositive = 0; % used to count false positive responses 
%contrast = 1; 
% PTB-3 correctly installed and functional? Abort otherwise. 
AssertOpenGL; 
Screen('Preference', 'SkipSyncTests',1) % this is not a good line to 
have, only used because using 2 monitors 
% This programme uses Psychophysics QUEST routines to determine 
threshold 
% to get these to work it is necessary to provide information about 
the 
% threshold we are looking for in particular an initial guess at the 
% treshold and the standard deviation 
% Provide our prior knowledge to QuestCreate, and receive the data 
struct "q". 
participant=[]; 
while isempty(participant) 
    participant=input('Subjects name please: ', 's'); 
end 
tGuess=[]; 
while isempty(tGuess) 
    tGuess=input('Estimate threshold (e.g. -1): '); 
end 
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tGuessSd=[]; 
while isempty(tGuessSd) 
    tGuessSd=input('Estimate the standard deviation of your guess, 
above, (e.g. 2): '); 
end 
pThreshold=0.82; 
beta=3.5;delta=0.01;gamma=0.5;% These values may not be right for yes 
/no 
% beta controls the steepness of the psychometric function. Typically 
3.5. 
% delta is the fraction of trials on which the observer presses 
blindly. Typically 0.01. 
% gamma is the fraction of trials that will generate response 1 when 
intensity==-inf. 
q=QuestCreate(tGuess,tGuessSd,pThreshold,beta,delta,gamma); 
q.normalizePdf=1; % This adds a few ms per call to QuestUpdate, but 
otherwise the pdf will underflow after about 1000 trials. 
  
% Use try and catch to rescue code from a crash 
try 
  
% Select screen with maximum id for output window: 
screenid = max(Screen('Screens')); 
  
% Open a fullscreen, onscreen window with gray background. Enable 
32bpc 
% floating point framebuffer via imaging pipeline on it, if this is 
possible 
% on your hardware while alpha-blending is enabled. Otherwise use a 
16bpc 
% precision framebuffer together with alpha-blending. We need alpha-
blending 
% here to superimpose the gabor blob on the background. The programme 
will 
% abort if your graphics hardware is not capable of any of this. 
PsychImaging('PrepareConfiguration'); 
%PsychImaging('AddTask', 'General', 'FloatingPoint16Bit'); 
PsychImaging('AddTask', 'General', 'FloatingPoint32BitIfPossible'); 
% Enable bitstealing aka PseudoGray shader: This line is needed so 
that 
% subsequent screen output is in the range 0-1 i.e. up to 100% of 
screen output. No need to call grey levels.  
% It also increase the number of grey scales that can be generated 
PsychImaging('AddTask', 'General', 'EnablePseudoGrayOutput'); 
% Sets up the final video output pipeline to include gamma correction 
PsychImaging('AddTask', 'FinalFormatting', 'DisplayColorCorrection', 
'SimpleGamma'); 
% Finally open a window according to the specs given with above 
% PsychImaging calls, clear it to a background color of 0.5 aka 50% 
% luminance: 
[win, winRect]=PsychImaging('OpenWindow',screenid, 0); 
% This wait allow you to see the 'gamma correction' kick in! First its 
not 
% there, then,.. 
WaitSecs (0.1); 
% OK, now apply the gamma correction to all outputs to the screen, so 
% easy! The default value here is gamma = 2 but need to determine 
exactly 
% what it is for your screen 
gamma = 1 / 2.0; 
PsychColorCorrection('SetEncodingGamma', win, gamma); 
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WaitSecs (0.5); 
  
% Enable alpha-blending, set it to a blend equation useable for linear 
% superposition with alpha-weighted source. This allows to linearly 
% superimpose gabor patches in the mathematically correct manner, 
should 
% they overlap. Alpha-weighted source means: The 'globalAlpha' 
parameter in 
% the 'DrawTextures' can be used to modulate the intensity of each 
pixel of 
% the drawn patch before it is superimposed to the framebuffer image, 
ie., 
% it allows to specify a global per-patch contrast value: 
Screen('BlendFunction', win, GL_SRC_ALPHA, GL_ONE); 
  
% Query frame duration: We use it later on to time 'Flips' properly 
for an 
% animation with constant framerate: 
ifi = Screen('GetFlipInterval', win); 
  
% Create a gabor patch: This is 100x100 matrix that has periperal 
values 
% around zero and a central value of 1. The gray scale range of the 
monitor 
% is 1 at the centre of the gabor. 
%[x,y] = meshgrid(-10:10, -10:10); 
%whiteBlob = (exp(-((x/40).^2)-((y/40).^2))) 
  
%Create an annulus 
[x,y] = meshgrid(-263:263, -263:263); 
    circle1 = 1 * (x.^2 + y.^2 <= (263)^2); 
    circle2 = 1 * (x.^2 + y.^2 <= (253)^2); 
    rawAnnulus = circle1-circle2; 
  
% Create blob movie, first determine frame rate 
rate = 1/ifi; 
  
% Determine number of frames avaliable for a given stimulus frequency 
framesAvaliable = rate/stimFreq; 
  
% Determine the step size to get through 360 degrees (1 cycle) in the 
% number of frames valiable 
step = 360/framesAvaliable; 
  
% Set up degrees, start a zero and increment in the loop according to 
the 
% step size 
x=-180; 
  
% Get the time at the very start to record the total experimental time 
exptStart = Screen('Flip', win); 
  
% Introduce experiment wait for signal to start 
%Screen('FrameRect', win ,[0,128,0], [540,300,740,500],1); 
Priority(2);% Uprate the priority for Matlab i.e. try to keep Windows 
out! 
Screen('DrawText', win, 'PUSH THE BUTTON WHEN YOU SEE THE RING', 350, 
383, [1,1,1]); 
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Screen ('Flip', win); 
WaitSecs (3); 
Screen('HideCursorHelper', win); 
Screen ('Flip', win); % Flipping removes the text from the screen 
  
Screen('DrawLine', win, [1,1,1], 640, 212, 640, 812,8); 
Screen('DrawLine', win, [1,1,1], 340, 512, 940, 512,8); 
Screen ('Flip', win); % Flip the fixation cross onto the screen 
  
% NOW WE CAN IMPLEMENT THE MAIN EXPT LOOP 
  
for k=1:trialsDesired; 
  
    % First pick up the threshold recommened by QUEST 
    tTest=QuestQuantile(q); % Recommended by Pelli (1987). 
  
    % Unlog tTest, this controls the luminance of the stimulus 
    luminance = 10^tTest; 
  
    % Generate the textures to be displayed during each frame, assume 
60Hz so 
    % going from 1 to 120 will be a 2s presentation 
    for i=1:120; 
        %Need to change contrast to a fraction 
        annulus = rawAnnulus * (luminance);% * sind(x); 
        gabortex(i)=Screen('MakeTexture', win, annulus, [], [], 2); 
        x=x+step; 
    end;     
     
    % Wait a random period of time before giving the presentation 
    randomdelay = rand*6; 
    StartSecs = GetSecs; 
    timeNow=0; 
    while timeNow <randomdelay  
        SecsNow = Getsecs; 
        timeNow = (SecsNow - StartSecs); 
        [ keyIsDown, timeSecs, keyCode ] = KbCheck; % this command 
checks the keyboard for an input 
        if keyIsDown % if a key is pushed this is what to do 
            falsePositive = falsePositive+1;% counts the incorrect 
responses  
            Beeper(400)  
            while KbCheck; end % this avoids KbCheck reporting 
multiple events 
        end 
    end      
     
    % Clear the screen and wait a bit 
    %Screen ('Flip', win); 
    %Screen('FrameRect', win, [200,200,200], [540,300,740,500]); 
    %Screen('DrawLine', win, [1,1,1], 640, 100, 640, 700); 
    %    Screen('DrawLine', win, [1,1,1], 340, 400, 940, 400); 
         
    response = 0; % This flag holds a record of if the stimulus is 
seen or not, 0=not seen 
    count = 0; % This is needed to count the number of presentations 
    vbl = Screen('Flip', win); 
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    tstart = vbl; % records the time the main presentation loop 
started 
  
    for i=1:120; 
        Screen('DrawLine', win, [1,1,1], 640, 212, 640, 812,8); 
        Screen('DrawLine', win, [1,1,1], 340, 512, 940, 512,8); 
        %Screen('DrawText', win, 1,0 ,0, [200,200,0]);    
        Screen('DrawTexture', win, gabortex(i),[],[],45); 
        % Check the frame presentation time, does it always match the 
        % frame referesh rate? 
        vbl = Screen('Flip', win, vbl + ifi/2); 
        %frametime(i)=vbl-lastTime;% puts frame time (ms) into an 
array 
        lastTime = vbl; 
        count = count+1; %Will count up to 120 
        % check for keyboard response during presentation 
        [ keyIsDown, timeSecs, keyCode ] = KbCheck; % this command 
checks the keyboard for an input 
        if keyIsDown % if a key is pushed this is what to do 
            response=1;% flags a correct response  
            break % breaks out of the presentation loop 
        end 
    end; 
     
    % Clear the screen of any residual gabor and get time stamp 
        Screen('DrawLine', win, [1,1,1], 640, 212, 640, 812,8); 
        Screen('DrawLine', win, [1,1,1], 340, 512, 940, 512,8); 
     
    tend = Screen ('Flip', win); % records the time the presentation 
stopped 
     
    % Check frames per second for this trial, store result in array 
avgfps 
    avgfps(k) = count / (tend - tstart); 
     
    % Now get the participants response 
    ResponseSecs = GetSecs;% gets the time the stimulus was flipped 
out 
             
    % Wait for a response for three seconds, if in the 1st second = 
correct 
    while 1 
        [ keyIsDown, timeSecs, keyCode ] = KbCheck; % this command 
checks the keyboard for an input 
        if keyIsDown % This bit of code is only executed if a button 
is pushed 
            fprintf('"%s" typed at time %.3f seconds\n', 
KbName(keyCode), timeSecs - exptStart) %ResponseSecs); 
            if (timeSecs - ResponseSecs)<1; % checks that response was 
within 1s of stimulus offset 
                response = 1; %this 'flag' means the response was 
correct 
                Beeper (1000) % make a 'beep' sound 
                 
            else 
                response = 0; %this means the response was incorrect 
(in this case too slow) 
                Beeper (600) 
                falsePositive = falsePositive+1;% counts the incorrect 
responses 
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                break 
            end 
  
            %while KbCheck; end % this avoids KbCheck reporting 
multiple events 
            break 
        end 
  
        % Now, if no button push + long wait, time is up! 
        SecsNow = GetSecs; 
        timeSincePresentation = (SecsNow - ResponseSecs); 
        if timeSincePresentation > 4; % If no response within 1s of 
stimulus, its missed, get out of loop 
            fprintf('stuck in loop') %ResponseSecs); 
            break 
             
        end % waiting for repsonse or time up 
         
        %while KbCheck; end % this avoids KbCheck reporting multiple 
events 
     
    end 
  
    % Print the results for this particular trial 
    fprintf('Trial %3d at %5.2f is 
%s\n',k,tTest,char(wrongRight(response+1))); 
    LuminancePresent(k)=tTest; 
    ResponseArray(k)=response; %this keeps track of right / wrong 
responses 
    LuminancePresentCdM2(k) = log10((10^tTest)*screenMax); 
     
    % Now update the QUEST routines with the last threshold value 
(this is all 
    % in logs) and let it know if the participant responded correctly 
(1) or 
    % incorrectly (0) 
    q=QuestUpdate(q,tTest,response); % Add the new datum (actual test 
intensity and observer response) to the database. 
  
    % Close all the windows that were opened for this presentation 
    Screen ('Close'); 
  
    % Now go back for the next trial 
end 
  
% Display cursor again now its all over 
Priority(0);% Resest normal priority 
Screen('ShowCursorHelper', win); 
  
% Ask Quest for the final estimate of threshold. 
t=QuestMean(q);     % Recommended by Pelli (1989) and King-Smith et 
al. (1994). Still our favorite. 
sd=QuestSd(q); 
  
fprintf('Final threshold estimate (mean±sd) is %.2f ± %.2f\n',t,sd); 
fprintf('68 percent sure true mean is between %.2f and %.2f\n (mean 
+/-SD)', (t+sd),(t-sd)); 
  
% Determine total experimental time and print this out 
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exptEnd = Screen('Flip', win); 
exptTotal = exptEnd - exptStart 
  
% Print out the frame per sec for each trial 
%avgfps; 
  
% Print out the number of false positives 
falsePositive 
  
% Close onscreen window, release all ressources: 
Screen('CloseAll'); 
  
% The presentation rate has been a problem / variable so, these lines 
are 
% used to plot frame time. 
figure(1) 
k=1:trialsDesired; 
plot (k,avgfps) 
xlabel ('Trial') 
ylabel ('Frames / sec') 
  
% Plot the stimuli presented 
figure(2) 
k=1:trialsDesired; 
plot (k,LuminancePresent, 'ob') 
xlabel ('Trial') 
ylabel ('Log luminance') 
  
% Dump all the QUEST data to Excel 
LuminancePresent = LuminancePresent(:); % This (:) changes the vector 
from a row to a column 
trialNumber = k(:); 
today = now; % this is a weird number that represents the current date 
and time, Excel understands! 
name ={participant}; 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', today,'Sheet1','B4'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', today,'Sheet1','B5'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', name,'Sheet1','B3'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', exptTotal,'Sheet1','F3'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', trialNumber,'Sheet1','A11'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', LuminancePresent,'Sheet1','B11'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', t,'Sheet1','F5'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', sd,'Sheet1','F6'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', falsePositive,'Sheet1','F7'); 
  
% Dump all the Luminance (cd/m2) data to Excel 
% Convert QUEST thresholds to cdm-2 thresholds 
LuminancePresentCdM2 = LuminancePresentCdM2(:); 
luminanceThreshold = log10((10^t)*screenMax); 
UpperSE=t+sd; 
LowerSE=t-sd; 
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luminanceThresholdUpperSE = log10((10^UpperSE)*screenMax); 
luminanceThresholdLowerSE = log10((10^LowerSE)*screenMax); 
  
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', today,'Cdm2','B4'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', today,'Cdm2','B5'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', name,'Cdm2','B3'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', exptTotal,'Cdm2','F3'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', trialNumber,'Cdm2','A11'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', LuminancePresentCdM2,'Cdm2','B11'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', luminanceThreshold,'Cdm2','F5'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', sd,'Cdm2','F6'); 
xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', falsePositive,'Cdm2','F7'); 
%xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', luminanceThreshold,'Sheet1','J5'); 
%xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', luminanceThresholdUpperSE,'Cdm2','J6'); 
%xlswrite('d:\Tamsin 2013 visit 1\QUEST annulus\QUEST 
results\OriginalResults.xls', luminanceThresholdLowerSE,'Cdm2','J7'); 
  
% All done, phew! 
catch % The following code is run if the experiment crashes  
    Screen('CloseAll'); 
    rethrow(lasterror); 
    psychrethrow(psychlasterror);  
end 
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